id,generic_name,company_name,contact_info,presentation,update_type,update_date,availability,related_info,resolved_note,reason_for_shortage,therapeutic_category,status,change_date,date_discontinued
7161,Abiraterone Acetate Tablets,"Janssen Research and Development, LLC",800-526-7736,250 mg tablets (NDC 57894-155-12),New,6/5/20,,,,,Oncology,To be Discontinued,,
7162,Acetaminophen (Ofirmev) Injection,Mallinckrodt,800-325-8888,"OFIRMEV® (Acetaminophen) Injection 1 g/100 mL (10 mg/mL), (NDC 43825-102-01, 43825-102-03)",New,6/9/22,,,,,Analgesia/Addiction,To be Discontinued,,
7163,Acetazolamide Injection,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,500 mg (NDC 23155-313-31),Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,
7164,Acetazolamide Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50)",Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,
7165,Acetazolamide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9503-01),Revised,6/17/22,This presentation is temporarily on backorder.,,,,Cardiovascular;Ophthalmology,Resolved,,
7166,Acetazolamide Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,500mg per vial (NDC 39822-0190-1),Revised,6/17/22,Available,,,,Cardiovascular;Ophthalmology,Resolved,,
7167,Acetic Acid Otic Solution,Wockhardt Bio A.G.,847-410-6929,"2% 15ml, (NDC 60432-741-15)",New,6/22/22,,,,,Anti-infective,To be Discontinued,,
7168,Acrivastine and Pseudoephedrine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)",New,6/2/20,,,,,Pulmonary/Allergy,To be Discontinued,,
7169,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02),New,7/27/20,,,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,,
7170,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02),New,7/27/20,,,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,,
7171,Adefovir Dipivoxil Tablets,"Gilead Sciences, Inc.",800-445-3235,10mg  (NDC 61958-0501-1),New,8/1/22,,,,,Antiviral,To Be Discontinued,8/1/22,8/1/22
7172,Adenosine Injection,Hospira,844-646-4398,90 mg/30 mL (3 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1932-02),New,6/28/22,,,,,Cardiovascular,To be Discontinued,,
7173,Adenosine Injection,Teva,800-545-8800,NDC 0703-8776-01 (60 mg/20 mL (3 mg/mL)),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiovascular,To be Discontinued,8/11/22,8/11/22
7174,Adenosine Injection,Teva,800-545-8800,NDC 0703-8777-01 (90 mg/30 mL (3 mg/mL)),New,8/11/22,,Product is  available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Cardiovascular,To be Discontinued,8/11/22,8/11/22
7175,Adenosine Injection,Hospira,844-646-4398,60 mg/20 mL (3 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1932-01),New,9/12/22,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,9/12/22,9/12/22
7176,"Albuterol Sulfate Aerosol, Metered","Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",90 mcg  (NDC 0254-1007-52),New,7/6/21,,,,,Pulmonary/Allergy,To be Discontinued,,
7177,Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,150 mg / 12.5 mg (NDC 70839-112-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,
7178,Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,150 mg / 25 mg (NDC 70839-125-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,
7179,Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,300 mg / 12.5 mg (NDC 70839-312-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,
7180,Aliskiren and Hydrochlorothiazide Tablets,Noden Pharma,844-399-5701,300 mg / 25 mg; (NDC 70839-325-30),New,12/16/21,,,,,Cardiovascular,To be Discontinued,,
7181,Alprostadil Injection,Teva,800-545-8800,NDC 0703-1501-02 (500 mcg/mL 1 mL Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Pediatric; Cardiovascular,To be Discontinued,8/11/22,8/11/22
7182,Alprostadil Suppository,"Mylan Specialty, a Viatris Company",800-796-9526,125 mcg (NDC 0037-8110-06),New,6/14/21,,,,,Urology,To be Discontinued,,
7183,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 12oz, (NDC 0135-0094-41)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,
7184,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 6oz, (NDC 0135-0094-42)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,
7185,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Chewable Tablet, Regular Strength, 80 mg/1, 14.2 mg/1, 100ct Bottle, (NDC 0135-0096-26)",New,8/6/21,,,,,Gastroenterology,To be Discontinued,,
7186,Amantadine Hydrochloride Capsules,Sandoz,800-525-8747,100 mg capsules  (NDCs 0781-2320-01 and 0781-2320-05),New,7/16/20,,,,,Antiviral;Neurology,To be Discontinued,,
7187,Ambrisentan Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","5 mg (NDC 49884-353-11, 49884-353-62 )",New,12/23/21,,,,,Cardiovascular,To be Discontinued,,
7188,Ambrisentan Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","10 mg (NDC 49884-354-11, 49884-354-62)",New,12/23/21,,,,,Cardiovascular,To be Discontinued,,
7189,Amifostine Injection,"Clinigen, Inc.",877-776-5385,ETHYOL® (amifostine) for injection: 3 x 500 mg vials (NDC 76310-017-50),Reverified,5/16/22,Shortage anticipated from June 2020; Estimated shortage duration:  Unknown,,,Other,Oncology;Other,Current,,
7190,Amikacin Sulfate Injection,Teva,800-545-8800,"NDC 0703-9032-03 (500 mg/2 mL (250 mg/mL), 10 x 2 mL Single Dose Vials)",New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Anti-infective,To be Discontinued,8/11/22,8/11/22
7191,Amikacin Sulfate Injection,Teva,800-545-8800,"NDC 0703-9040-03  (1 g/4 mL (250 mg/mL), 10 x 4 mL Vials)",New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Anti-infective,To be Discontinued,8/11/22,8/11/22
7192,Amino Acids,B. Braun Medical Inc.,800-227-2862,"Plenamine 15% Amino Acids Injection 2,000mL S4505 (NDC 00264-4500-05)",New,6/8/22,Available,,,,Gastroenterology,Current,,
7193,Amino Acids,B. Braun Medical Inc.,800-227-2862,"Plenamine 15% Amino Acids Injection 1,000mL S4500 (NDC 00264-4500-00)",Revised,6/8/22,Available,,,,Gastroenterology,Current,,
7194,Amino Acids,"ICU Medical, Inc.",877-976-7747,Aminosyn II 15% Sulfite-Free BLK PK 2000 mL (Legacy Hospira NDC 0409-7171-17)(ICU Medical NDC 0990-7171-17),Reverified,10/3/22,Unavailable,,,Other,Gastroenterology,Current,,
7195,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 10% Sulfite-Free BLK PK 2000 mL (NDC 0409-7172-17) (ICU Medical NDC 0990-7172-17),Reverified,10/3/22,Unavailable,,,Other,Gastroenterology,Current,,
7196,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN™-PF 7%, Sulfite-Free, 500 mL (NDC 0409-4178-03) (ICU Medical NDC 0990-4178-03)",Reverified,10/3/22,Available,,,,Gastroenterology,Current,,
7197,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN-PF 10%  Sulfite-Free  (Pediatric Formula) 1000 mL   (Legacy Hospira NDC 0409-4179-05) (ICU Medical NDC 0990-4179-05)""""",,10/3/22,Unavailable,,,Other,Gastroenterology,Current,,
7198,Amino Acids,Baxter Healthcare,888-229-0001,"15% CLINISOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion. Product Codes: 2B6189 15% 2000 mL (NDC 0338-0502-06), 2B6187 15% 500 mL (NDC 0338-0502-03)",Reverified,9/28/22,Available,,,,Gastroenterology,Current,,
7199,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 60 count bottle (NDC 0185-0144-60)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
7200,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 90 count bottle (NDC 0185-0144-09)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
7201,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 500 count bottle (NDC 0185-0144-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
7202,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 500 count bottle (NDC 0245-0145-15)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
7203,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 30 count bottle (NDC 0245-0145-30)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
7204,Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,10 mg (NDCs 0378-2610-01 and 0378-2610-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,,
7205,Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,25 mg (NDCs 0378-2625-01 and 0378-2625-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,,
7206,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2","10mg (NDCs 0603-2212-02, 0603-2212-16, 0603-2212-21, and 0603-2212-32)",New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7207,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2","25mg (NDCs 0603-2213-02, 0603-2213-21, 0603-2213-30, and 0603-2213-32)",New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7208,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg (NDCs 0603-2214-21 and 0603-2214-32),New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7209,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",75mg (NDCs 0603-2215-21 and 0603-2215-25),New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7210,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",100mg (NDCs 0603-2216-21 and 0603-2216-25),New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7211,Amitriptyline Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",150mg (NDC 0603-2217-21),New,12/16/21,,,,,Psychiatry,To be Discontinued,,
7212,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 tablets (NDC 0591-5714-01)",Revised,10/5/22,Available,,,,Psychiatry,Current,,
7213,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 tablets (NDC 0591-5713-01)",Revised,10/5/22,"Backorder, Recovery expected Nov-22",,,Other,Psychiatry,Current,,
7214,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"100 mg, 100 tablets (NDC 0591-5715-01)",Revised,10/5/22,Product is Available,,,,Psychiatry,Current,,
7215,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"150 mg, 30 tablets (NDC 00591-5716-30)",Revised,10/5/22,Allocation,,,,Psychiatry,Current,,
7216,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,12.5  mg 100 count (NDC 0555-0776-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7217,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,15  mg 100 count (NDC 0555-0777-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7218,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,7.5  mg 100 count (NDC 0555-0775-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7219,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,10  mg 100 count (NDC 0555-0972-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7220,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0555-0973-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7221,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,30 mg 100 count (NDC 0555-0974-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7222,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0555-0971-02),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7223,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"5 mg, 100 Count Bottle (NDC 68382-950-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7224,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"7.5 mg, 100 Count Bottle (NDC 68382-951-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7225,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"10 mg, 100 Count Bottle (NDC 68382-952-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7226,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"12.5 mg, 100 Count Bottle (NDC 68382-953-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7227,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"15 mg, 100 Count Bottle (NDC 68382-954-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7228,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"20 mg, 100 Count Bottle (NDC 68382-955-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7229,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"30 mg, 100 Count Bottle (NDC 68382-956-01)",Revised,7/12/21,,,,,Psychiatry,To be Discontinued,,
7230,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"30 mg, 100 Count Bottle (NDC 0185-0864-01)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7231,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"20 mg, 100 Count Bottle (NDC 0185-0853-01)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7232,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"10 mg, 100 Count Bottle (NDC 0185-0842-01)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7233,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"5 mg, 100 Count Bottle (NDC 0185-0831-01)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7234,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 10mg 100 (NDC 57844-0110-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7235,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 12.5mg 100 (NDC 57844-0112-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7236,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 15mg 100 (NDC 57844-0115-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7237,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 20mg 100 (NDC 57844-0120-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7238,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 30mg 100 (NDC 57844-0130-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7239,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 5mg 100 (NDC 57844-0105-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7240,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 7.5mg 100 (NDC 57844-0117-01),Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7241,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,5mg [1.25/1.25/1.25/1.25mg] 100s (NDC 0378-4541-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7242,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,7.5mg [1.875/1.875/1.875/1.875mg] 100s (NDC 0378-4542-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7243,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,10mg [2.5/2.5/2.5/2.5mg] 100s (NDC 0378-4543-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7244,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,12.5mg [3.125/3.125/3.125/3.125mg] 100s (NDC 0378-4544-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7245,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,15mg [3.75/3.75/3.75/3.75mg] 100s (NDC 0378-4545-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7246,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,20mg [5/5/5/5mg] 100s (NDC 0378-4546-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7247,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,30mg [7.5/7.5/7.5/7.5mg] 100s (NDC 0378-4547-01),Revised,5/31/22,,,,,Psychiatry,Resolved,,
7248,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01)",Revised,5/31/22,,,,,Psychiatry,Resolved,,
7249,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01)",Revised,5/31/22,,,,,Psychiatry,Resolved,,
7250,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01)",Revised,5/31/22,,,,,Psychiatry,Resolved,,
7251,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01)",Revised,5/31/22,,,,,Psychiatry,Resolved,,
7252,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01)",Revised,5/31/22,,,,,Psychiatry,Resolved,,
7253,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"5 mg, 100 count (NDC 0527-1500-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7254,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"7.5 mg, 100 count (NDC 0527-1501-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7255,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"10 mg, 100 count (NDC 0527-1502-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7256,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"12.5 mg, 100 count (NDC 0527-1503-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7257,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"15 mg, 100 count (NDC 0527-1504-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7258,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"20 mg, 100 count (NDC 0527-1505-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7259,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Lannett Company, Inc.",844-834-0530,"30 mg, 100 count (NDC 0527-1506-37)",Revised,5/31/22,,,Available,,Psychiatry,Resolved,,
7260,"Amphetamine Oral Suspension, Extended Release","Tris Pharma, Inc.",732-940-0358,Amphetamine (Dyanavel XR) EQ 2.5MG BASE/ML (NDC 27808-102-01),Revised,8/26/22,,,,,Psychiatry,Resolved,8/26/22,
7261,Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,250 mg (NDC 67457-353-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,,
7262,Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,500 mg (NDC 67457-350-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,,
7263,Ampicillin for Injection,Pfizer,844-646-4398,1 g; Single Dose Vial (Powder) (NDC 0409-3726-01),New,7/29/22,,Supply expected to exhaust 01Aug2022; Discontinuation of the manufacture of the drug.,,,,To Be Discontinued,7/29/22,7/29/22
7264,Ampicillin for Injection,Pfizer,844-646-4398,2 g; Single Dose Vial (Powder) (NDC 0409-3720-01,New,7/29/22,,Discontinuation of the manufacture of the drug.,,,,To Be Discontinued,7/29/22,7/29/22
7265,Ampicillin for Injection,Pfizer,844-646-4398,500 mg; Single Dose Vial (Powder) (NDC 0409-3718-01),New,6/22/22,,,,,Antibiotic,To be Discontinued,,
7266,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,1 MG 100 Capsules (NDC 0172-5240-60),Revised,7/20/21,,,,,Hematology,Resolved,,
7267,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,0.5 MG 100 Capsules (NDC 0172-5241-60),Revised,7/20/21,,,,,Hematology,Resolved,,
7268,Anagrelide Hydrochloride Capsules,Takeda Pharmaceuticals USA Inc.,877-825-3327,"AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,,
7269,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,0.5 mg per capsule Bottles of 100 (NDC 13668-453-01),Revised,7/20/21,,,Available,,Hematology,Resolved,,
7270,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,"1 mg per capsule, Bottles of 100 (NDC 13668-462-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,,
7271,Aspirin/Dipyridamole (Aggrenox) Extended Release Capsules,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,25mg/200mg capsules (NDC 0597-0001-60),New,5/26/20,,,,,Cardiovascular,To be Discontinued,,
7272,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25)",Revised,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7273,Atropine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20),Reverified,9/14/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7274,Atropine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3340-1),Reverified,8/12/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7275,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe(NDC 0409-1630-10),Revised,9/30/22,Next Delivery: November 2022; Estimated Recovery: May 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
7276,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe(NDC 0409-9630-05),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
7277,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34),Revised,9/30/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7278,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual)",Revised,9/30/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7279,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25)",Revised,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7280,Atropine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
7281,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-525-08)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7282,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 20 mL multi-dose vial, pack of 10 (NDC 16729-512-43)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7283,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-526-08)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7284,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.05 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-483-03)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7285,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 10 mL prefilled syringe, pack of 10 (NDC 16729-484-45)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7286,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-484-90)",Reverified,4/6/22,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
7287,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-3253-94)",Revised,10/1/21,Available,,,,Oncology,Current,,
7288,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-9253-94)",Revised,10/1/21,Available,,,,Oncology,Current,,
7289,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"VIDAZA, , 100 mg single-dose vial in cartons of 1 vial, (NDC 59572-102-01)",Revised,10/1/21,Available,,,,Oncology,Current,,
7290,Azacitidine for Injection,"Fresenius Kabi USA, LLC",1-888-386-1300,"100 mg per vial, single dose vial, PF, (NDC 63323-771-39)",Reverified,9/14/22,Available,,,Demand increase for the drug,Oncology,Current,,
7291,Azacitidine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",1-800-631-2174,"100 mg per vial, (NDC 0143-9606-01)",Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Oncology,Current,,
7292,Azacitidine for Injection,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"100 mg per vial, (NDC 43598-305-62)",Revised,3/4/22,Approximately 2 months of inventory on hand,,,Demand increase for the drug,Oncology,Current,,
7293,Azacitidine for Injection,Armas Pharmaceuticals Inc,1-732-637-1971,100 mg per vial (NDC 72485-201-01),Reverified,5/19/21,Limited availability,,,Demand increase for the drug,Oncology,Current,,
7294,Azacitidine for Injection,Accord Healthcare Inc.,"866-941-7875, option 2",100 mg per vial (NDC 16729-306-10),Revised,6/10/21,Limited availability.,,,Shortage of an active ingredient,Oncology,Current,,
7295,Azacitidine for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg per vial (NDC 67457-254-30),Reverified,9/28/22,Unavailable,,,Other,Oncology,Current,,
7296,Azacitidine for Injection,Cipla Limited,844-247-5287,100 mg per vial (NDC 69097-805-40),Revised,6/8/21,Available,,,Demand increase for the drug,Oncology,Current,,
7297,Azacitidine for Injection,Teva Pharmaceuticals,800-545-8800,100 mg/vial Lyophilized Powder (NDC 68001-0313-56),Reverified,10/5/22,"Backorder, Recovery expected TBD",Product is manufactured and labeled for Blue Point Laboratories,,,Oncology,Current,,
7298,Azacitidine for Injection,Breckenridge Pharmaceutical,860-828-8140,100 mg per vial (NDC 51991-797-98),Reverified,2/18/22,Available,,,,Oncology,Current,,
7299,Azacitidine for Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,100 mg per vial (NDC 71288-115-30),New,10/7/21,Available,,,,Oncology,Current,,
7300,Azithromycin (Azasite) Ophthalmic Solution 1%,Thea Pharma Inc.,781-832-3667,"Azasite (Azithromycin Ophthalmic Solution) 1% (NDC 82584-307-03), 2.5mL",Revised,6/3/22,On backorder.,,,Other,Ophthalmology,Current,,
7301,Bacitracin Ophthalmic Ointment,Padagis US LLC,763-732-0225,3.5 g (NDC 0574-4022-35),New,9/10/21,,,,,Ophthalmology,To be Discontinued,,
7302,Bacteriostatic 0.9% Sodium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 30 mL (NDC 63323-924-30)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Increase in demand,Gastroenterology;Other;Pediatric,Current,,
7303,Bacteriostatic 0.9% Sodium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (90 mg per 10 mL), (9mg/mL), Multiple Dose Plastic Vial, 10 mL, (NDC 63323-924-10)",Revised,9/14/22,Available,Check wholesaler inventory,,Increase in demand,Gastroenterology;Other;Pediatric,Current,,
7304,Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc.",844-646-4398,10 mL Multiple Dose LifeShield™ Plastic Fliptop Vial (NDC 00409-1966-12),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
7305,Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc.",844-646-4398,20 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-05),Revised,9/12/22,Available,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
7306,Bacteriostatic 0.9% Sodium Chloride Injection,"Hospira, Inc.",844-646-4398,30 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-1966-07),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
7307,Bacteriostatic Water for Injection,"Hospira, Inc.",844-646-4398,30 mL Multiple Dose Plastic Fliptop Vial (NDC 00409-3977-03),Reverified,9/12/22,Next Delivery: October 2022; Estimated Recovery: May 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Other,Current,,
7308,Belatacept (Nulojix) Lyophilized Powder for Injection,Bristol Myers Squibb Co.,800-721-5072 ; 877-417-1523,20cc vial 250mg lyophilized powder per vial for IV infusion (NDC 0003-0371-13),Revised,2/25/21,"No disruption to existing patients is anticipated. Until further notice, BMS will continue to limit distribution of Nulojix via the US NULOJIX Distribution Program, initiated 2/15/2017. Starting in August 2018, the restrictions of the NDP were eased to al",,,Demand increase for the drug,Transplant,Current,,
7309,Belladonna and Opium Suppositories,Padagis US LLC,866-634-9120,16.2mg/60 mg suppository (NDC: 0574-7040),New,8/3/22,Currently out of stock. No estimated release date available.,Manufacturing delay due to active ingredient shortage,,"Regulatory delay, shortage of active ingredient",Urology,Current,,
7310,Belladonna and Opium Suppositories,Padagis US LLC,866-634-9120,"Belladonna and Opium Suppositories, 16.2mg/30 mg (NDC 0574-7045)",New,8/3/22,Currently out of stock. No estimated release date available.,Manufacturing delay due to active ingredient shortage,,"Regulatory delay, shortage of active ingredient",Urology,Current,,
7311,Benzonatate Capsules,Pfizer Pharmaceuticals,800-533-4535,Tessalon 100 mg perles; Bottle of 100 (NDC 0069-0122-01),New,6/8/21,,,,,Pulmonary/Allergy,To be Discontinued,,
7312,Betamethasone Valerate Topical Foam,Ingenus Pharmaceuticals LLC,866-321-5031,0.12% (NDCs 50742-315-01 and 50742-315-50),New,11/30/21,,,,,Dermatology,To be Discontinued,,
7313,Bivalirudin in 0.9% Sodium Chloride Injection,Baxter,888-229-0001,250 mg/50 mL (NDC 0338-9572-24),New,7/12/22,,Discontinuation of the manufacture of the drug.,,,Hematology,To be Discontinued,7/12/22,7/12/22
7314,Bivalirudin in 0.9% Sodium Chloride Injection,Baxter,888-229-0001,500 mg/100 mL (NDC 0338-9576-12),New,7/12/22,,Discontinuation of the manufacture of the drug.,,,Hemtology,To be Discontinued,7/12/22,7/12/22
7315,Bleomycin Injection,Teva,800-545-8800,NDC 0703-3154-01 (15 Units/Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until SEPT 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7316,Bleomycin Injection,Teva,800-545-8800,NDC 0703-3155-01 (30 Units/Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7317,"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup",Wockhardt Bio A.G.,847-410-6929,4 Fl Oz (118ml) (NDC 60432-275-04),New,8/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Pulmonary/Allergy; Gastroenterology,To be Discontinued,8/26/22,8/26/22
7318,"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup",Wockhardt Bio A.G.,847-410-6929,1 pint (475ml) (NDC 60432-275-16),New,8/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Pulmonary/Allergy; Gastroenterology,To be Discontinued,8/26/22,8/26/22
7319,Budesonide Capsules,Teva Pharmaceuticals,800-545-8800,3 mg capsules (NDC 0093-7445-01),New,12/23/19,,,,,Gastroenterology,To be Discontinued,,
7320,Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 4 mL vial (NDC 0641-6008-10)",Revised,8/26/22,Inventory is currently available,,,Demand increase for the drug,Cardiovascular,Current,,
7321,Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)",Revised,8/26/22,Inventory is currently available,,,Demand increase for the drug,Cardiovascular,Current,,
7322,Bumetanide Injection,"Hospira, Inc.",844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04),Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Cardiovascular,Current,,
7323,Bumetanide Injection,"Hospira, Inc.",844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10),Revised,9/12/22,Next Delivery and Estimated Recovery: February 2025,,,Demand increase for the drug,Cardiovascular,Current,,
7324,Bumetanide Injection,Pfizer,844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1412-04),New,7/19/22,,Stock anticipated to be available through September 2022,,,Cardiology; Renal,To be Discontinued,7/19/22,7/19/22
7325,Bumetanide Injection,Pfizer,844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 0409-1412-10),New,7/19/22,,Stock anticipated to be available through August 2022,,,Cardiology; Renal,To be Discontinued,7/19/22,7/19/22
7326,Bumetanide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,1mg/4mL vial (NDC 70860-405-04),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
7327,Bumetanide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,2.5mg/10mL vial (NDC 70860-406-10),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
7328,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57),Revised,9/14/22,Backordered.  Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7329,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57),Revised,9/14/22,Backordered.  Next release October 2022.,,,Demand increase for the drug,Anesthesia,Current,,
7330,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17),Revised,9/14/22,Backordered.  Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7331,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37),Revised,9/14/22,Backordered.  Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7332,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17),Revised,9/14/22,Backordered.  Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7333,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37),Revised,9/14/22,Backordered.  Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7334,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31)",Revised,9/14/22,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7335,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL)  SDV  (NDC 63323-460-37),Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7336,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7337,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7338,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7339,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7340,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7341,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01),Revised,9/12/22,Next Delivery: April 2023; Estimated Recovery: December 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7342,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: March 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7343,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30)",Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: March 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7344,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: January 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7345,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29)",Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: March 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7346,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50)",Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7347,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7348,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57),Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7349,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL)                    MDV (NDC 63323-467-57),Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7350,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF,         SDV (NDC 63323-464-17)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7351,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7352,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF,             Sterile-Pak, SDV (NDC 63323-464-31)",Revised,9/14/22,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7353,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL)  MPF,                 SDV  (NDC 63323-466-17)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7354,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                 SDV (NDC 63323-466-37)",Revised,9/14/22,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7355,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                Sterile-Pak, SDV (NDC 63323-466-31)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7356,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF,             SDV (NDC 63323-472-17)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
7357,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF,     SDV (NDC 63323-472-37)",Revised,9/14/22,4 month expiry (12/2022 & 1/2023 expiry) dating available by request.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
7358,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 10 mL Single Dose Vials (NDC 55150-167-10),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7359,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 30 mL Single Dose Vials (NDC 55150-168-30),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7360,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 10 mL Single Dose Vials (NDC 55150-169-10),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7361,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-170-30),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7362,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 10 mL Single Dose Vials (NDC 55150-171-10),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7363,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 30 mL Single Dose Vials (NDC 55150-172-30),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7364,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7365,Bupivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
7366,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: December 2023,,,Demand increase for the drug,Anesthesia,Current,,
7367,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia,Current,,
7368,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01),Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Anesthesia,Current,,
7369,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01),Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: December 2022,,,Demand increase for the drug,Anesthesia,Current,,
7370,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: July 2023,,,Demand increase for the drug,Anesthesia,Current,,
7371,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01),Revised,9/12/22,Limited Supply Available. Next Delivery: March 2023; Estimated Recovery: July 2023,,,Demand increase for the drug,Anesthesia,Current,,
7372,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01),Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia,Current,,
7373,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02),Revised,9/12/22,Next Delivery: December 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7374,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409-3613-01),Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Anesthesia,Current,,
7375,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10),Revised,9/12/22,Next Delivery and Estimated Recovery: February 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7376,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30),Revised,9/12/22,Next Delivery and Estimated Recovery: May 2023,,,Demand increase for the drug,Anesthesia,Current,,
7377,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50),Revised,9/12/22,Next Delivery and Estimated Recovery: June 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7378,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10),Revised,9/12/22,Next Delivery and Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Anesthesia,Current,,
7379,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Anesthesia,Current,,
7380,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: December 2022,,,Demand increase for the drug,Anesthesia,Current,,
7381,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10),Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia,Current,,
7382,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29),Revised,9/12/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7383,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409- 1761-02),Revised,9/12/22,Next Delivery and Estimated Recovery: TBD,,,Demand increase for the drug,Anesthesia,Current,,
7384,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 5 mL single-dose ampules (NDC 59923-717-05),Revised,12/9/21,Available,,,,Anesthesia,Current,,
7385,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 10 mL single-dose ampules (NDC 59923-719-10),Revised,12/9/21,Available,,,,Anesthesia,Current,,
7386,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 5 mL single-dose ampules (NDC 59923-718-05),Revised,12/9/21,Available,,,,Anesthesia,Current,,
7387,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 10 mL single-dose ampules (NDC 59923-720-10),Revised,12/9/21,Available,,,,Anesthesia,Current,,
7388,Bupivacaine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"Bupivacaine Spinal, USP (7.5 mg/mL in 8.25% dextrose) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)",Reverified,9/28/22,Stocked out - recovery TBD,,,Manufacturing Delay,Anesthesia,Current,,
7389,Bupivacaine Hydrochloride Injection,"Huons Co., Ltd",+82-2-854-4700 or via email intbiz@huons.com,"HCl 0.75% & Dextrose 8.25%, Injectable spinal (NDC 73293-0002)",New,6/21/21,Available,,,,Anesthesia,Current,,
7390,Busulfan Injection,American Regent/Luitpold,800-645-1706,6 mg/mL  (NDC 0517-0920-08),New,8/6/21,,,,,Hematology,To be Discontinued,,
7391,Busulfan Injection,Apotex Corp.,800-706-5575,6mg/mL (NDCs 60505-6177-0 and 60505-6177-8),New,10/15/21,,,,,Hematology,To be Discontinued,,
7392,Calcitonin Salmon Nasal Spray,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",200 IU/spray (NDC 49884-161-11),New,8/29/22,,,,,Musculoskeletal,To be Discontinued,8/29/22,8/29/22
7393,Calcium Disodium Versenate Injection,Bausch Health,800-321-4576,1000 mg/5 mL (200 mg/mL) (NDC 99207-240-05),Reverified,10/25/21,Not currently available. Estimated Shortage duration TBD,,,Requirements related to complying with good manufacturing practices,Other,Current,,
7394,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mg calcium gluconate per 10 mL (100 mg/mL), single dose vial (NDC 63323-360-01, 1 vial; NDC 63323-360-19, 25 vials)",Revised,9/14/22,Available,Check wholesaler inventory,,Available,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7395,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5,000 mg calcium gluconate per 50 mL (100 mg/mL), single dose vial (NDC 63323-360-03, 1 vial; NDC 63323-360-59, 25 vials)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Demand increase for the drug,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7396,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10,000 mg calcium gluconate per 100 mL (100 mg/mL), pharmacy bulk package vial (NDC 63323-360-05, 1 vial; NDC 63323-360-61, 20 vials)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase for the drug,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7397,Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,1000 mg/50 mL (20 mg/mL) single-dose bag (NDC 44567-620-24),Reverified,5/3/22,Available,,,,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7398,Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,2000 mg/100 mL (20 mg/mL) single-dose bag (NDC 44567-621-24),Reverified,5/3/22,Available,,,,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7399,Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,1000mg/100mL (10mg/mL) Calcium Gluconate single-dose bag (NDC 44567-0622-24),Reverified,5/3/22,Available,,,,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
7400,Capreomycin Injection,Akorn Pharmaceuticals,800-932-5676,"Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50)",Revised,5/5/21,,,,,Anti-Infective,To be Discontinued,,
7401,Captopril Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,12.5mg; 25mg; 50mg; 100mg (NDC 0378-3007-10; 0378-3007-01; 0378-3012-10; 0378-3012-01; 0378-3017-10; 0378-3017-01; 0378-3022-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,
7402,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/15mg 100s Tabs (NDC 00378-0081-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,
7403,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/25mg 100s Tabs (NDC 00378-0083-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,
7404,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/15mg 100s Tabs (NDC 00378-0084-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,
7405,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/25mg 100s Tabs (NDC 00378-0086-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,,
7406,Carbamazepine Oral Suspension,Wockhardt Bio A.G.,847-410-6929,"100mg/5ml 450mL, (NDC 60432-129-16)",New,6/22/22,,,,,Neurology; Pediatric,To be Discontinued,,
7407,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose,"Chiesi USA, Inc.",888-466-6505 x6511,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10),New,3/20/18,,,,,Cardiovascular,To be Discontinued,,
7408,Caspofungin Acetate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,50 mg (NDC 67457-831-50),New,7/23/20,,,,,Anti-Infective;Pediatric,To be Discontinued,,
7409,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single-dose ADD-Vantage Vial (NDC 00409-2585-01,Reverified,9/12/22,Available,,,Other,Anti-Infective,Current,,
7410,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 2 g (25 vials) (NDC 60505-6231-05),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7411,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 1 g (25 vials) (NDC 60505-6142-05),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7412,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,10g 10 vials (NDC 25021-102-99),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7413,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,500mg 25 vials (NDC 25021-100-10),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7414,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 2 gram/50 mL in DUPLEX Catalog 3105-11 (NDC 00264-3105-11),Reverified,6/10/22,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
7415,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 1 gram/50 mL in DUPLEX Catalog 3103-11 (NDC 0264-3103-11),Reverified,6/10/22,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
7416,Cefazolin Injection,WG Critical Care,888-493-0861,500mg SDV (NDC 44567-706-25),Reverified,10/3/22,Available,,,Demand increase for the drug,Anti-Infective,Current,,
7417,Cefazolin Injection,WG Critical Care,888-493-0861,1g SDV (NDC 44567-707-25),Reverified,10/3/22,Available,,,Demand increase for the drug,Anti-Infective,Current,,
7418,Cefazolin Injection,WG Critical Care,888-493-0861,10g PBP (NDC 44567-708-10),Reverified,10/3/22,Available,,,Demand increase for the drug,Anti-Infective,Current,,
7419,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Reverified,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
7420,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9923-90),Reverified,4/8/22,Inventory is currently available,,,Demand increase for the drug,Anti-Infective,Current,,
7421,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9924-90),Reverified,4/8/22,Inventory is currently available,,,Demand increase for the drug,Anti-Infective,Current,,
7422,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mg/ 100 mL vial (NDC 0143-9983-03),Reverified,4/8/22,Inventory is currently available,,,Demand increase for the drug,Anti-Infective,Current,,
7423,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 500 mg (NDC 0781-3450-95),Reverified,10/3/22,Available,,,,Anti-Infective,Current,,
7424,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 1 g (NDC 0781-3451-96),Reverified,10/3/22,Available,,,,Anti-Infective,Current,,
7425,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 10 g (NDC 0781-3452-95),Reverified,10/3/22,Available,,,,Anti-Infective,Current,,
7426,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,1g 25 vials (NDC 25021-101-10),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7427,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 1 gram/50 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3503)(NDC 0338-3503-41)",Revised,9/28/22,Available,,,,Anti-Infective,Current,,
7428,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 2 gram/100 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3508)(NDC 0338-3508-41)",Revised,9/28/22,Available,,,Manufacturing Delay,Anti-Infective,Current,,
7429,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 10 g (10 vials) (NDC 60505-6143-04),Reverified,8/22/22,Available,,,,Anti-Infective,Current,,
7430,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1100-1),Reverified,10/6/22,Available,,,,Anti-Infective,Current,,
7431,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,300 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1300-1),Reverified,10/6/22,Available,,,,Anti-Infective,Current,,
7432,Cefdinir Capsules,Sandoz,800-525-8747,300 mg capsules  (NDC 0781-2176-60),New,7/9/20,,,,,Anti-Infective,To be Discontinued,,
7433,Cefdinir Powder for Suspension,Sandoz,800-525-8747,125 mg/5 mL (NDCs 0781-6077-46 and 0781-6077-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,,
7434,Cefdinir Powder for Suspension,Sandoz,800-525-8747,250 mg/5 mL (NDCs 0781-6078-46 and 0781-6078-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,,
7435,Cefixime Oral Capsules,Ascend Laboratories LLC.,201-326-9004,400 mg (50’s HDPE Bottle pack)(NDC 67877-584-50),Revised,3/16/22,"Currently unavailable, Estimated recovery: June/July 2022",,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,
7436,Cefixime Oral Capsules,Lupin,866-587-4617,400 mg Bottle of 50 capsules (NDC 68180-423-08),Reverified,7/12/22,"Limited availability, Manufacturing and distribution is ongoing.",,,Demand increase for the drug,Anti-Infective,Current,,
7437,Cefixime Oral Capsules,Lupin,866-587-4617,400 mg Unit dose Package of 10 (1 blister of 10 capsules) (NDC 68180-423-11),Reverified,7/12/22,"Limited availability, Manufacturing and distribution is ongoing.",,,Demand increase for the drug,Anti-Infective,Current,,
7438,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"2g/vial, (NDC 21586-012-2)",Reverified,10/14/21,Available,,,Other,Anti-Infective;Pediatric,Current,,
7439,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"1g/vial, (NDC 21586-011-2)",Reverified,10/14/21,Available,,,Other,Anti-Infective;Pediatric,Current,,
7440,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9930-10),Reverified,4/8/22,Currently unavailable,,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
7441,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9931-25),Reverified,4/8/22,Currently unavailable,,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
7442,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 g/ 10 mL vial (NDC 0143-9933-25),Reverified,4/8/22,Currently unavailable,,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
7443,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 g/ 100 mL vial (NDC 0143-9935-01),Reverified,4/8/22,Currently unavailable,,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
7444,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,1 gram/50 mL in DUPLEX (NDC 00264-3173-11),Revised,6/9/22,,,,,Anti-Infective,To be Discontinued,,
7445,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,2 gram/50 mL in DUPLEX (NDC 00264-3175-11),Revised,6/9/22,,,,,Anti-Infective,To be Discontinued,,
7446,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g SDV (NDC 63323-0385-10),Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler for inventory,,Manufacturing delay,Anti-Infective,Current,,
7447,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 g SDV (NDC 63323-0386-20),Revised,9/14/22,Available,Check wholesaler for inventory,,Manufacturing delay,Anti-Infective,Current,,
7448,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 g PBP (NDC 63323-0396-61),Revised,9/14/22,No release date available at this time.,,,Manufacturing delay,Anti-Infective,Current,,
7449,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),Reverified,10/13/21,Discontinued,,,,Anti-Infective,Current,,
7450,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1g vial (NDC 0143-9878-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7451,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2g vial (NDC 0143-9877-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7452,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10g vial (NDC 0143-9876-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7453,Cefoxitin for Injection,Apotex Corp.,800-706-5575,1 g (25 vials) (NDC 60505-0759-05),Revised,11/18/21,,,,,Anti-Infective,Resolved,,
7454,Cefoxitin for Injection,Apotex Corp.,800-706-5575,2 g (25 vials) (NDC 60505-0760-05),Revised,11/18/21,,,,,Anti-Infective,Resolved,,
7455,Cefoxitin for Injection,Apotex Corp.,800-706-5575,10 g (10 vials) (NDC 60505-0761-04),Revised,11/18/21,,,,,Anti-Infective,Resolved,,
7456,Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g per vial; SDV; (NDC 63323-341-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7457,Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 grams per vial; SDV; (NDC 63323-342-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7458,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"10 g, package of 10 vials (NDC 25021-111-99)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7459,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"1 g, package of 10 vials (NDC 25021-109-10)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7460,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"2 g, package of 10 vials (NDC 25021-110-20)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7461,Cefoxitin for Injection,WG Critical Care,888-493-0861,1 g (NDC 44567-245-25),Revised,11/18/21,Available,,Available,,Anti-Infective,Resolved,,
7462,Cefoxitin for Injection,WG Critical Care,888-493-0861,2 g (NDC 44567-246-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7463,Cefoxitin for Injection,WG Critical Care,888-493-0861,10 g (NDC 44567-247-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7464,Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7465,Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,,
7466,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 1g Bag 24 x 50mL (NDC 24987-0412-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,
7467,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 2g Bag 24 x 50mL (NDC 24987-0413-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,
7468,"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution 1 Single-use vials (NDC 0456-2700-01)",Revised,2/7/22,,,Available,,Anti-Infective,Resolved,,
7469,"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution Carton containing 10 vials  (NDC 0456-2700-10)",Revised,2/7/22,,,Available,,Anti-Infective,Resolved,,
7470,Ceftolozane and Tazobactam (Zerbaxa) Injection,Merck Sharp & Dohme Corp.,800-672-6372,Supplied in single-dose vials containing ceftolozane 1 g (equivalent to 1.147 g of ceftolozane sulfate) and tazobactam 0.5 g (equivalent to 0.537 g of tazobactam sodium) per vial. Vials are supplied in cartons containing 10 vials (NDC 67919-030-01),Revised,3/14/22,,,Available,,Anti-Infective,Resolved,,
7471,Cefuroxime Sodium (Zinacef) Injection,"Teligent Pharma, Inc.",856-697-1441,Cefuroxime Sodium (Zinacef) Premix Sol Frozen 1.5g Bag 24 x 50mL (NDC 24987-0425-00),New,3/20/18,,,,,Anti-Infective;Pediatric,To be Discontinued,,
7472,Cetirizine Hydrochloride Solution,Torrent Pharma Inc.,908-280-3333,"Oral Solution, 1 mg/mL 120 mL (NDC 1366859607) and 480 mL (NDC 1366859611)",New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,
7473,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 500 count (NDC 0555-0159-04)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7474,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count (NDC 0555-0158-02)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7475,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 1000 count (NDC 0555-0033-05)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7476,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count (NDC 0555-0033-02)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7477,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count (NDC 0555-0159-02)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7478,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 500 count (NDC 0555-0158-04)",Reverified,10/5/22,Available,,,,Neurology;Psychiatry,Current,,
7479,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"10mg, 100ct (NDC 42806-562-01)",Reverified,3/8/22,Available,,,,Neurology;Psychiatry,Current,,
7480,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"25mg, 100ct (NDC 42806-563-01)",Reverified,3/8/22,Available,,,,Neurology;Psychiatry,Current,,
7481,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"5mg, 100ct (NDC 42806-564-01)",Reverified,3/8/22,Available,,,,Neurology;Psychiatry,Current,,
7482,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,5 mg (NDC 43547-251-10),New,11/19/19,,,,,Neurology;Psychiatry,To be Discontinued,,
7483,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,10 mg (NDC 43547-252-10),New,11/19/19,,,,,Neurology;Psychiatry,To be Discontinued,,
7484,Chloroprocaine Hydrochloride Injection,B. Braun Medical Inc.,800-227-2862,"Clorotekal® (Chloroprocaine HCl Injection, USP) 5mL ampules 50 mg/5 mL (10 mg/mL) Catalog D7055 (NDC 0264-7055-05)",New,5/17/21,Product available,,,Other,Anesthesia,Current,,
7485,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nescacaine 1% (300 mg per 30 mL) (10 mg per mL); MDV; (NDC 63323-475-37),Revised,9/14/22,Available,Check wholesaler for inventory,,,Anesthesia,Current,,
7486,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nescacaine 2% (600 mg per 30 mL) (20 mg per mL); MDV; (NDC 63323-476-37),Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,,Anesthesia,Current,,
7487,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nesacaine 2% (400 mg per 20 mL) (20 mg per mL); SDV; (NDC 63323-477-27),Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
7488,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nesacaine 3% (600 mg per 20 mL) (30 mg per mL); SDV; (NDC 63323-478-27),Revised,9/14/22,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
7489,Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% (20 mg/mL), 20 mL vial (NDC 0143-9209-10)",Revised,4/8/22,Inventory is currently available,,,Demand increase for the drug,Anesthesia,Current,,
7490,Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"3% (30 mg/mL), 20 mL vial (NDC 0143-9210-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
7491,Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"10 mg/5 mL Single Dose Vial, Package of 10 vials (NDC 55150-284-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7492,Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg / 10 mL Multiple-Dose Vial, Package of 10 vials (ndc 55150-286-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7493,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/20 mL (10 mg/mL) Single-dose vials (NDC 0703-2045-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7494,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,20 mg/10 mL (2 mg/mL) Multiple-dose vials (NDC 0703-2056-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7495,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,10 mg/5 mL (2 mg/mL) Single-dose vials (NDC 0703-2033-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7496,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/mL 10 vials (NDC 70069-141-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,
7497,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/ml 10 vials (NDC 70069-161-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,
7498,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,10mg/mL 10 vials (NDC 70069-151-10),Revised,7/27/21,,,,,Anesthesia,Resolved,,
7499,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,10 mg per 5 mL single dose vial (NDC 71288-712-06),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7500,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,200 mg per 20 mL single dose vial (NDC 71288-713-21),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7501,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,20 mg per 10 mL  multi dose vial (NDC 71288-712-11),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7502,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7503,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7504,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7505,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/ml; 5mL (NDC 0781-3150-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7506,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/mL; 10mL (NDC 0781-3152-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7507,Cisatracurium Besylate Injection,Sandoz,800-525-8747,1-mg/mL; 20mL (NDC 0781-3153-95_,Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7508,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,10mg/5mL (2mg/mL) Single Dose Vial (NDC 00409-1098-02),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7509,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose Vial (NDC 00409-1103-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7510,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,20mg/10mL (2mg/mL) Multi-Dose Vial (NDC 00409-1208-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7511,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 5 mL Single-dose vial (NDC 0074-4378-05, 0074-4378-24, 0074-4378-36)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7512,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 10 mL Multiple-dose vial (NDC 0074-4380-10, 0074-4380-79, 0074-4380-81)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7513,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"10 mg/mL, 20 mL Single-dose vial (NDC 0074-4382-20, 0074-4382-91, 0074-4382-93)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,,
7514,Cladribine Injection,Mylan Laboratories Ltd.,800-796-9526,1 mg/mL (NDC 67457-450-10),New,5/20/22,,,,,Oncology,To be Discontinued,,
7515,"Clindamycin and Benzoyl Peroxide Gel, 1%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45g jar (NDC 0781-7263-68); 35g pump (NDC 0781-7275-43); 50g jar (NDC 0781-7287-50); 50g pump (NDC 0781-7291-46),New,9/30/21,,,,,Dermatology,To be Discontinued,,
7516,"Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45 g tube (NDC 0781-7161-19),New,9/30/21,,,,,Dermatology,To be Discontinued,,
7517,Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,30mL (NDC 52565-018-29),New,6/21/21,,,,,,To be Discontinued,,
7518,Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,60mL (NDC 52565-018-59),New,6/21/21,,,,,,To be Discontinued,,
7519,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-039-15),New,6/21/21,,,,,,To be Discontinued,,
7520,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-039-30),New,6/21/21,,,,,,To be Discontinued,,
7521,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,45g (NDC 52565-039-45),New,6/21/21,,,,,,To be Discontinued,,
7522,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-039-60),New,6/21/21,,,,,,To be Discontinued,,
7523,Clobetasol Propionate Topical Foam,Ingenus Pharmaceuticals LLC,866-321-5031,0.05% (NDCs 50742-304-01 and 50742-304-50),New,11/16/21,,,,,Dermatology,To be Discontinued,,
7524,Clobetasol Propionate Topical Solution 0.05%,Wockhardt,800-346-6854,25 mL (NDC 6432-133-25) || 50 mL (NDC 60432-133-50),New,6/13/22,,,,,Dermatology,To be Discontinued,,
7525,"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,25 mL bottle (NDC 63646-500-25),New,11/1/21,,,,,Dermatology,To be Discontinued,,
7526,"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,50 mL bottle (NDC 63646-500-50),New,11/1/21,,,,,Dermatology,To be Discontinued,,
7527,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg  (90s)(NDC 0378-1910-77),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7528,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (100s)(NDC 0378-1910-01),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7529,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (1000s)(NDC 0378-1910-10),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7530,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (90s)(NDC 0378-1912-77),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7531,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (100s)(NDC 0378-1912-01),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7532,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (1000s)(NDC 0378-1912-10),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7533,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (100s)(NDC 0378-1914-01),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7534,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (500s)(NDC 0378-1914-05),New,5/8/18,,,,,Neurology;Pediatric,To be Discontinued,,
7535,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0185-0063-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7536,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0185-0063-05)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7537,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0185-0063-10)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7538,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0781-8018-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7539,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0781-8018-05)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7540,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0781-8018-10)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7541,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-752-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7542,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-752-02)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7543,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-469-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7544,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-469-02)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7545,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0185-0064-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7546,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0185-0064-05)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7547,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0185-0064-10)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7548,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0781-5567-01)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7549,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0781-5567-05)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7550,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0781-5567-10)",New,6/5/18,,,,,Neurology;Pediatric,To be Discontinued,,
7551,Clonidine Hydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.1mg  (NDC 10370-257-02),New,11/30/21,,,,,Psychiatry,To be Discontinued,,
7552,Clonidine Hydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",0.1mg  (NDC 10370-257-02),New,3/22/22,,,,,Cardiovascular,To be Discontinued,,
7553,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"12.5 mg tablet, 100 CT Bottle (NDC 18860-101-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7554,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablets, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-102-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7555,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablet, 100  CT bottle (NDC 18860-102-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7556,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-104-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7557,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-105-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7558,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 100 CT Bottle (NDC 18860-105-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7559,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-106-01)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7560,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablets, 100 CT Bottle (NDC 18860-106-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7561,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg Tablet, 100 CT Bottle (NDC 18860-104-10)",New,11/22/19,,,,,Psychiatry,To be Discontinued,,
7562,Codeine Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension,Aytu BioPharma,855-298-8246,"14.7 mg of codeine (equivalent to 20 mg codeine phosphate); and chlorpheniramine polistirex, which contains 2.8 mg of chlorpheniramine (equivalent to 4 mg chlorpheniramine maleate) per 5 mL (NDCs 69654-480-01 and 69654-480-02)",New,6/13/22,,,,,Pulmonary/Allergy,To be Discontinued,,
7563,Conivaptan Hydrochloride (Vaprisol) in 5% Dextrose Plastic Container,Cumberland Pharmaceuticals Inc.,615-255-0068,20 mg/100 mL (NDC 66220-160-10),New,3/14/22,Next delivery April 2022.  Estimated recovery 3Q 2022.,,,Other,Cardiovascular,Current,,
7564,"Conjugated Estrogens/Bazedoxifene (DUAVEE) Tablet, Film Coated",Pfizer,800-533-4535,Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; 2 blisters of 15 each (NDC 0008-1123-12),New,9/21/22,Next Delivery and Estimated Recovery: Late Q3 2023,Shortage per Manufacturer: Manufacturing Delay,,,Reproductive,Current,,
7565,"Conjugated Estrogens/Bazedoxifene (DUAVEE) Tablet, Film Coated",Pfizer,800-533-4535,Conjugated estrogens 0.45 mg/bazedoxifene 20 mg; blister of 7 each (US Sample) (NDC 63539-122-07),New,9/21/22,Next Delivery and Estimated Recovery: Late Q3 2023,Shortage per Manufacturer: Manufacturing Delay,,,Reproductive,Current,,
7566,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON-PVC. (NDC 24571-113-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7567,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK0/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-108-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7568,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (DC 24571-114-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7569,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-105-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7570,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/3.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-103-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7571,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-102-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7572,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol B22GK4/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-111-06)",Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7573,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM BK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-116-06),Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7574,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM B22K4/0 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-117-06),Reverified,9/28/22,,,Available,,Renal,Resolved,9/19/22,
7575,Cortisone Acetate Tablets,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg, bottles of 100 (NDC 0143-9700-01)",Reverified,4/8/22,Currently Unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient,Endocrinology/Metabolism;Rheumatology,Current,,
7576,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 2ML (NDC 0065-0359-02)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7577,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 5ML (NDC 0065-0359-05)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7578,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 0.5% 15ML (NDC 0065-0395-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7579,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 2ML (NDC 0065-0396-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7580,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 5ML (NDC 0065-0396-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7581,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 2ML (NDC 0065-0397-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7582,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 5ML (NDC 0065-0397-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7583,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 15ML (NDC 0065-0397-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7584,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 15ML (NDC 61314-396-01),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7585,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 2ML (NDC 61314-396-03),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
7586,Cyclopentolate Ophthalmic Solution,Bausch & Lomb Incorporated,800-321-4576,"Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 2 mL bottle (NDC 24208-735-01) and 15 mL bottle (NDC 24208-735-06)",Revised,6/24/21,On backorder. Estimated availability: Mid-September 2021,,,Other,Ophthalmology,Current,,
7587,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 15mL 1 Bottle (NDC 17478-097-12)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
7588,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 2mL, 1 Bottle (NDC 17478-097-02)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
7589,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 5mL 1 Bottle/EA (NDC 17478-097-10)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
7590,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Opht Sol 1% 10mg/mL, 2mL, 1 Bottle (NDC 17478-100-02)",Revised,6/24/21,On backorder. Estimated availability: August 2021,,,Other,Ophthalmology,Current,,
7591,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Ophth 1% 10mg/mL, 15mL, 1 Bottle (NDC 17478-100-12)",Revised,6/24/21,On backorder. Estimated availability: August 2021,,,Other,Ophthalmology,Current,,
7592,Cysteamine Hydrochloride Ophthalmic Solution,"Leadiant Biosciences, Inc.",866-634-2765,"0.44%, 15 mL bottle (old NDC 54482-020-01) (NEW NDC 54482-020-02)",Revised,6/8/22,,,"NDC 54482-020-01 has been discontinued and replaced by NDC 54482-020-02, which is available.",,Ophthalmology,Resolved,,
7593,Cysteine Hydrochloride Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154 or 230,Elcys (Cysteine Hydrochloride injection) 500mg/10ml Single-dose vials (NDC 51754-1007-1) Packaged as 10 per carton (NDC 51754-1007-3),Revised,9/3/19,,,Available,,Other;Pediatric,Resolved,,
7594,Cytarabine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 g/20 mL (100 mg/mL), single dose vial (NDC 63323-120-20)",Revised,9/14/22,Backordered. Next release October 2022.,,,,Oncology;Pediatric,Current,,
7595,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 61703-305-38)",Reverified,9/12/22,Available,,,,Oncology;Pediatric,Current,,
7596,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"2 g/20 mL (100 mg/mL), single dose vial (NDC 61703-319-22)",Reverified,9/12/22,Available,,,Other,Oncology;Pediatric,Current,,
7597,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"500 mg/25 mL (20 mg/mL), multiple dose vial (NDC 61703-304-36)",Reverified,9/12/22,Available,,,Other,Oncology;Pediatric,Current,,
7598,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 61703-303-46)",Reverified,9/12/22,Available,,,Other,Oncology;Pediatric,Current,,
7599,Cytarabine Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,"2 g/20 mL (100 mg/mL), single dose vial (NDC 71288-109-20)",Reverified,5/18/22,"Currently, no inventory",,,Other,Oncology;Pediatric,Current,,
7600,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"2 g/20 mL (100 mg/mL), single dose vial (NDC 67457-452-20)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
7601,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 67457-455-52)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
7602,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 67457-454-50)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
7603,Cytotec (Misoprostol) Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 0025-1451-20),New,6/11/21,,,,,Gastroenterology,To be Discontinued,,
7604,Dacarbazine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,200 mg/vial (NDC 0143-9245-10),Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Oncology,Current,,
7605,Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 10x20mL (NDC 00703-5075-03),Reverified,10/5/22,Backordered – Est date of availability TBD,,,Demand increase for the drug,Oncology,Current,,
7606,Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 1x20mL (NDC 00703-5075-01),Reverified,10/5/22,Backordered – Est date of availability TBD,,,Demand increase for the drug,Oncology,Current,,
7607,Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per vial, Single Dose Amber Vial (NDC 63323-127-10)",Reverified,9/14/22,Available,,,Manufacturing delay,Oncology,Current,,
7608,Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per vial, Single Dose Amber Vial (NDC 63323-128-20)",Reverified,9/14/22,Available,,,Manufacturing delay,Oncology,Current,,
7609,Dacarbazine Injection,Teva,800-545-8800,NDC 0703-5075-03 (200 mg 10 X 20 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7610,Dacarbazine Injection,Teva,800-545-8800,NDC 0703-5075-01 (200 mg 1 X 20 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7611,Daptomycin Injection,"Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc.",800-672-6372,500 mg (NDC 67919-012-01),New,8/2/22,,,,,Anti-Infective,To Be Discontinued,8/2/22,8/2/22
7612,Daptomycin Injection,Pfizer,844-646-4398,350 mg lyophilized; 15 mL Single-dose vial (NDC 0409-5933-01),New,7/26/22,,Supply expected to exhaust 01Sep2022; Replaced with NDC 0409-0120-01; Discontinuation of the manufacture of the drug.,,,Anti-Infective,To Be Discontinued,7/26/22,7/26/22
7613,Daptomycin Injection,Pfizer,844-646-4398,500 mg lyophilized; 15 mL Single-dose vial (NDC 0409-2757-01),New,7/26/22,,Supply expected to exhaust 01Oct2022; Replaced with NDC 0409-0122-01; Discontinuation of the manufacture of the drug.,,,Anti-Infective,To Be Discontinued,7/26/22,7/26/22
7614,Daptomycin Injection,"Fresenius Kabi USA, LLC",888-386-1300,350mg (NDC 63323-585-15),New,5/17/22,,,,,Anti-Infective,To be Discontinued,,
7615,Daptomycin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500mg (NDCs 63323-371-10, 63323-371-19, and 63323-871-15)",New,5/17/22,,,,,Anti-Infective,To be Discontinued,,
7616,Daptomycin Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg (NDC 67919-011-01),New,10/8/21,,,,,Anti-Infective,To be Discontinued,,
7617,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"Extended release, 7.5 mg, 90 count bottle (NDC 0591-4375-19)",New,6/17/20,,,,,Urology,To be Discontinued,,
7618,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 30 count bottle (NDC: 0591-4380-30)",New,6/17/20,,,,,Urology,To be Discontinued,,
7619,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 30 (NDC 0430-0171-15)",New,6/4/20,,,,,Urology,To be Discontinued,,
7620,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of  90 (NDC 0430-0171-23)",New,6/4/20,,,,,Urology,To be Discontinued,,
7621,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg , 337500 TABLETS in 1 DRUM (NDC 0430-0171-00)",New,6/4/20,,,,,Urology,To be Discontinued,,
7622,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 7 (NDC 0430-0171-96)",New,6/4/20,,,,,Urology,To be Discontinued,,
7623,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 0430-0170-15)",New,6/4/20,,,,,Urology,To be Discontinued,,
7624,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of  90 (NDC 0430-0170-23)",New,6/4/20,,,,,Urology,To be Discontinued,,
7625,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, 337500 TABLETS in 1 DRUM (NDC 0430-0170-00)",New,6/4/20,,,,,Urology,To be Discontinued,,
7626,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, Bottle of 7 (NDC 0430-0170-96)",New,6/4/20,,,,,Urology,To be Discontinued,,
7627,Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets,Abbvie,800-255-5162,"200mg; 8.33mg; 50mg; 33.33 tablets, (NDC 0074-0063-28)",New,5/22/18,,,,,Antiviral,To be Discontinued,,
7628,Daunorubicin Hydrochloride Injection,Teva,800-545-8800,"20 mg/4 mL, 10 Single Dose Vial Tray (NDC 0703-5233-13)",New,8/11/22,,Product is temporarily unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7629,Daunorubicin Hydrochloride Injection (Novaplus®* Label),Teva Pharmaceuticals,800-545-8800,"5 mg/mL, 20 mg 4 mL/Vial x 10 (NDC 0703-5233-93)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Oncology,To be Discontinued,9/13/22,9/13/22
7630,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,180 mg/1 (NDC 00093-3516-56),New,7/20/20,,,,,Hematology,To be Discontinued,,
7631,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,90 mg/1 (NDC 00093-3517-56),New,7/20/20,,,,,Hematology,To be Discontinued,,
7632,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,360 mg/1 (NDC 00093-3515-56),New,7/20/20,,,,,Hematology,To be Discontinued,,
7633,Desmopressin Acetate Injection,Teva,800-545-8800,NDC 0703-5051-03 (4 mcg/mL 10 x 1 mL  Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Hematology; Endocrinology,To be Discontinued,8/11/22,8/11/22
7634,Desmopressin Acetate Injection,Teva,800-545-8800,NDC 0703-5054-01 (4 mcg/mL 10 mL Muti Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Hematology; Endocrinology,To be Discontinued,8/11/22,8/11/22
7635,Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,10 mcg/0.1mL (NDCs 55566-2500-0 and 69918-501-05),New,5/14/21,Unavailable,,,Other,Hematology,Current,,
7636,Desmopressin Acetate Nasal Spray,Apotex Corp.,800-706-5575,10 mcg/0.1mL (NDC 60505-0815-0),Reverified,8/22/22,Available,,,,Hematology,Current,,
7637,Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,"1.5 mg/mL, (NDC 0053-6871-00)",Revised,5/14/21,Unavailable,,,Other,Hematology,Current,,
7638,Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT),Janssen Pharmaceuticals,800-526-7736,ORTHO-CEPT (NDC 50458-196-15),Revised,10/8/14,,,,Discontinuation of the manufacture of the drug.,,To Be Discontinued,,
7639,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection SDV [4 mg / 1 ml] 25PK (NDC 67457-423-12),Reverified,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7640,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [20 mg / 5 ml] 25PK (NDC 67457-422-54),Reverified,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7641,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [120 mg / 30 ml] 25 PK (NDC 67457-421-30),Reverified,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7642,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [100 mg / 10 ml] 10PK (NDC 67457-420-10),Reverified,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7643,Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,4 mg/1 mL SDV (NDC 55150-237-01),Revised,9/28/22,On long term backorder,,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7644,Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,20 mg/5 mL MDV  (NDC 55150-238-05),Revised,9/28/22,On long term backorder,,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7645,Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,120 mg/30 mL MDV (NDC 55150-239-30),Revised,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7646,Dexamethasone Sodium Phosphate Injection,"Somerset Therapeutics, LLC",732-554-1019,"Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL, 1 mL Single Dose Vial (Preservative Free)(NDC 70069-021-25)",Reverified,4/20/22,Available,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7647,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mg per 5 mL (4 mg per mL); MDV;  Amber vial (NDC 63323-165-05),Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7648,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per 10 mL (10 mg per mL); MDV;  Amber Vial (NDC 63323-516-10),Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7649,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30),Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7650,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01),Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7651,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01),Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7652,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6145-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7653,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 5 mL vial (NDC 0641-6146-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7654,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-0367-25)",Revised,4/8/22,Inventory is currently available,,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7655,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-106-10)",Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7656,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-109-10)",Revised,9/14/22,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7657,Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,10 mg/1 mL SDV (NDC 55150-304-25),Revised,9/28/22,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7658,Dexamethasone Sodium Phosphate Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),866-850-2876,100 mg/10 mL MDV (contains preservative)(NDC 55150-305-10),Revised,9/28/22,Backordered — next shipment TBD,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
7659,Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"200mcg/50mL, single dose bag (NDC 55150-296-10)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7660,Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"400mcg/100mL, single dose bag (NDC 55150-297-10)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7661,Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1388-8 box of 20; NDC 70121-1388-1 individual)",Reverified,4/7/22,Available,,,,Anesthesia,Current,,
7662,Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1389-7 box of 10; NDC 70121-1389-1 individual)",Reverified,4/7/22,Available,,,,Anesthesia,Current,,
7663,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.2 mg / 50 ml (Solution in Single Use Vials/Bottles), 20PK (NDC 67457-924-50)",Revised,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7664,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.4 mg / 100 ml (Solution in Single Use Vials/Bottles), 10PK (NDC 67457-925-10)",Revised,9/28/22,Available,,,Demand increase for the drug,,Current,,
7665,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"200 mcg/50 mL (4 mcg/mL), 50 mL single dose vial, box of 25 (NDC 42023-186-20)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
7666,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"400 mcg/100 mL (4 mcg/mL), 100 mL single dose vial, box of 10 (NDC 42023-187-10)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
7667,Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-976-58)",Reverified,9/28/22,Inventory available,,,,Anesthesia,Current,,
7668,Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-975-58)",Reverified,9/28/22,Inventory available,,,,Anesthesia,Current,,
7669,Dexmedetomidine Injection,Hong Kong King Friend Industrial Co. Ltd.,844-824-8426,"200 mcg/2 mL (100 mcg/mL) single dose vial, box of 25 (NDC 71288-505-03)",Reverified,4/7/22,Available,,,,Anesthesia,Current,,
7670,Dexmedetomidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mcg/mL, 2 mL vial (NDC 0143-9532-25)",Reverified,4/8/22,Inventory is currently available,,,Demand increase for the drug,Anesthesia,Current,,
7671,Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-239-93)",Reverified,4/21/22,Available,,,,Anesthesia,Current,,
7672,Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-432-93), Novaplus",Reverified,4/21/22,Available,,,,Anesthesia,Current,,
7673,Dexmedetomidine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 55150-209-02)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7674,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 0338-9555-24)",Reverified,9/28/22,Available,,,,Anesthesia,Current,,
7675,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 0338-9557-12)",Reverified,9/28/22,Available,,,,Anesthesia,Current,,
7676,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 43066-555-24), Novaplus",Reverified,9/28/22,Available,,,,Anesthesia,Current,,
7677,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 43066-557-12), Novaplus",Reverified,9/28/22,Available,,,,Anesthesia,Current,,
7678,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 63323-671-20)",Reverified,9/14/22,Backordered. Next release September 2022.,,,Demand increase for the drug,Anesthesia,Current,,
7679,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 25 (NDC 63323-671-50)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7680,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 63323-671-00)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7681,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 63323-421-02)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7682,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/4 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-600-04)",Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7683,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"1000 mcg/10 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-601-04)",Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7684,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"200 mcg/50 mL (4 mcg/mL), single dose bag, box of 24 (NDC 44567-602-24)",Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7685,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/100 mL (4 mcg/mL), box of 24 (NDC 44567-603-24)",Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7686,Dexmedetomidine Injection,Jiangsu Hengrui Medicine Co. Ltd.,Athenex: 855-273-0154,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 70860-605-03)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7687,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 67457-251-02)",Revised,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
7688,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"100 mcg/mL, 2 mL single dose vial, box of 25 (NDC 42023-146-25)",Reverified,9/21/22,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
7689,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 0409-1660-20)",Revised,9/12/22,Depleted. Next Delivery and Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
7690,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 20 (NDC 0409-1660-50)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia,Current,,
7691,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 0409-1660-10)",Revised,9/12/22,Available,,,Other,Anesthesia,Current,,
7692,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 0409-1638-02)",Revised,9/12/22,Available,,,Other,Anesthesia,Current,,
7693,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 50 mL single dose bottle, box of 20 (NDC 71225-126-05)",Revised,6/1/22,Available,,,,Anesthesia,Current,,
7694,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 100 mL single dose bottle, box of 10 (NDC 71225-126-06)",Revised,6/1/22,Available,,,,Anesthesia,Current,,
7695,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-1070-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,
7696,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100s (NDC 0378-1071-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,
7697,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-1072-01)",New,5/8/18,,,,,Neurology;Pediatric;Psychiatry,To be Discontinued,,
7698,Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 250 mL Viaflex Plastic Container. Product Code 2B0162Q (NDC 0338-0023-02)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7699,Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 500 mL Viaflex Plastic Container. Product Code 2B0163Q (NDC 0338-0023-03)",Revised,9/28/22,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7700,Dextrose 10% Injection,Baxter Healthcare,888-229-0001,"10% Dextrose Injection, 1000 mL Viaflex Plastic Container. Product Code 2B0164X (NDC 0338-0023-04)",Revised,9/28/22,Available,,,Manufacturing Delay,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7701,Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00),New,3/1/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7702,Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 500 mL Excel Bag L5201 (NDC 0264-7520-10),New,3/1/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7703,Dextrose 10% Injection,B. Braun Medical Inc.,800-227-2862,10% 250 mL Excel Bag L5202 (NDC 0264-7520-20),New,3/1/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7704,Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (25 grams per 250 mL) (NDC 63323-824-74)",Reverified,9/14/22,Backordered. Next release September 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7705,Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (50 grams per 500 mL) (NDC 63323-824-75)",Reverified,9/14/22,Backordered. Next release October 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7706,Dextrose 10% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10% Dextrose Injection, Single dose freeflex bag, (100 mg per mL), (100 grams per 1,000 mL) (NDC 63323-824-76)",Reverified,9/14/22,Backordered. Next release September 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7707,Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7930-02), (ICU Medical NDC 0990-7930-02)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7708,Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7930-03), (ICU Medical NDC 0990-7930-03)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7709,Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7930-09), (ICU Medical NDC 0990-7930-09)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7710,Dextrose 10% Injection,"ICU Medical, Inc.",877-946-7747,"10% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7938-19) (ICU Medical NDC 0990-7938-19)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7711,Dextrose 25% Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"2.5 g/10 mL (250 mg/mL), plastic syringe, 10 per bundle (NDC 0409-1775-10)",Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
7712,Dextrose 5% Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7713,Dextrose 5% Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7714,Dextrose 5% Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02),Revised,9/12/22,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7715,Dextrose 5% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61)",Revised,9/14/22,Backordered. Next release October 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7716,Dextrose 5% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74)",Revised,9/14/22,Backordered. Next release September 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7717,Dextrose 5% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75)",Revised,9/14/22,Backordered. Next release October 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7718,Dextrose 5% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10)",Revised,9/14/22,Available,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7719,Dextrose 5% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50)",Revised,9/14/22,Backordered. Next release October 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7720,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02)",Reverified,10/3/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7721,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61)",Reverified,10/3/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7722,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13)",Reverified,10/3/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7723,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20)",Reverified,10/3/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7724,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23)",Reverified,10/3/22,Allocated to Contracted Customers Only,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7725,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36)",Reverified,10/3/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7726,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7727,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7728,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7729,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7730,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7731,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7732,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7733,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38)",Revised,9/28/22,"Limited Supply, Recovery late Sept 2022",,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7734,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7735,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30)",Revised,9/28/22,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7736,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30)",Revised,9/28/22,Available on allocation,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7737,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18)",Revised,9/28/22,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7738,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7739,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7740,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7741,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7742,Dextrose 5% Injection,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7743,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 500 mL Excel Bag L5101 (NDC 0264-7510-10),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7744,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7745,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 250 mL Excel Bag L5102 (NDC 0264-7510-20),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7746,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7747,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7748,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7749,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 500 mL Excel Bag L5201 (NDC 0264-7520-10),New,2/16/22,Product available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7750,Dextrose 5% Injection,B. Braun Medical Inc.,800-227-2862,10% 250 mL Excel Bag L5202 (NDC 0264-7520-20),New,2/16/22,Product on allocation for contracted customers,,,Other,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7751,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7752,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7753,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 50 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-06) (ICU Medical NDC 0990-7923-06)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7754,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 100 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-11) (ICU Medical NDC 0990-7923-11)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7755,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 250 mL VisIV™ Container (Legacy Hospira NDC 0409-7922-25) (ICU Medical NDC 0990-7922-25)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7756,Dextrose 5% Injection,"ICU Medical, Inc.",877-946-7747,"5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09)",Reverified,10/3/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Other;Pediatric,Current,,
7757,Dextrose 50% Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"25 g/50 mL (0.5 g/mL), syringe, 10 per carton (NDC 76329-3302-1) (old NDC 76329-3301-1)",Reverified,8/12/22,Backorder due to increase in demand,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
7758,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,"25 g/50 mL (0.5 g/mL), plastic syringe, 10 per bundle (NDC 0409-7517-16)",Revised,9/30/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
7759,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,"25 g/50 mL (0.5 g/mL), glass syringe, 10 per bundle (NDC 0409-4902-34)",Revised,9/30/22,Next Delivery: October 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
7760,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,"25 g/50 mL (0.5 g/mL), single dose vial, 25 per tray (NDC 0409-6648-02)",Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: July 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
7761,Diazepam Oral Solution (Concentrate),"Lannett Company, Inc.",215-333-9300,5 mg/mL (NDC 0527-1768-36),New,1/5/22,,,,,Neurology,To be Discontinued,,
7762,Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel - 10mg 2 Syrg per pack, (NDC 68682-652-20)",Revised,9/22/22,Available,Estimated availability September 2022,,,Neurology,Current,,
7763,Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel – 2.5mg 2 Syrg per pack, (NDC 68682-650-20)",Revised,9/22/22,Currently unavailable,Estimated availability: TBD,,,Neurology,Current,,
7764,Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Rectal Gel 2.5mg (NDC  66490-650-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,
7765,Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Acudial 10 mg (NDC 0187-0658-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,
7766,Diazepam Rectal Gel,Bausch Health,908-927-1400,Diastat Acudial 20 mg (NDC 0187-0659-20),Revised,9/22/22,No longer available,No plans to manufacture.  All volumes converted to generic version,,,Neurology,Current,,
7767,Diazepam Rectal Gel,Bausch Health,908-927-1400,"Diazepam Rectal Gel - 20mg 2 Syrg per pack, (NDC 68682-655-20)",Revised,9/22/22,Available,,,,Neurology,Current,,
7768,Diclofenac Sodium Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0355-01),New,4/4/18,,,,,Analgesia/Addiction;Rheumatology,To be Discontinued,,
7769,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,
7770,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,
7771,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01)",New,5/9/18,,,,,Antiviral,To be Discontinued,,
7772,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-063-15),New,7/6/21,,,,,Dermatology,To be Discontinued,,
7773,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-063-30),New,7/6/21,,,,,Dermatology,To be Discontinued,,
7774,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-063-60),New,7/6/21,,,,,Dermatology,To be Discontinued,,
7775,Diflunisal Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"500 mg, Bottle of 60 (NDC 14539-673-06)",Revised,9/7/22,"Product is available, on allocation",,,Demand increase for the drug,Analgesia/Addiction,Current,,
7776,Diflunisal Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"500 mg, Bottle of 100 (NDC 14539-673-01)",Revised,9/7/22,"Product is available, on allocation",,,Demand increase for the drug,Analgesia/Addiction,Current,,
7777,Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 100 (NDC 0093-9222-01)",Revised,10/5/22,Available,,,Other,Analgesia/Addiction,Current,,
7778,Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 500 (NDC 0093-9222-05)",Revised,10/5/22,"Backorder, Recovery expected Jan-23",,,Other,Analgesia/Addiction,Current,,
7779,Diflunisal Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, Bottle of 60 (NDC 0093-9222-06)",Revised,10/5/22,Available,,,Other,Analgesia/Addiction,Current,,
7780,Difluprednate (Durezol) Ophthalmic Emulsion,Novartis,888-669-6682,0.05% 5mL in 8mL bottle (NDC 0065-9204-07),Revised,10/15/19,,,,,Ophthalmology,Resolved,,
7781,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) Ampule (NDC 0515-260-10),Revised,10/6/21,Available,,,Delay in shipping of the drug,Cardiovascular,Current,,
7782,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) vial (NDC 70515-261-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
7783,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) ampoule (NDC 70515-262-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
7784,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) vial (NDC 70515-263-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
7785,Digoxin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"250 mcg/mL, 2 mL  (NDC 0641-1410-35)",Reverified,4/8/22,Inventory is currently available,,,Other,Cardiovascular,Current,,
7786,Digoxin Injection,Sandoz,800-525-8747,500mcg/2 mL; 10 ampules (NDC 0781-3059-95),Reverified,10/3/22,"Unavailable, resupply Q4 2022/Q1 2023",,,Shortage of an active ingredient,Cardiovascular,Current,,
7787,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1171-02),New,6/8/21,,,,,Cardiovascular,To be Discontinued,,
7788,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,
7789,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,
7790,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",New,4/8/22,,,,,Cardiovascular,To be Discontinued,,
7791,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,25 mg/5mL vial (NDC 70860-301-05),Reverified,9/28/22,On allocation,,,,Cardiovascular,Current,,
7792,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,50 mg/10mL vial (NDC 70860-301-10),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
7793,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,125 mg/25mL vial (NDC 70860-301-25),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
7794,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 5 mL vial  (NDC 0641-6013-10)",Revised,8/26/22,Inventory is currently available,,,Demand increase for the drug,Cardiovascular,Current,,
7795,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial (NDC 0641-6014-10)",Revised,8/26/22,Inventory is currently available,,,Demand increase for the drug,Cardiovascular,Current,,
7796,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 30 mL vial (NDC 0641-6015-10)",Revised,8/26/22,Inventory is currently available,,,Demand increase for the drug,Cardiovascular,Current,,
7797,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
7798,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-02),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
7799,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10)",Revised,4/8/22,"On allocation, then discontinued.",,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
7800,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",Revised,4/8/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
7801,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",Revised,4/8/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
7802,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",Revised,4/8/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
7803,Dimercaprol (Bal in Oil) Injection,Akorn Pharmaceuticals,800-932-5676,"3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03)",Revised,6/29/21,,,Available,,Hematology;Other,Resolved,,
7804,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"100 mg capsules, bottle of 100 (NDC 59762-0386-1)",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
7805,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"150 mg capsules, bottle of 100 (NDC 59762-0400-1)",Reverified,9/12/22,Next Delivery & Recovery: October 2022,,,,Cardiovascular,Current,,
7806,Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"100 mg capsules, bottle of 100 (NDC 0093-3127-01)",Reverified,10/5/22,Product is Available,,,,Cardiovascular,Current,,
7807,Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg capsules, bottle of 100 (NDC 0093-3129-01)",Reverified,10/5/22,"Backorder, Recovery expected March 2023",,,,Cardiovascular,Current,,
7808,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 100 mg capsules, bottle of 100 (NDC 0025-2732-31)",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
7809,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 150 mg capsules, bottle of 100 (NDC 0025-2742-31)",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
7810,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 100 mg capsules; bottle of 100 (NDC 0025-2752-31)",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
7811,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 150 mg capsules; bottle of 100 (NDC 0025-2762-31)",Reverified,9/12/22,Next Delivery and Estimated Recovery: September 2022,,,,Cardiovascular,Current,,
7812,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100s (NDC 0378-4140-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
7813,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100s (NDC 0378-4141-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
7814,Dobutamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793",Reverified,9/28/22,"Limited Supply on Allocation, Recovery Q4",Third-Party Supplier Issue,,Third-Party Supplier Issue,Cardiovascular;Pediatric;Renal,Current,,
7815,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
7816,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
7817,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32),Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Cardiovascular;Pediatric;Renal,Current,,
7818,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
7819,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
7820,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01),Revised,9/12/22,Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: February 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
7821,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: February 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
7822,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,125 mcg (0.125 mg) capsules; Bottle of 60 (NDC 59762-0037-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,
7823,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,250 mcg (0.25 mg) capsules; Bottle of 60 (NDC 59762-0038-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,
7824,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4535,500 mcg (0.5 mg) capsules; Bottle of 60 (NDC 59762-0039-2),New,5/21/21,,,,,Cardiovascular,To be Discontinued,,
7825,Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 5 mL vial (NDC 0143-9252-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Cardiovascular,Current,,
7826,Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 10 mL vial (NDC 0143-9254-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Cardiovascular,Current,,
7827,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"400 mg/250 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-22)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Cardiovascular,Current,,
7828,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/500 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-24)",Revised,9/12/22,Next Delivery and Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
7829,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/250 mL (3,200 mcg/mL); Flexible Container (NDC 00409-7810-22)",Revised,9/12/22,Next Delivery and Estimated Recovery: November 2022,,,Demand increase for the drug,Cardiovascular,Current,,
7830,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-5820-01),Revised,9/12/22,Available,,,Other,Cardiovascular,Current,,
7831,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/10 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9104-20),Revised,9/12/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,
7832,Dopamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"800 mcg/mL (250 mL bag) Product code 2B0832 (NDC 0338-1005-02), 800 mcg/mL (500 mL bag)  Product code 2B0833 (NDC 0338-1005-03), 1600 mcg/mL (250 mL bag) Product code 2B0842 (NDC 0338-1007-02), 1600 mcg/mL (500 mL bag) Product code 2B0843 (NDC 0338-1007-0",Revised,8/12/22,Available,,,,Cardiovascular,Current,,
7833,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 17478-605-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7834,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 50383-233-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7835,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt-PF® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 0.2 mL single use, 60 count (NDC 17478-604-30)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7836,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 61314-030-02)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7837,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 24208-486-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7838,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Aurobindo Pharma,866-850-2876,"Dorzolamide HCl and Timolol Maleate (Cosopt® PF) Ophthalmic Solution 2%/0.5% Preservative Free, 2mL single use container (NDC 65862-0947-60)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7839,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 0591-2482-79)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7840,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,
7841,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,
7842,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",New,4/20/18,,,,,Ophthalmology,To be Discontinued,,
7843,Dorzolamide Hydrochloride Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 61314-019-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7844,Dorzolamide Hydrochloride Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 50383-232-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7845,Dorzolamide Hydrochloride Ophthalmic Solution,Merck Sharp & Dohme Corp.,800-637-2579,"Trusopt® Dorzolamide hydrochloride ophthalmic solution 2%, for topical ophthalmic use 10ml, (NDC 0006-3519-36)",New,4/11/22,,,,,Ophthalmology,To be Discontinued,,
7846,Dorzolamide Hydrochloride Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride USP 2%, 10 mL (NDC 24208-485-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,,
7847,Doxepin Hydrochloride Oral Solution,Wockhardt Bio A.G.,847-410-6929,"10gm/mL, 118 mL (NDC 60432-651-04)",New,7/26/22,,Discontinuing the manufacture of the product due to business reasons,,,Neurology,To Be Discontinued,7/26/22,7/26/22
7848,Doxercalciferol Injection,Hospira,844-646-4398,4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vial (NDC 00409-1330-01),New,9/12/22,,Discontinuation of the manufacture of the drug,,,Endocrinology/Metabolism,To be Discontinued,9/12/22,9/12/22
7849,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg  (NDC 49884-726-01),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,
7850,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",100mg  (NDCs 49884-0727-03 and 49884-0727-04),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,
7851,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",150mg  (NDC 49884-0305-02),New,6/28/22,,,,,Anti-Infective,To be Discontinued,,
7852,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",50mg (NDC 49884-726-01),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,
7853,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",100mg (NDCs 49884-727-03 and 49884-727-04),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,
7854,Doxycycline Capsules,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",150mg (NDC 49884-305-02),New,1/31/22,,,,,Anti-Infective,To be Discontinued,,
7855,Doxycycline Hyclate Powder for Suspension,"Hospira, Inc.",844-646-4398,25mg/5mL (NDC 0069-0970-65),New,11/15/21,,,,,Anti-Infective,To be Discontinued,,
7856,Doxycycline Hyclate Tablets,Teva Pharmaceuticals,800-545-8800,"75 mg tablets, 60 count (NDC 0591-6100-60)",Revised,6/22/22,,,,,Anti-Infective,To be Discontinued,,
7857,Doxycycline Hyclate Tablets,Teva Pharmaceuticals,800-545-8800,150mg  (NDC 0591-6125-60),New,6/21/22,,,,,Anti-Infective,To be Discontinued,,
7858,Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Fera Pharmaceuticals,516-277-1448,Phospholine Iodide 0.125% echothiophate iodide for ophthalmic solution 5ml (NDC 48102-053-05),Revised,6/1/22,"Available starting June 1st, 2022 through limited distribution by AllianceRx Walgreens Prime Specialty Pharmacy.",,,Delay in manufacturing,Ophthalmology,Current,,
7859,Efavirenz Capsules,Bristol-Myers Squibb Co.,800-332-2056,50mg (NDC 0056-0470-30),New,9/28/22,,"Product available until March 31, 2023.",,,Antiviral,To be Discontinued,9/28/22,9/28/22
7860,Efavirenz Capsules,Bristol-Myers Squibb Co.,800-332-2056,200mg (NDC 0056-0474-92),New,9/28/22,,"Product available until March 31, 2023.",,,Antiviral,To be Discontinued,9/28/22,9/28/22
7861,Efavirenz Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,600 mg (NDC 0378-2233-93),New,11/2/21,,,,,Antiviral,To be Discontinued,,
7862,Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2.5mg/2mL, vial (NDC 0143-9786-10)",Reverified,4/8/22,This presentation is currently available.,,,Demand increase for the drug,Cardiovascular,Current,,
7863,Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1.25mg/mL, vial  (NDC 0143-9787-10)",Reverified,4/8/22,This presentation is currently available.,,,Demand increase for the drug,Cardiovascular,Current,,
7864,"Epinephrine Injection, 0.1 mg/mL","Hospira, Inc.",844-646-4398,1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4933-01),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pulmonary/Allergy,Current,,
7865,"Epinephrine Injection, 0.1 mg/mL","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"0.1mg/mL, 10mL, (NDC 76329-3316-1)",Reverified,8/12/22,Backorder due to the increase in demands,,,Demand increase for the drug,Cardiovascular;Pulmonary/Allergy,Current,,
7866,"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.3 mg EpiPen® (NDC 49502-500-02); Authorized Generic (NDC 49502-102-02),Reverified,9/28/22,Available,,,,Pulmonary/Allergy,Current,,
7867,"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.15 mg EpiPen® (NDC 49502-501-02); Authorized Generic (NDC 49502-101-02),Reverified,9/28/22,Available,,,,Pulmonary/Allergy,Current,,
7868,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)",Revised,10/3/22,Available,,,,Pulmonary/Allergy,Current,,
7869,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)",Revised,10/3/22,Available,,,,Pulmonary/Allergy,Current,,
7870,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)",Reverified,1/27/21,Available,,,,Pulmonary/Allergy,Current,,
7871,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)",Reverified,1/27/21,Available,,,,Pulmonary/Allergy,Current,,
7872,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)",Reverified,1/27/21,Available,,,,Pulmonary/Allergy,Current,,
7873,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)",Reverified,10/5/22,Available,,,,Pulmonary/Allergy,Current,,
7874,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 78670-130-02))",Revised,5/19/22,Available,,,,Pulmonary/Allergy,Current,,
7875,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 78670-131-02)",Revised,5/19/22,Available,,,,Pulmonary/Allergy,Current,,
7876,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)",Reverified,10/5/22,Available,,,,Pulmonary/Allergy,Current,,
7877,Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,NDC 0703-9258-09 ( 2 x 50 mL vials Sterile Diluent),New,9/12/22,,Product is available with an expected supply duration until AUG' 2022.  No future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22
7878,Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,"NDC 0703-1985-01 (0.5 mg/vial (500,000 ng))",New,9/12/22,,Product is unavailable and no future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22
7879,Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection,Teva,800-545-8800,"NDC 0703-1995-01 (1.5 mg/vial (1,500,000 ng))",New,9/12/22,,Product is unavailable and no future production expected for an extended period.,,,,To be Discontinued,9/12/22,9/12/22
7880,Eptifibatide Injection,Teva Pharmaceuticals,800-545-8800,"0.75 mg/mL, 75 mg, 100 mL/Vial (NDC 0703-1179-01)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Cardiovascular,To be Discontinued,9/13/22,9/13/22
7881,Ergotamine Tartrate and Caffeine (Cafergot) Tablets,Sandoz,800-525-8747,1mg/100mg (NDC 0781-5405-01),New,7/2/20,,,,,Neurology,To be Discontinued,,
7882,Ertapenem Injection,"Merck Sharp & Dohme Corp. a subsidiary of Merck and Co., Inc.",800-672-6372,1g (NDC 0006-3843-71),New,8/2/22,,,,,Anti-Infective,To Be Discontinued,8/2/22,8/2/22
7883,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-070-35),Revised,8/1/22,Unavailable. Estimated availability 1Q2023.,New manufacturing site being qualified.,,Discontinuation of manufacture of the drug (from existing site).,Ophthalmology; Pediatric,Current,,
7884,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g tube (unit dose) (NDC17478-070-31),Revised,8/1/22,Unavailable. Estimated availability 1Q2023.,New manufacturing site being qualified.,,Discontinuation of manufacture of the drug (from existing site).,Ophthalmology; Pediatric,Current,,
7885,Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 1 gram, 50-count (00574-4024-50)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,
7886,Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 3.5 gram, 1-count (00574-4024-35)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,
7887,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,"Erythromycin Ophthalmic Ointment USP, 0.5% 3.5 g in 1 tube (NDC 24208-910-55)",Revised,8/1/22,Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis.,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,
7888,Erythromycin Ophthalmic Ointment,Padagis US LLC,763-732-0225,"Erythromycin 0.5% Ophthalmic Ointment 3.5 gram, 24-count (00574-4024-39)",Revised,8/1/22,Available and shipping,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,
7889,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,"Erythromycin Ophthalmic Ointment USP, 0.5% 1 g in carton of 50 (NDC 24208-910-19)",Revised,8/1/22,Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis.,,,Demand increase for the drug,Ophthalmology; Pediatric,Current,,
7890,Esomeprazole Sodium for Injection,"Mylan Institutional, a Viatris company",800-796-9526,"40 mg vial, box of 10 (NDC 67457-392-99)",New,9/16/21,,,,,Gastroenterology;Pediatric,To be Discontinued,,
7891,Ethambutol Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,400mg  (NDC 0555-0923-02),New,11/5/21,,,,,Anti-Infective,To be Discontinued,,
7892,Etomidate Injection,"Avet Pharmaceuticals, Inc.",855-228-9470,20 mg/10mL carton of 10 (NDC 23155-160-41),New,10/5/22,Product available upon request,,,,Anesthesia,Current,,
7893,Etomidate Injection,"Avet Pharmaceuticals, Inc.",855-228-9470,40 mg/20 mL carton of 10 (NDC 23155-160-42),New,10/5/22,Product available upon request,,,,Anesthesia,Current,,
7894,Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 20 mL vial (NDC 25021-674-20)",New,10/5/22,Available,Marketed by Sagent,,,Anesthesiology,Current,,
7895,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 72572-160-10)",New,10/5/22,Pending information,Distributed by Civica,,,Anesthesiology,Current,,
7896,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 72572-161-10)",New,10/5/22,Pending information,Distributed by Civica,,,Anesthesiology,Current,,
7897,Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 10 mL vial (NDC 65219-445-10)",New,10/5/22,Available,Marketed by Fresenius Kabi,,,Anesthesiology,Current,,
7898,Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 20 mL vial (NDC 65219-447-20)",New,10/5/22,Available,Marketed by Fresenius Kabi,,,Anesthesiology,Current,,
7899,Etomidate Injection,"Caplin Steriles, Ltd.",,"2 mg/mL, 10 mL vial (NDC 25021-674-10)",New,10/5/22,Available,Marketed by Sagent,,,Anesthesiology,Current,,
7900,Etomidate Injection,"Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.)",,"2 mg/mL, 10 mL vial (NDC 55150-221-10)",New,10/5/22,Currently on backorder,Next shipment anticipated in Oct.,,Other,Anesthesiology,Current,,
7901,Etomidate Injection,"Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.)",,"2 mg/mL, 20 mL vial (NDC 55150-222-10)",New,10/5/22,Currently on backorder,Next shipment TBD,,Other,Anesthesiology,Current,,
7902,Etomidate Injection,Gland Pharma Limited,,"2 mg/mL, 10 mL vial (NDC 72266-146-10)",New,10/5/22,Pending information,"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",,,Anesthesiology,Current,,
7903,Etomidate Injection,Gland Pharma Limited,,"2 mg/mL, 20 mL vial (NDC 72266-147-10)",New,10/5/22,Pending information,"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",,,Anesthesiology,Current,,
7904,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9506-10)",New,10/5/22,Currently on backorder,,,Demand increase for the drug,Anesthesiology,Current,,
7905,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9507-10)",New,10/5/22,Currently on backorder,,,Demand increase for the drug,Anesthesiology,Current,,
7906,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus",New,10/5/22,Pending information,,,,Anesthesiology,Current,,
7907,Etomidate Injection,"Hikma Pharmaceuticals, LLC (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus",New,10/5/22,Pending information,,,,Anesthesiology,Current,,
7908,Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 10 mL vial (NDC 67457-902-10)",New,10/5/22,Q1 2023,,,Demand increase for the drug,Anesthesiology,Current,,
7909,Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 20 mL vial (NDC 67457-903-20)",New,10/5/22,Available,,,,Anesthesiology,Current,,
7910,Etomidate Injection,"Hospira, Inc., a Pfizer Company",800-646-4398,"Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01)",New,10/5/22,Next delivery: March 2023; Estimated recovery: December 2023,Manufacturing Delay,,Other,Anesthesiology,Current,,
7911,Etomidate Injection,"Hospira, Inc., a Pfizer Company",800-646-4398,"Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02)",New,10/5/22,Next delivery: February 2023; Estimated recovery: March 2023,Manufacturing Delay,,Other,Anesthesiology,Current,,
7912,Etoposide (Toposar) Injection,Teva,800-545-8800,NDC 0703-5653-01 (100 mg/5 mL (20 mg/mL) 5 mL Multiple-dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7913,Etoposide (Toposar) Injection,Teva,800-545-8800,NDC 0703-5656-01 (500 mg/25 mL (20 mg/mL) 25 mL Multiple-dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7914,Etoposide (Toposar) Injection,Teva,800-545-8800,DC 0703-5657-01 (1 gram/50 mL (20 mg/mL) 50 mL Multiple-dose Vial ),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
7915,Exenatide (BYDUREON) Extended Release for Injectable Suspension,AstraZeneca,800-236-9933,"BYDUREON® (exenatide extended-release) for injectable suspension, for subcutaneous use;  Single Dose Tray presentation; (2 mg) (NDC 0310-6520-04)",New,4/3/18,,,,,Endocrinology/Metabolism,To be Discontinued,,
7916,Famotidine Injection,Baxter Healthcare,888-229-0001,"Famotidine Injection premix, 20mg/50 mL in GALAXY Plastic Container (NDC 0338-5197-41)",Reverified,9/28/22,"Stocked Out, Recovery Q4",,Available,,Gastroenterology,Resolved,,
7917,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 2 mL vial (NDC 0641-6022-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7918,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 4 mL vial (NDC 0641-6023-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7919,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6021-10)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7920,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7921,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7922,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7923,Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [200 mg / 20 ml] 10PK (NDC 67457-457-20),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7924,Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 70860-751-02 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7925,Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"200 mg per 20 mL(10 mg per mL), multiple dose vial with preservatives, (NDC 70860-751-20 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7926,Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Single Dose Vials) [20 mg / 2 ml] 25PK (NDC 67457-433-22),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7927,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 100 Count (NDC 0172-5728-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7928,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 1000 Count (NDC 0172-5728-80),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7929,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 500 Count (NDC 0172-5728-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7930,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 100 Count (NDC 0172-5729-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7931,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 500 Count (NDC 0172-5729-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7932,Famotidine Tablets,Aurobindo Pharma,732-839-9400,20 mg - 100/Bottle (NDC 65862-859-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7933,Famotidine Tablets,Aurobindo Pharma,732-839-9400,40 mg - 100/Bottle (NDC 65862-860-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7934,Famotidine Tablets,Alembic Pharmaceuticals,908-393-9604,20 mg Bottle of 100 counts (NDC 62332-001-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7935,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,20 mg Bottle of 1000 counts (NDC 62332-001-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7936,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 100 counts (NDC 62332-002-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7937,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 500 counts (NDC 62332-002-71),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7938,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 1000 counts (NDC 62332-002-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7939,Famotidine Tablets,"Carlsbad Technology, Inc.",,20mg 100 count (NDC 61442-121-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7940,Famotidine Tablets,"Carlsbad Technology, Inc.",,20 mg 1000 count (NDC 61442-121-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7941,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 100 count (NDC 61442-122-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7942,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 1000 count (NDC 61442-122-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,,
7943,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,40 mg (NDC 55111-796-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,,
7944,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,80 mg (NDC 55111-797-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,,
7945,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,40mg  (NDC NDC 55111-796-30),New,11/30/21,,,,,Rheumatology,To be Discontinued,,
7946,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,80mg  (NDC NDC 55111-797-30),New,11/30/21,,,,,Rheumatology,To be Discontinued,,
7947,Febuxostat Tablets,"Mylan, A Viatris company",800-796-9526,40mg T 30s (NDC 0378-3925-93),New,9/21/22,,,,,Rheumatology,To be Discontinued,9/21/22,9/21/22
7948,Febuxostat Tablets,"Mylan, A Viatris company",800-796-9526,80mg T 30s (NDC 0378-3926-93),New,9/21/22,,,,,Rheumatology,To be Discontinued,9/21/22,
7949,Fenoldopam Mesylate (Corlopam) Injection,Pfizer,844-646-4398,20 mg/2 mL (10 mg/mL) Single Dose Vial (NDC 00409-3373-02),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22
7950,Fenoldopam Mesylate (Corlopam) Injection,Pfizer,844-646-4398,10 mg/mL (10 mg/mL) Single Dose Vial (NDC 00409-3373-01),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22
7951,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mcg per 1 mL (50 mcg per mL) Single Dose Simplist PFS  (NDC 63323-808-11),Revised,9/14/22,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7952,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 1 mL vial
(NDC 0641-6247-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7953,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL)  SDV (NDC 63323-806-20)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7954,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50)",Revised,9/14/22,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7955,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01),Revised,9/14/22,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7956,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02),Revised,9/14/22,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7957,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05),Revised,9/14/22,Backordered. Next release not available at this time.,,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
7958,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32),Revised,9/12/22,Next Delivery and Estimated Recovery: February 2025,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7959,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32),Revised,9/12/22,Next Delivery and Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7960,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35),Revised,9/12/22,Limited Supply Available. Next Delivery: January 2023; Estimated Recovery: May 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7961,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,1000 mcg/20 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-38),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Pediatric,Current,,
7962,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7963,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7964,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28),Revised,9/12/22,Limited Supply Available. Next Delivery: December 2022; Estimated Recovery: March 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7965,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31)",Revised,9/12/22,Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7966,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
7967,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL ampul (NDC 0641-6024-10),Revised,4/8/22,Currently not available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7968,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL ampul (NDC 0641-6025-10),Revised,4/8/22,Currently not available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7969,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL ampul (NDC 0641-6026-05),Revised,4/8/22,Currently not available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7970,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 2 mL vial
(NDC 0641-6027-25)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7971,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 5 mL vial
(NDC 0641-6028-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7972,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL vial (NDC 0641-6029-25),Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7973,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL  50 mL vial
(NDC 0641-6030-01)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
7974,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule 10 pack (NDC 17478-0030-02),Revised,2/12/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
7975,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule; 25 pack (NDC 17478-0030-25),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
7976,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 10 pack (NDC 17478-0030-05),Revised,2/12/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
7977,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,20 mL ampule (NDC 17478-0030-20),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
7978,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 25 pack (NDC 17478-0030-55),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
7979,Finasteride Tablets,Mylan Pharmaceuticals Inc.,800-RXMYLAN (1-800-796- 9526),5 mg tablet (NDC 0378-5036-05)(NDC 0378-5036-77)(NDC 0378-5036-93),New,5/23/18,,,,,Urology,To be Discontinued,,
7980,Floxuridine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9270-01),Reverified,4/8/22,This presentation is temporarily on backorder.,,,Other,Oncology,Current,,
7981,Fluconazole (Diflucan) Tablets,"Hospira, Inc.",844-646-4398,50 mg tablets; Bottle of 30 (NDC 00049-3410-30),New,9/15/22,,Stock anticipated to be available through October 2022; Discontinuation of the manufacture of the drug,,,Anti-Infective,To be Discontinued,9/15/22,9/15/22
7982,Fludarabine Phosphate Injection,Areva Pharmaceuticals,812-399-0479,50 mg/2 mL (NDC 59923-604-02),New,10/3/22,Product anticipated mid/late October 2022,,,,Oncology,Current,,
7983,Fludarabine Phosphate Injection,Teva Pharmaceuticals,800-545-8800,"Lyophilized Powder for Injection, 50 mg /vial (NDC 45963-0609-55, 1 Single-Dose Vial)",Reverified,10/5/22,Available,,,Other,Oncology,Current,,
7984,Fludarabine Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 2 mL (25 mg per mL), Single dose vial, PF (NDC: 63323-192-02)",Reverified,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Demand increase,Oncology,Current,,
7985,Fludrocortisone Acetate Tablets,Teva Pharmaceuticals,800-545-8800,"0.1 mg, 100 count bottle (NDC 0555-0997-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,
7986,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 100 count bottle (NDC 0115-7033-01)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,
7987,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 500 count bottle (NDC 0115-7033-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,,
7988,Flumazenil Injection,Mylan,800-796-9526,"0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53)",New,12/16/19,,,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,,
7989,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-054-15),New,6/21/21,,,,,,To be Discontinued,,
7990,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-054-30),New,6/21/21,,,,,,To be Discontinued,,
7991,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-054-60),New,6/21/21,,,,,,To be Discontinued,,
7992,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-040-15),New,6/21/21,,,,,,To be Discontinued,,
7993,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-040-30),New,6/21/21,,,,,,To be Discontinued,,
7994,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-040-60),New,6/21/21,,,,,,To be Discontinued,,
7995,Fluocinonide Topical Solution,Teva Pharmaceuticals,800-545-8800,0.5 mg/mL  (NDC 0472-0829-02),New,8/3/21,,,,,Dermatology,To be Discontinued,,
7996,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR ((fluorescein injection, USP) 10% (NDC 17478-253-10), 5mL",Revised,10/4/22,Currently available,,,Other,Ophthalmology,Current,,
7997,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR ((fluorescein injection, USP) 25% (NDC 17478-250-20), 2mL",Revised,10/4/22,On backorder.,,,Other,Ophthalmology,Current,,
7998,Fluorescein Injection,Alcon,800-268-4574,Fluorescite 5 mL in vial (NDC 0065-0092-65),New,5/2/22,Available,,,,Ophthalmology,Current,,
7999,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 1.0 mg 100 sterile strips (NDC 17478-404-01),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,
8000,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 0.6 mg 300 sterile strips (NDC 17478-403-03),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,
8001,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 100 Strips per box (ndc 17238-900-11),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,
8002,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 300 Strips per box (NDC 17238-900-30),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,,
8003,Fluorometholone Ophthalmic Ointment,Abbvie,800-678-1605,FML (flourometholone) Ointment 0.1% 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0316-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,
8004,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 100 count bottle (NDC 0781-2823-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8005,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 1000 count bottle (NDC 0781-2823-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8006,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 100 count bottle (NDC 0781-2822-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8007,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 1000 count bottle (NDC 0781-2822-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8008,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 100 count bottle (NDC 0781-2824-01)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8009,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 1000 count bottle (NDC 0781-2824-10)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8010,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 30 count bottle (NDC 0781-2824-31)",New,2/23/18,,,,,Psychiatry,To be Discontinued,,
8011,Flurazepam Hydrochloride Capsules,"Rising Pharma Holdings, Inc.",732-917-6058,15mg C 100s (NDC 0378-4415-01),New,8/3/22,Anticipated availability: August 2023.,Delay is due to manufacturing delays at the contract manufacturing facility.,,,Neurology; Other,Current,,
8012,Flurazepam Hydrochloride Capsules,"Rising Pharma Holdings, Inc.",732-917-6058,30mg C 100s (NDC 0378-4430-01),New,8/3/22,Anticipated availability: August 2023.,Delay is due to manufacturing delays at the contract manufacturing facility.,,,Neurology; Other,Current,,
8013,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",100 mg. 30’s count (NDC 10370-175-11),Revised,5/24/22,"A limited inventory will be available in June, July and August 2022. Estimated recovery September 2022",,,Delay in shipping of the drug,Psychiatry,Current,,
8014,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",150 mg. 30’s count (NDC 10370-176-11),Revised,5/24/22,"A limited inventory will be available in June, July and August 2022. Estimate recovery October 2022",,,Delay in shipping of the drug,Psychiatry,Current,,
8015,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03)",Revised,10/5/22,Allocation,,,Requirements related to complying with good manufacturing practices,Psychiatry,Current,,
8016,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03)",Revised,10/5/22,"Backorder, Recovery expected Oct-22",,,Requirements related to complying with good manufacturing practices,Psychiatry,Current,,
8017,Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/2 mL, package of 25 vials (NDC 67457-516-25)",New,9/3/21,,,,,Neurology;Pediatric,To be Discontinued,,
8018,Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg/10 mL, package of 10 vials (NDC 67457-517-01)",New,8/4/21,,,,,Neurology;Pediatric,To be Discontinued,,
8019,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
8020,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
8021,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10),Reverified,9/28/22,Available,,,,Cardiovascular,Current,,
8022,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,20 mg/2 mL single-dose vial (NDC 25021-311-02),Reverified,8/22/22,Backorder. Estimated availability Aug 2022,,,,Cardiovascular,Current,,
8023,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,40 mg/4 mL single-dose vial (NDC25021-311-04),Reverified,8/22/22,Backorder. Estimated availability July 2022,,,,Cardiovascular,Current,,
8024,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,100 mg/10 mL single-dose vial (NDC 25021-311-10),Reverified,8/22/22,Available,,,,Cardiovascular,Current,,
8025,Furosemide Injection,Gland Pharma Limited,866-625-1618,"2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,
8026,Furosemide Injection,Gland Pharma Limited,866-625-1618,"4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,
8027,Furosemide Injection,Gland Pharma Limited,866-625-1918,"10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10)",Reverified,7/1/22,Available,,,Demand increase for the drug,Cardiovascular,Current,,
8028,Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"100 mg/10 mL (10 mg/mL) syringe, bundle of 10 (NDC 0409-1639-10)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22
8029,Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"100 mg/10 mL (10 mg/mL) syringe, individual (NDC 0409-1639-21)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22
8030,Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"40 mg/4 mL (10 mg/mL) syringe, bundle of 10 (NDC 0409-9631-04)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22
8031,Furosemide Injection,"Hospira, Inc., a Pfizer Company",844-646-4398,"40 mg/4 mL (10 mg/mL) syringe, individual (NDC 0409-9631-14)",New,9/28/22,,,,,Cardiovascular,To be Discontinued,9/28/22,9/28/22
8032,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02)",Revised,9/14/22,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
8033,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04)",Revised,9/14/22,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
8034,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Cardiovascular,Current,,
8035,Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,20 mg/2 mL single-dose vial (NDC 55150-322-25),Reverified,9/28/22,"Currently on backorder, next shipment TBD",,,Delay in shipping of the drug,Cardiovascular,Current,,
8036,Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,40 mg/4 mL single-dose vial (NDC 55150-323-25),Reverified,9/28/22,"Currently on backorder, next shipment TBD",,,Delay in shipping of the drug,Cardiovascular,Current,,
8037,Furosemide Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,100 mg/10 mL single-dose vial (NDC 55150-324-25),Reverified,9/28/22,"Currently on backorder, next shipment TBD",,,Delay in shipping of the drug,Cardiovascular,Current,,
8038,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25)",Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8039,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25)",Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8040,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25)",Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8041,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,20 mg/mL (NDC 23155-473-41),Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8042,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,40 mg/4mL (NDC 23155-473-42),Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8043,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,100 mg/10mL (NDC 23155-473-44),Reverified,8/26/22,Available,,,,Cardiovascular,Current,,
8044,Furosemide Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02),Revised,9/28/22,Available,,,Other,Cardiovascular,Current,,
8045,Furosemide Injection,"Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04),Revised,9/28/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022,,,Demand increase for the drug,Cardiovascular,Current,,
8046,Furosemide Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10),Revised,9/28/22,Next Delivery: September 2022; Estimated Recovery: November 2022,,,Demand increase for the drug,Cardiovascular,Current,,
8047,Furosemide Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL; Ansyr Plastic syringe (NDC 0409-1639-10),Revised,9/28/22,Unavailable,,,,Cardiovascular,Current,,
8048,Furosemide Injection,"Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Ansyr Plastic syringe (NDC 0409-9631-04),Revised,9/28/22,Unavailable,,,,Cardiovascular,Current,,
8049,Furosemide Oral Solution,Wockhardt,800-346-6854,"10 mg/mL, 60mL (NDC 60432-0613-60)",New,4/11/22,,,,,Cardiovascular,To be Discontinued,,
8050,"Furosemide Oral Solution, 10 mg/mL",Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"10 mg/mL, 4 oz. (NDC 60432-613-04)",New,5/19/22,,,,,Cardiovascular,To be Discontinued,,
8051,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07)",Revised,6/8/22,,,,,Anti-Infective,To be Discontinued,,
8052,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05)",Revised,6/8/22,,,,,Anti-Infective,To be Discontinued,,
8053,Gentamicin and Prednisolone Acetate Ophthalmic Suspension,Abbvie,800-678-1605,"PRED G® (gentamicin and prednisolone acetate ophthalmic suspension) NDC 0023-0106-05/ 1 Bottle, Dropper in 1 Carton> 5 mL in 1 Bottle, Dropper, (NDC 0023-0106-10) / 1 Bottle, Dropper in 1 Carton> 10 mL in 1 Bottle, Dropper",New,6/9/22,,,,,Ophthalmology,To be Discontinued,,
8054,Gentamicin Sulfate and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,PRED-G- gentamicin sulfate 0.3% and prednisolone acetate 0.6% ointment 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0066-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,
8055,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Demand increase for the drug,Anti-Infective,Current,,
8056,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20)",Revised,9/14/22,Backordered. Next release October 2022.,,,Demand increase for the drug,Anti-Infective,Current,,
8057,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02)",Revised,9/14/22,Available,Check wholesaler inventory,,Demand increase for the drug,Anti-Infective,Current,,
8058,Gentamicin Sulfate Injection,"Hospira, Inc.",844-646-4398,80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03),Revised,9/12/22,Next Delivery: December 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anti-Infective,Current,,
8059,Gentamicin Sulfate Injection,"Hospira, Inc.",844-646-4398,80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25),Revised,9/12/22,Next Delivery: December 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anti-Infective,Current,,
8060,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 60 mg/50 mL, (NDC 0338-0507-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8061,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL, (NDC 0338-0509-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8062,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80mg/100 mL, (NDC 0338-0503-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8063,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/50 mL, (NDC 0338-0511-41)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8064,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/100 mL, (NDC 0338-0505-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8065,Gentamicin Sulfate Injection,Baxter,888-229-0001,"Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 120 mg/100 mL, (NDC 0338-0507-48)",Revised,8/31/22,Available,,,,Anti-Infective,Current,,
8066,Gentamicin Sulfate Solution,Abbvie,800-678-1605,GENOPTIC® (gentamicin sulfate) Ophthalmic solution/drops (NDC 60758-188-05) -- 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,
8067,Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 10 mg/1 unit (NDC 10370-746-01),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8068,Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 10 mg/1 unit (NDC 10370-746-05),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8069,Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 5 mg/1 unit (NDC 10370-745-01),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8070,Glipizide Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",Extended-release 5 mg/1 unit (NDC 10370-745-05),New,2/9/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8071,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01)",New,5/28/20,,,,,Endocrinology/Metabolism,To be Discontinued,,
8072,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05)",New,5/28/20,,,,,Endocrinology/Metabolism,To be Discontinued,,
8073,Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1.25 mg/250 mg 100 Count (NDC 00228-2751-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22
8074,Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg/500 mg 100 Count (NDC 00228-2752-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22
8075,Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg/500 mg 500 Count (NDC 00228-2752-50),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22
8076,Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/500 mg 100 Count (NDC 00228-2753-11),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22
8077,Glyburide and Metformin Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/500 mg 500 Count (NDC 00228-2753-50),New,9/6/22,,Discontinuation of the manufacture of the drug.,,,Endocrinology,To be Discontinued,9/6/22,9/6/22
8078,Granisetron Hydrochloride Injection,Teva Pharmauceuticals,800-545-8800,"1 mg/mL, 1 mg, 1 mL/Vial (NDC 0703-7971-03)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Gastroenterology,To be Discontinued,9/13/22,9/13/22
8079,Granisetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"1 mg/mL, 4 mg, 4 mL/Vial (NDC 0703-7973-01)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Gastroenterology,To be Discontinued,9/13/22,9/13/22
8080,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 1 mg, 100 Count (NDC 42806-048-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,
8081,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 2 mg, 100 Count (NDC 42806-296-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,
8082,Guanfacine Hydrochloride Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,1 mg (NDC 0378-1160-01),Reverified,12/8/21,Unavailable,,,Other,Cardiovascular,Current,,
8083,Guanfacine Hydrochloride Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,2 mg (NDC 0378-1190-01),Reverified,12/8/21,Unavailable,,,Other,Cardiovascular,Current,,
8084,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets 100 count bottle (NDC 0591-0444-01),Revised,10/5/22,"Backorder, Recovery expected Nov-22",,,,Cardiovascular,Current,,
8085,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablets 100 count bottle (NDC 0591-0453-01),Revised,10/5/22,Allocation,,,,Cardiovascular,Current,,
8086,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
8087,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
8088,Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7133-01 (500 mg/5 mL (100 mg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22
8089,Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7131-03 (100 mg/mL 10 x 1 mL Single Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22
8090,Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7121-03 (50 mg/mL 10 x 1 mL Single Dose Vials),New,8/11/22,,Product is available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22
8091,Haloperidol Decanoate Injection,Teva,800-545-8800,NDC 0703-7123-01 (250 mg/5 mL (50 mg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Psychiatry,To be Discontinued,8/11/22,8/11/22
8092,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8093,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8094,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8095,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8096,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0334-01),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8097,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg (NDC 0378-0355-01),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8098,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,
8099,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,
8100,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,
8101,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,,
8102,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-13-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8103,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-83-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8104,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count unit dose (NDC 0781-13-9113),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8105,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-13-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8106,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-83-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8107,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8108,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-13-9801),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8109,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8110,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-13-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8111,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-83-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8112,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-13-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8113,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-83-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8114,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count unit dose (NDC 0781-13-9613),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8115,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-13-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8116,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-83-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8117,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count unit dose (NDC 0781-13-9713),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8118,Haloperidol Tablets,Sandoz,800-525-8747,20 mg 100 count bottle (NDC 0781-83-9301),Revised,11/20/19,,,,,Psychiatry,Resolved,,
8119,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL.  Product code 2B0944  (NDC 0338-0433-04)",Revised,9/28/22,Available,,,Manufacturing Delay,Hematology,Current,,
8120,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL.  Product code 2B0953 (NDC 0338-0431-03)",Revised,9/28/22,Unavailable,,,Other,Hematology,Current,,
8121,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: December 2022,,,Demand increase for the drug,Hematology,Current,,
8122,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)",Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Hematology,Current,,
8123,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container.  Product code AHB0953U (NDC 0338-0424-18)",Revised,9/28/22,Limited Supply Recovery Q4,,,Manufacturing Delay,Hematology,Current,,
8124,Heparin Sodium and Sodium Chloride 0.9% Injection,B. Braun Medical Inc.,800-227-2862,"1,000 USP units in 500 mL. Product code P8721 (NDC 0264-9872-10)",Revised,3/25/22,Available. On 100% allocation.,,,Demand increase for the drug,Hematology,Current,,
8125,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Other,Hematology,Current,,
8126,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10)",Revised,9/14/22,Available,Check wholesaler for inventory,,Other,Hematology,Current,,
8127,Histrelin Acetate Implant,"Endo Pharmaceuticals, Inc.",800-462-3636,Vantas 50 mg Implantation Kit (NDC 67979-500-01),Revised,9/21/21,,,,,Oncology,To be Discontinued,,
8128,Hydralazine Hydrochloride Injection,American Regent/Luitpold,800-645-1706,20mg/ml SDV ( NDC 0517 - 0901-25 ),Revised,6/29/21,,,Available,,Cardiovascular,Resolved,,
8129,Hydralazine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per mL, SDV (NDC 63323-614-01)",Revised,6/29/21,,,Available,,Cardiovascular,Resolved,,
8130,Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 10) (NDC 17478-934-01)",Revised,6/29/21,,,,,Cardiovascular,Resolved,,
8131,Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 25) (NDC 17478-934-15)",Revised,6/29/21,,,,,Cardiovascular,Resolved,,
8132,Hydralazine Hydrochloride Injection,"Mylan Institutional, a Viatris company",800-796-9526,20 mg / 1 ml] 25PK (NDC 67457-291-01),Revised,6/29/21,,,,,Cardiovascular,Resolved,,
8133,Hydralazine Hydrochloride Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,20 mg/mL per vial (NDC 39822-0500-4),Revised,6/29/21,,,,,Cardiovascular,Resolved,,
8134,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg/25 mg (NDC 0378-2025-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,
8135,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5 mg/ 20 mg (NDC 0378-2012-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,
8136,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/ 12.5 mg (NDC 0378-1012-01),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,
8137,Hydrochlorothiazide and Spironolactone (Aldactazide) Tablets,Pfizer,800-533-4535,50 mg tablet; bottle of 100 (NDC 0025-1021-31),New,9/8/22,,Supply expected to exhaust mid September 2022,,,Cardiovascular,To be Discontinued,9/8/22,9/8/22
8138,Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,Perrigo Pharmaceuticals,269-673-8451,Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16),New,6/5/18,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,
8139,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 12 suppositories (NDC 59741-301-12),New,11/25/19,,,,,Other;Urology,To be Discontinued,,
8140,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 24 suppositories (NDC 59741-301-24),New,11/25/19,,,,,Other;Urology,To be Discontinued,,
8141,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 100 suppositories (NDC 59741-301-01),New,11/25/19,,,,,Other;Urology,To be Discontinued,,
8142,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,5 mg tablet; bottle of 50 (NDC 59762-0073-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8143,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,10 mg tablet; bottle of 100 (NDC 59762-0074-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8144,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,20 mg tablet; bottle of 100 (NDC 59762-0075-1),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8145,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 20 mg tablet; bottle of 100 (NDC 0009-0044-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8146,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 5 mg tablet; bottle of 50 (NDC 0009-0012-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8147,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 10 mg tablet; bottle of 100 (NDC 0009-0031-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8148,Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,100mg/100 count (NDC 00115-1697-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8149,Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,20mg/100 count (NDC 00115-1700-01),Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8150,Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 50 count bottles (NDC 64380-970-25)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8151,Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 100 count bottles (NDC 64380-971-06)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8152,Hydrocortisone Tablets,Strides Pharma Inc.,855-273-0146,"20 mg, 100 count bottles (NDC 64380-972-06)",Revised,6/8/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8153,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-121-11)",Revised,8/12/22,Available,,,,Analgesia/Addiction,Current,,
8154,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-010-11)",Revised,8/12/22,Available,,,,Analgesia/Addiction,Current,,
8155,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06)                                                                                           Microvault",Revised,8/12/22,Available,,,,Analgesia/Addiction,Current,,
8156,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11)                                                                                                                                                                                     Microvault",Revised,8/12/22,Available,,,,Analgesia/Addiction,Current,,
8157,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg per 1 mL, Single dose vial, (NDC 63323-852-25)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8158,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-853-25)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8159,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-854-10)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8160,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8161,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8162,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8163,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06)",Revised,9/14/22,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
8164,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10)                                                                                                                                       Blister pack",Revised,9/14/22,Check wholesalers for inventory,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8165,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10)",Revised,9/14/22,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8166,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10)",Revised,9/14/22,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8167,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC0703-0110-03),Reverified,10/5/22,Available,,,,Analgesia/Addiction,Current,,
8168,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC 0703-0113-03),Reverified,10/5/22,Available,,,,Analgesia/Addiction,Current,,
8169,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1 ML (NDC 0703-0018-01),Reverified,10/5/22,Available,,,,Analgesia/Addiction,Current,,
8170,Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 1 mL vial (NDC 0641-0121-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8171,Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0641-2341-41)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8172,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8173,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/1 mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-10),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8174,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1312-10),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8175,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31),Revised,9/12/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8176,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8177,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8178,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01),Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Analgesia/Addiction,Current,,
8179,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Glass Ampul (NDC 00409-3356-01),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8180,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Glass Ampul (NDC 00409-2540-01),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8181,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3365-01),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8182,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8183,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8184,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8185,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01)",Reverified,5/19/21,Available,,,,Analgesia/Addiction,Current,,
8186,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05)",Reverified,5/19/21,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8187,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50)",Reverified,5/19/21,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8188,Hydroxocobalamin Injection,SERB SA,,"Hydroxocobalamin Injection (Cyanokit) intravenous powder for solution for injection, 5 gram, vial, (NDC 11704-0370-01)",Revised,1/20/22,,,Available,,Endocrinology/Metabolism;Other,Resolved,,
8189,Hydroxocobalamin Injection,Teva Pharmaceuticals,800-545-8800,"Hydroxocobalamin Injection 1000MCG/ML, 1X30ML(NDC 0591-2888-30)",Revised,1/21/22,,,Available,,Endocrinology/Metabolism,Resolved,,
8190,Hydroxyprogesterone Caproate Injection,American Regent/Luitpold,800-645-1706,"Hydroxyprogesterone Caproate Injection, USP 250mg/mL 1mL Single Dose Vial (NDC 0517-1767-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,
8191,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,"Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml (NDC 71225-104-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,
8192,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single dose auto-injector 1.1mL for subcutaneous injection: (NDC 64011-247-02),Revised,8/2/19,,,,,Reproductive,Resolved,,
8193,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,,
8194,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Multi-dose vial 5mL for intramuscular injection: (NDC 64011-243-01),Revised,8/2/19,,,,,Reproductive,Resolved,,
8195,Hydroxyprogesterone Caproate Injection,Prasco Laboratories,866-525-0688,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,,
8196,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,Hydroxyprogesterone Caproate Injection USP 250 mg/1 mL single-dose vial (NDC 55150-309-01),Revised,8/2/19,,,,,Reproductive,Resolved,,
8197,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,"Hydroxyprogesterone Caproate Injection USP 1,250 mg/5 mL multiple-dose vial (NDC 55150-310-01)",Revised,8/2/19,,,,,Reproductive,Resolved,,
8198,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,Hydroxyprogesterone Caproate Injection 250 mg/ 1 ml (NDC 71225-105-01),Revised,8/2/19,,,,,Reproductive,Resolved,,
8199,Hydroxypropyl (Lacrisert) Cellulose Ophthalmic Insert,"Bausch Health Americas, Inc.",800-321-4576,"Lacrisert, 5 mg per ophthalmic insert, 60 unit dose blister pack (NDC 24208-800-60)",Revised,12/3/21,"Unavailable, Resupply expected July 2023",,,Other,Ophthalmology,Current,,
8200,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 100 count (NDC 0555-0324-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8201,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 100 count (NDC 0555-0323-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8202,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 500 count (NDC 0555-0323-04),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8203,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 100 count (NDC 0555-0302-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8204,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 500 count (NDC 0555-0302-04),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8205,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 100 count (NDC 0185-0674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8206,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 500 count (NDC 0185-0674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8207,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 100ct (NDC 00115-1803-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8208,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 500ct (NDC 00115-1803-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8209,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 100ct (NDC 00115-1804-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8210,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 500ct (NDC 00115-1804-02),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8211,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8212,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8213,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 100 count (NDC 14539-674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8214,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 500 count (NDC 14539-674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8215,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 100 count (NDC 14539-675-01),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8216,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 500 count (NDC 14539-675-05),Revised,2/17/21,,,,,Psychiatry,Resolved,,
8217,Hyoscyamine Sulfate Injection,"Meda Pharmaceuticals Inc, A Viatris company",800-796-9526,"Levsin® Injection, 0.5mg, (NDC 0037-9001-05)",New,9/13/22,,Product will be available until stock out or expiry (October 2023).,,,Anesthesia; Gastroenterology; Urology,To be Discontinued,9/13/22,9/13/22
8218,Ibutilide Fumarate Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 67457-366-10)",Revised,9/28/22,Unavailable,Re-supply October 2022.,,Other,Cardiovascular,Current,,
8219,Ibutilide Fumarate Injection,Pfizer Pharmaceuticals,844-646-9526,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-01)",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
8220,Ibutilide Fumarate Injection,Pfizer Pharmaceuticals,844-646-4398,"1 mg/10 mL (0.1 mg/mL), single dose vial (NDC 0009-3794-22), Novaplus",Reverified,9/12/22,Available,,,Other,Cardiovascular,Current,,
8221,Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4155-11 (10 mg/10 mL (1 mg/mL) 10 mL Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUN' 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
8222,Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4156-11 (20 mg/20 mL (1 mg/mL) 20 mL Single Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUL' 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
8223,Idarubicin Hydrochloride Injection,Teva,800-545-8800,NDC 0703-4154-11 (5 mg/5 mL (1 mg/mL) 5 mL Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
8224,Ifosfamide Injection,Teva,800-545-8800,NDC 0703-3427-11 (1 g/20 mL (50 mg/mL) Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
8225,Ifosfamide Injection,Teva,800-545-8800,NDC 0703-3429-11 (3 g/60 mL (50 mg/mL) Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
8226,Imipenem and Cilastatin for Injection,HQ Specialty Pharma,201-857-8290,"500 mg per vial, single dose vial, sterile powder (NDC 44567-0705-10)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,
8227,Imipenem and Cilastatin for Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg  imipenem  equivalent  and  500 mg  cilastatin  equivalent  and  20 mg  sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59),Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,
8228,Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,
8229,Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg/500 mg per vial, single dose vial, sterile powder (NDC  63323-322-25)",Revised,6/8/22,,,Available,,Anti-Infective,Resolved,,
8230,Imipramine Tablets,Sandoz,800-525-8747,10 mg 100 ct (NDC 0781-1762-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,
8231,Imipramine Tablets,Sandoz,800-525-8747,25 mg 100 ct (NDC 0781-1764-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,
8232,Imipramine Tablets,Sandoz,800-525-8747,25 mg 1000 ct (NDC 0781-1764-10),New,2/28/22,,,,,Psychiatry,To be Discontinued,,
8233,Imipramine Tablets,Sandoz,800-525-5747,50 mg 100 ct (NDC 0781-1766-01),New,2/28/22,,,,,Psychiatry,To be Discontinued,,
8234,Imipramine Tablets,Sandoz,800-525-8747,50 mg 1000 ct (NDC 0781-1766-10),New,2/28/22,,,,,Psychiatry,To be Discontinued,,
8235,Indigotindisulfonate Sodium Injection,American Regent,800-645-1706,Indigo Carmine injection 5mL ampule (NDC 0517-0375-05),Revised,8/24/22,"Out of Stock, no plans to manufacture until sometime in 2023",,,Shortage of an active ingredient,Medical Imaging,Current,,
8236,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100s (NDC 0378-0143-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8237,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000s (NDC 0378-0143-10)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8238,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100s (NDC 0378-0147-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8239,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 500s (NDC 0378-0147-05)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8240,Indomethacin Injection,Hospira,844-646-4398,1 mg Single Dose Vial (NDC 0409-1113-01),New,8/15/22,,Limited supply available. Product expected to exhaust by November 2022,,,Pediatric; Cardiovascular,To be Discontinued,8/15/22,8/15/22
8241,Indomethacin Injection,Navinta LLC,609-883-1135,1 mg per vial (NDC 68382-470-01),New,8/17/22,,Navinta has made a business decision to discontinue this product.,,,Pediatric; Cardiovascular,To be Discontinued,8/17/22,8/17/22
8242,Insulin Lispro (Humalog Mix50/50),Eli Lilly and Company,800-545-5979,"Humalog (Insulin Lispro) Mix50/50, 10ml vial (NDC 0002-7512-01)",New,6/30/22,,,,,,To be Discontinued,,
8243,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4350-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,
8244,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4351-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,
8245,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01)",New,4/23/21,,,,,Antiviral,To be Discontinued,,
8246,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,
8247,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,
8248,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01),New,9/12/19,,,,,Antiviral;Oncology,To be Discontinued,,
8249,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 100 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-10)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8250,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 200 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-70)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8251,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 50 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-05)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8252,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 320 mg Iodine/mL: 150 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-383-50)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8253,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 270 mg Iodine/mL: 100 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-381-10)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8254,Iodixanol Injection,"JIANGSU HENGRUI PHARMACEUTICALS CO LTD (ANDA holder); Fresenius Kabi USA, LLC (marketing and US distribution partner)",888.386.1300  or (customerservice.usa@fresenius-kabi.com),"Iodixanol Injection, USP, 270 mg Iodine/mL: 150 mL in single-dose polypropylene bottle, boxes of 10 (NDC 65219-381-50)",Revised,7/18/22,Available,,,Other,Medical Imaging,Current,,
8255,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-23), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8256,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-62), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8257,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-66), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8258,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-67), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8259,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-16), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8260,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-19), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Drug Shortage Resolved.  Product Available as of August 26, 2022.",,,Other,Medical Imaging,Current,,
8261,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-21), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8262,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-16), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of October 2022.,,,Other,Medical Imaging,Current,,
8263,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-19), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 05, 2022.",,,Other,Medical Imaging,Current,,
8264,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-21), 320 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order October 10, 2022.",,,Other,Medical Imaging,Current,,
8265,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-64), 320 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 100 mL in 1 BOTTLE, PLASTIC",Revised,9/2/22,"Product available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8266,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2223-17), 320 mg/1 mL, VISIPAQUE INJECTION, SOLUTION, IV VISIPAQUE 320mgI/ml USB 10x100 VIAL ml USA",Revised,9/2/22,"Backordered. Product will be available for order September 22, 2022.",,,Other,Medical Imaging,Current,,
8267,Iodixanol Injection,GE Healthcare,800-292-8514,"Iodixanol (Visipaque) Injection NDC (0407-2222-17), 270 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 05, 2022.",,,Other,Medical Imaging,Current,,
8268,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-98), 350 mg/1 mL, OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 350mgI/ml USB PH10x500ml USA",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8269,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-72), 350 mg/1 mL OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 350mgI/ml USB IBP 10x500ml USA",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8270,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-88), OMNIPAQUE 350 mg/1 mL, INJECTION, SOLUTION, IV  10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8271,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-48), 350 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8272,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-10), 240 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 10 ml USA",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8273,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-20), 240 mg/1 mL, OMNIPAQUE INJECTION,  SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 20 ml USA",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8274,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-89), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order October 30, 2022.",,,Other,Medical Imaging,Current,,
8275,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-91), 350 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 350mgI/ml USB 10x100 ml USA",Revised,9/2/22,"Product available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8276,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1411-10), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 10 ml USA",Revised,9/2/22,"Product available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8277,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-68), 300 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8278,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1411-20), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 20 ml USA",Revised,9/2/22,"Product available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8279,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-72),300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 5, 2022.",,,Other,Medical Imaging,Current,,
8280,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-89), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of August.,,,Other,Medical Imaging,Current,,
8281,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-48), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of August.,,,Other,Medical Imaging,Current,,
8282,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1416-12), 12 mg/1 mL, SOLUTION, ORAL",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8283,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1415-09), 9 mg/1 mL, SOLUTION, ORAL",Revised,9/2/22,"Backordered. Product will be available for order September 5, 2022.",,,Other,Medical Imaging,Current,,
8284,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-34), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8285,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-30), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 05, 2022.",,,Other,Medical Imaging,Current,,
8286,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-35), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8287,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-33), 240 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8288,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-53), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8289,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-10), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8290,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-94), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8291,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-93), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8292,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-95), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8293,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1412-38), 240 mg/1 mL, INJECTION, SOLUTION, IT",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8294,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1401-52), 140 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 05, 2022.",,,Other,Medical Imaging,Current,,
8295,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-86), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8296,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-87), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of August.,,,Other,Medical Imaging,Current,,
8297,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-88), 300 mg/1 mL, INJECTION, SOLUTION, IT",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8298,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-42), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8299,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-90), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,8/12/22,"Backordered. Product will be available for order September 5, 2022.",,,Other,Medical Imaging,Current,,
8300,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-85), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8301,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-84), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,"Product Available as of July 1, 2022.",,,Other,Medical Imaging,Current,,
8302,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-82), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of September.,,,Other,Medical Imaging,Current,,
8303,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-87), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8304,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-86), 350 mg/1 mL, INJECTION, SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8305,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-59), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8306,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-65), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8307,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-61), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order October 30, 2022.",,,Other,Medical Imaging,Current,,
8308,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-63), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,"Backordered. Product will be available for order September 5, 2022.",,,Other,Medical Imaging,Current,,
8309,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-62), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8310,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-66), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8311,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1414-76), 350 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of 2022.,,,Other,Medical Imaging,Current,,
8312,Iohexol Injection,GE Healthcare,800-292-8514,"Iohexol (Omnipaque) NDC (0407-1413-69), 300 mg/1 mL, INJECTION,  SOLUTION, IV",Revised,9/2/22,Backordered. Product availability is likely to be impacted until the end of January 2023.,,,Other,Medical Imaging,Current,,
8313,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  350, 6 X 500 ML (NDC 0270-9350-06)",Reverified,9/9/22,"Estimated Availability: October 4, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8314,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 350, 10 X 200 ML (NDC 0270-7350-20)",Reverified,9/9/22,"Estimated Availability: September 26, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8315,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 300, 6 X 500 ML (NDC 0270-9300-06)",Reverified,9/9/22,"Estimated Availability: September 29, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8316,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 400, 9 X 500 ML (NDC 0270-9400-01)",Reverified,9/9/22,"Estimated Availability: September 9, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8317,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 350, 9 X 500 ML (NDC 0270-9350-09)",Reverified,9/9/22,"Estimated Availability: September 6, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8318,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  350, 30 X 150 ML (NDC 0270-7350-15)",Reverified,9/9/22,"Estimated Availability: September 21, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8319,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 6 X 500 ML (NDC 0270-9400-06)",Reverified,9/9/22,"Estimated Availability: October 11, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8320,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  300, 56 X 100 ML (NDC 0270-7300-10)",Reverified,9/9/22,"Estimated Availability: September 13, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8321,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  250, 56 X 100 ML (NDC 0270-7250-10)",Reverified,9/9/22,"Estimated Availability: September 2, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8322,Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 56 X 100 ML (NDC 0270-7400-16)",Reverified,9/9/22,"Estimated Availability: September 16, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8323,Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 30 X 200 ML (NDC 0270-7400-20)",Reverified,9/9/22,"Estimated Availability: September 7, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8324,Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  300, 10 X 200 ML (NDC 0270-7300-20)",Reverified,9/9/22,"Estimated Availability: September 1, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8325,Iomeprol Injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON)  400, 6 X 500 ML (NDC 0270-9400-03)",Reverified,9/9/22,"Estimated Availability: September 15, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8326,Iomeprol injection,Bracco,877-272-2269 or Bracco.otc@diag.bracco.com,"Iomeprol injection (IOMERON) 400, 10 X 100 ML (NDC 0270-7400-10)",Reverified,9/9/22,"Estimated Availability: September 14, 2022","Bracco, in conjunction with FDA, has initiated a temporary importation of Iomeron® (iomeprol injection) into the U.S. market to address drug shortages.  To place an order, please contact Bracco Customer Service at 1-877-272-2269 or at Bracco.otc@diag.bracco.com. For more information see Bracco’s website: https://imaging.bracco.com/us-en/products/ct-ct-colonography/iomeron",,Other,Medical Imaging,Current,,
8327,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200), 10x50mL vial, (NDC 0270-1314-30)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8328,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200M), 10x20mL vial, (NDC 0270-1411-25)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8329,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x150mL bottle, (NDC 0270-1317-09)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8330,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x50mL bottle, (NDC 0270-1317-05)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8331,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250 PBP),  10x200mL bottle, (NDC 0270-1317-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8332,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300), 10x75mL bottle, (NDC 0270-1315-47)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8333,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 6x500mL bottle, (NDC 0270-1315-98)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8334,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 10x200mL bottle, (NDC 0270-1315-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8335,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 6x500mL bottle, (NDC 0270-1316-98)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8336,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 10x200mL bottle, (NDC 0270-1316-41)",New,7/1/21,,,,,Medical Imaging,To be Discontinued,,
8337,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 50 mL in 1 VIAL, GLASS (NDC 50419-344-05)",Reverified,9/28/22,"Product availability is likely impacted until end of 2022, expect stock in Q1 2023","Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8338,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 50 mL in 1 VIAL, GLASS (NDC 50419-346-05)",Reverified,9/28/22,"Product availability is likely impacted until end of 2022, expect stock in Q1 2023","Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8339,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 100 mL in 1 VIAL, GLASS  (NDC 50419-346-10)",Reverified,9/28/22,Product available,"Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8340,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 370 mg Iodine per mL: 10 VIAL, GLASS in 1 CARTON; > 150 mL in 1 VIAL, GLASS  (NDC 50419-346-15)",Reverified,9/28/22,Product available,"Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8341,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 100 mL in 1 VIAL, GLASS (NDC 50419-344-10)",Reverified,9/28/22,Product available,"Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8342,Iopromide (Ultravist) Injection,Bayer HealthCare Pharmaceuticals Inc.,888-842-2937,"ULTRAVIST Injection; 300 mg Iodine per mL; 10 VIAL, GLASS in 1 CARTON; > 150 mL in 1 VIAL, GLASS  (NDC 50419-344-15)",Reverified,9/28/22,Product available,"Bayer, in conjunction with FDA has initiated a temporary importation of foreign labeled Ultravist (Iopromide) Injection into the U.S. market to address drug shortage. To place an order contact clscricustomerlogistics@bayer.com or call 1-724-940-7890.",,Demand increase,Medical Imaging,Current,,
8343,Isoniazid Injection,Sandoz,800-525-8747,10 mL (100 mg/mL) Multiple dose vial (NDC 0781-3056-70),Revised,10/4/22,Available,,,,Anti-Infective,Current,,
8344,IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,"Nutrilipid (20% IV Fat Emulsion) in 1,000mL Bag Catalog S4600 (NDC 00264-4460-00)",Revised,9/9/22,"Product available, on allocation to contracted customers",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8345,IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 500mL Bag Catalog S4601 (NDC 0264-4460-10),Revised,9/9/22,"Product available, on allocation to contracted customers",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8346,IV Fat Emulsion,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 250mL Bag Catalog S4603 (NDC 00264-4460-30),Revised,9/9/22,"Product available, on allocation to contracted customers",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8347,IV Fat Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (20 grams per 100 mL) (NDC 63323--820-00)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8348,IV Fat Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (50 grams per 250 mL) (NDC 63323--820-74)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8349,IV Fat Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (100 grams per 500 mL) (NDC 63323-820-50)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8350,IV Fat Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20%, PBP (0.2 grams per mL) (200 grams per 1000 mL) (NDC 63323-820-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8351,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 100 mL, Product Code EADB9520, (NDC 0338-954-005)",Revised,9/28/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8352,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 1000 mL, Product Code EADB9524, (NDC 0338-954-008)",Revised,9/28/22,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8353,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 250 mL, Product Code EADB9521, (NDC 0338-954-006)",Revised,9/28/22,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8354,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 500 mL, Product Code EADB9523, (NDC 0338-954-007)",Revised,9/28/22,Available,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8355,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 100 mL, Product Code 2B6061, (NDC 0338-051-958)",Revised,9/28/22,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8356,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 250 mL, Product Code 2B6062, (NDC 0338-051-909)",Revised,9/28/22,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8357,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 1000 mL, Pharmacy Bulk Package, Product Code 2B6064, (NDC 0338-051-914)",Revised,9/28/22,Limited Supply; Recovery November,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8358,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 500 mL, Product Code 2B6063, (NDC 0338-051-913)",Revised,9/28/22,"Limited Supply on Allocation, Recovery late Sep",,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8359,IV Fat Emulsion,Baxter Healthcare,888-229-0001,"Intralipid 30% IV Fat Emulsion, 500 mL, Pharmacy Bulk Package, Product Code 2B6065, (NDC 0338-052-013)",Revised,9/28/22,Available on allocation,,,Demand increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
8360,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL vial (NDC 0143-9508-10)",Revised,6/3/22,This presentation is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
8361,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9509-10)",Revised,6/3/22,This presentation is temporarily on backorder.,,,,Anesthesia,Current,,
8362,Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,200 mg / 20 mL (NDC 67457-181-20),Revised,9/28/22,Available,,,,Anesthesia,Current,,
8363,Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,500 mg / 10 mL (NDC 67457-001-10),Revised,9/28/22,Available,,,,Anesthesia,Current,,
8364,Ketamine Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1000 mg / 10 mL (NDC 67457-108-10),Revised,9/28/22,"Currently on backorder, next shipment Late November 2022",,,,Anesthesia,Current,,
8365,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05),Reverified,9/12/22,Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Anesthesia,Current,,
8366,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10),Reverified,9/12/22,Next Delivery and Estimated Recovery: February 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
8367,Ketamine Injection,Par Pharmaceutical,201-802-4000,"10 mg/mL, 20 mL MDV (NDC 42023-113-10)",Revised,8/12/22,Contact customer service at 1-800-828-9393,,,Demand increase,Anesthesia,Current,,
8368,Ketamine Injection,Par Pharmaceutical,201-802-4000,"100 mg/mL, 5 mL MDV (NDC 42023-115-10)",Revised,8/12/22,Releases to be intermittent – Please check wholesalers for inventory,,,Demand increase,Anesthesia,Current,,
8369,Ketamine Injection,Par Pharmaceutical,201-802-4000,"50 mg/mL, 10 mL MDV (NDC 42023-114-10)",Revised,8/12/22,Releases to be intermittent – Please check wholesalers for inventory,,,Demand increase for the drug,Anesthesia,Current,,
8370,Ketoprofen Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"200 mg Extended-Release Capsules, bottle of 100 (NDC 0378-8200-01)",Reverified,9/28/22,Available,,,Other,Analgesia/Addiction;Rheumatology,Current,,
8371,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",New,11/25/19,,,,,Analgesia/Addiction;Rheumatology,To be Discontinued,,
8372,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0093-3193-01)",Reverified,4/29/22,Unavailable,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
8373,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 100 count bottle (NDC 0093-3195-01)",Reverified,4/29/22,Unavailable,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
8374,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 500 count bottle (NDC 0093-3195-05)",Reverified,4/29/22,Unavailable,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
8375,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",New,11/25/19,,,,,Analgesia/Addiction;Rheumatology,To be Discontinued,,
8376,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 69336-127-10)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
8377,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 69336-127-11)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
8378,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
8379,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",Revised,1/19/21,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
8380,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"50 mg, 100 count bottle (NDC 23155-021-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
8381,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"75 mg, 100 count bottle (NDC 23155-022-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
8382,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory.,,,Analgesia/Addiction,Current,,
8383,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10)",Revised,9/14/22,Available,Check wholesaler for inventory.,,,Analgesia/Addiction,Current,,
8384,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20)",Revised,9/14/22,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
8385,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 30 mg/ mL.  Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25)",Revised,9/28/22,Available,,,,Analgesia/Addiction,Current,,
8386,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 15 mg/mL. Single dose glass flip top vial. 10 units per carton (NDC 0338-0069-10)",Reverified,9/28/22,Available,,,,Analgesia/Addiction,Current,,
8387,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 1 mL vial (NDC 72266-118-25)",Reverified,9/28/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8388,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 2 mL vial (NDC 72266-119-25)",Reverified,9/28/22,Available,,,Available,Analgesia/Addiction,Current,,
8389,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"15 mg/mL, 1 mL vial (NDC 0641-6041-25)",Reverified,4/8/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
8390,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 1 mL vial (NDC 0641-6042-25)",Reverified,4/8/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
8391,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 2 mL vial (NDC 0641-6043-25)",Reverified,4/8/22,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
8392,Ketorolac Tromethamine Injection,Virtus Pharmaceuticals,888-843-3593,30MG/ML (NDC 69543-0386-25),New,3/26/18,Available,,,Other,Analgesia/Addiction,Current,,
8393,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,15 mg/mL vial (NDC 70860-700-01 and 70860-700-02),Reverified,9/12/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8394,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,30 mg/mL vial (NDC 70860-701-01 and 70860-701-03),Reverified,9/12/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8395,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,60 mg/mL vial (NDC 70860-701-02 and 70860-701-04),Reverified,9/12/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8396,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01),Reverified,8/22/22,Backordered. Estimated availability TBD,,,Manufacturing delays,Analgesia/Addiction,Current,,
8397,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02),Reverified,8/22/22,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
8398,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01),Reverified,8/22/22,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
8399,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-2287-23),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8400,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-31),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8401,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-61),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8402,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01),Revised,9/12/22,Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: November 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8403,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01),Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8404,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Analgesia/Addiction,Current,,
8405,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01)",Revised,9/14/22,Available,Check wholesaler for inventory,,Manufacturing delays,Analgesia/Addiction,Current,,
8406,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01)",Revised,9/14/22,Available,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,,
8407,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02)",Revised,9/14/22,Available,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,,
8408,Lactulose Solution,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"10 g/15 mL- (NDC 60432-037-08) [8 oz (237 mL)], (NDC 60432-037-32) [32 oz (946 mL)], (NDC 60432-038-16) [16 oz (473 mL)] and (NDC 60432-038-64) [64 oz (1892 mL)]",New,5/26/22,,,,,Gastroenterology,To be Discontinued,,
8409,Lactulose Solution,Torrent Pharma Inc.,908-280-3333,10 g/15 mL (ORAL) 8 oz (NDC 13668580-08) || 16 oz. (NDC 13668-580-10) || 32 oz (NDC 13668-580-12),New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,
8410,Lactulose Solution,Torrent Pharma Inc.,908-280-3333,10 g / 15 mL (ORAL-RECTAL) 8 oz (NDC 13668-574-08) || 16 oz (NDC 13668-574-10) || 32 oz (NDC 13668-574-12),New,6/9/22,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,
8411,Lamivudine and Tenofovir Disoproxil Fumarate Tablets,"Celltrion, Inc.",201-988-4615,300 mg; 300 mg (NDC 72606-002-01),New,9/1/21,,,,,Antiviral,To be Discontinued,,
8412,Lamivudine and Zidovudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine and Zidovudine Tablets 150mg and 300mg (NDC 0378-5180-91),New,3/16/18,,,,,Antiviral,To be Discontinued,,
8413,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 100mg (NDC 0378-5168-93),New,3/16/18,,,,,Antiviral,To be Discontinued,,
8414,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 150mg (NDC 0378-5169-91),New,3/16/18,,,,,Antiviral,To be Discontinued,,
8415,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 300mg (NDC 0378-5170-93),New,3/16/18,,,,,Antiviral,To be Discontinued,,
8416,Lanoxin (digoxin) Tablets,Concordia Pharmaceuticals Inc.,866-243-5382,Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55),New,5/22/18,,,,,Cardiovascular,To be Discontinued,,
8417,Leucovorin Calcium for Injection,Teva,800-545-8800,NDC 0703-5140-01 (100 mg/vial Single-Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Pediatric,To be Discontinued,8/11/22,8/11/22
8418,Leucovorin Calcium for Injection,Teva,800-545-8800,NDC 0703-5145-01 (350 mg/vial Single-Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Pediatric,To be Discontinued,8/11/22,8/11/22
8419,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-10)",Revised,9/14/22,Backordered. Next release not available at this time.,Check Wholesaler Inventory,,Manufacturing Delay,Oncology;Pediatric,Current,,
8420,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50)",Revised,9/14/22,Available,Check Wholesaler Inventory,,Manufacturing Delay,Oncology;Pediatric,Current,,
8421,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg vial (NDC 67457-528-10),Reverified,9/28/22,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8422,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,200 mg vial (NDC 67457-529-20),Reverified,9/28/22,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8423,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,350 mg vial (NDC 67457-530-35),Reverified,9/28/22,Unavailable,Re-supply in September 2022.,,Demand increase for the drug,Oncology;Pediatric,Current,,
8424,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,500mg vial (NDC 25021-828-50),Revised,8/22/22,Backordered. Estimated availability Oct 2022,,,Manufacturing delay,Oncology;Pediatric,Current,,
8425,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mg SDV (NDC 63323-710-50),Revised,9/14/22,Backordered. Next release September 2022.,Check Wholesaler Inventory,,Demand increase for the drug,Oncology;Pediatric,Current,,
8426,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg SDV (NDC 63323-711-00),Revised,9/14/22,Backordered. Next release September 2022.,Check Wholesaler Inventory,,Manufacturing delay,Oncology;Pediatric,Current,,
8427,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,50 mg vial (NDC 25021-813-10),Revised,8/22/22,Available.,,,Manufacturing delay,Oncology;Pediatric,Current,,
8428,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,100mg vial (NDC 25021-814-30),Revised,8/22/22,Backordered. Estimated availability Oct 2022,,,Manufacturing delay,Oncology;Pediatric,Current,,
8429,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,200mg vial (NDC 25021-815-30),Revised,8/22/22,Available.,,,,Oncology;Pediatric,Current,,
8430,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,350mg vial (NDC 25021-816-30),Revised,8/22/22,Available,,,,Oncology;Pediatric,Current,,
8431,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,"100mg/vial, 20mL (NDC 0703-5140-01)",Reverified,10/5/22,Backordered – Estimated date of availability TBD,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8432,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,350mg/vial 30mL (NDC 0703-5145-01),Reverified,10/5/22,Backordered – Estimated date of availability TBD,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8433,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg, 10 mL vial (NDC 0143-9555-01)",Revised,1/13/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8434,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg, 20 mL vial (NDC 0143-9554-01)",Revised,1/13/22,Inventory is currently available.,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8435,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"200 mg, 30 mL vial (NDC 0143-9553-01)",Revised,1/13/22,Inventory is currently available.,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8436,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"350 mg, 50 mL vial (NDC 0143-9552-01)",Revised,1/13/22,Inventory is currently available.,,,Demand increase for the drug,Oncology;Pediatric,Current,,
8437,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 22.5 mg (NDC 62935-223-05),Reverified,1/12/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8438,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 30 mg (NDC 62935-303-30),Reverified,1/12/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8439,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 45 mg (NDC 62935-453-45),Reverified,1/12/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8440,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Fensolvi 45 mg (NDC 62935-153-50),Reverified,1/12/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8441,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 7.5 mg Kit (NDC 62935-753-75),Reverified,1/12/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8442,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 30mg (NDC 0074-9694-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8443,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 22.5 mg PDS Kit (NDC 0074-3346-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8444,Leuprolide Acetate Injection,Abbvie,800-621-1020,Lupron Depot 6 Months 45mg PDS Kit (NDC 0074-3473-03),Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8445,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 7.5 mg PDS Kit (NDC 0074-3642-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8446,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 4 Months 30 mg PDS Kit (NDC 0074-3683-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8447,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 3.75 mg PDS Kit (NDC 0074-3641-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8448,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 11.25 mg PDS Kit (NDC 0074-3663-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8449,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 11.25 mg PDS Kit (NDC 0074-2282-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8450,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 15 mg PDS Kit (NDC 0074-2440-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8451,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 7.5 mg PDS Kit (NDC 0074-2108-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8452,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 11.25mg (NDC 0074-3779-03)",Revised,10/3/22,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
8453,Levoleucovorin Calcium Pentahydrate Injection,Ingenus Pharmaceuticals LLC,866-321-5031,10 mg/1mL (NDC 50742-494-17),New,12/10/21,,,,,Oncology;Pediatric,To be Discontinued,,
8454,Levoleucovorin Calcium Pentahydrate Injection,Ingenus Pharmaceuticals LLC,866-321-5031,10 mg 1mL (NDC 50742-495-25),New,12/10/21,,,,,Oncology;Pediatric,To be Discontinued,,
8455,Levoleucovorin Injection,Sandoz,800-525-8747,175 mg/17.5 mL (10 mg/mL) (NDC 0781-3201-94 ),New,5/5/22,,,,,Oncology;Pediatric,To be Discontinued,,
8456,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26)",New,4/27/18,,,,,Anesthesia,To be Discontinued,,
8457,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30)",New,4/27/18,,,,,Anesthesia,To be Discontinued,,
8458,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03)",Reverified,8/26/22,Available on allocation,,,,Cardiovascular,Current,,
8459,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02)",Reverified,8/26/22,Available on allocation,,,Demand increase,Cardiovascular,Current,,
8460,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
8461,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
8462,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
8463,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 2 mL Ampoule (NDC 55150-158-72),Revised,9/28/22,Currently on backorder - next shipment anticipated Mid Oct,,,Demand increase for the drug,Anesthesia,Current,,
8464,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 5 mL Ampoule (NDC 55150-159-74),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8465,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 2 mL Ampoule (NDC 55150-160-72),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8466,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 2 mL Single Dose Vial (NDC 55150-161-02),Revised,9/28/22,Currently on backorder - next shipment anticipated End Oct,,,Demand increase for the drug,Anesthesia,Current,,
8467,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 5 mL Single Dose Vial (NDC 55150-162-05),Revised,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
8468,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 30 mL Single Dose Vial (NDC 55150-163-30),Revised,9/28/22,Currently on backorder - next shipment anticipated Mid Oct,,,Demand increase for the drug,Anesthesia,Current,,
8469,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 2 mL Single Dose Vial (NDC 55150-164-02),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8470,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 5 mL Single Dose Vial (NDC 55150-165-05),Revised,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
8471,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-02),Revised,9/30/22,Next Delivery: October 2022; Estimated Recovery: November 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8472,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8473,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8474,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8475,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)",Revised,9/14/22,Backordered. Next release September 2022.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8476,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8477,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)",Revised,9/14/22,Backordered. Next release October 2022.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8478,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8479,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8480,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8481,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)",Revised,9/14/22,Backordered. Next release November 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8482,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8483,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8484,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05),Revised,9/30/22,Next Delivery: November 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
8485,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-32),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: November 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8486,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual)",Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: February 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8487,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (1%; 10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02),Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8488,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02; NDC 0409-4276-17, individual)",Revised,9/30/22,Next Delivery: October 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8489,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,40 mg/2 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-01),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
8490,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-02),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: February 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8491,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34),Revised,9/30/22,Available,,,,Anesthesia;Pediatric,Current,,
8492,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34),Revised,9/30/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
8493,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05),Revised,9/30/22,Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8494,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual)",Revised,9/30/22,Limited Supply Available. Next Delivery: January 2023; Estimated Recovery: March 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8495,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02)",Revised,9/30/22,Next Delivery and Estimated Recovery: October 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8496,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (4%; 40 mg/mL); Glass Ampul (NDC 0409-4283-01),Revised,9/30/22,Next Delivery: November 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8497,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,Xylocaine Cardiac 100 mg/5 mL (2%; 20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: December 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
8498,Lidocaine Hydrochloride (Xylocaine) Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)(old NDC 0548-3390-00)",Reverified,8/12/22,Backordered due to the increase in demands,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8499,Lidocaine Hydrochloride (Xylocaine) Injection,American Regent/Luitpold,800-645-1706,"1%, 50 mL vial package of 25 (NDC 00517-0625-25)",Reverified,3/30/21,Unavailable-No product available for release. No plan to manufacture.,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
8500,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8501,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8502,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8503,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8504,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)",Revised,9/14/22,Backordered. Next release October 2022.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8505,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)",Revised,9/14/22,Backordered. Next release October 2022.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8506,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8507,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)discontinued",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8508,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8509,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued",Revised,9/14/22,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8510,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8511,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)",Revised,9/14/22,Backordered. Next release November 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8512,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)",Revised,9/14/22,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8513,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01),Revised,9/30/22,Next Delivery: April 2023; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
8514,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01),Revised,9/30/22,Next Delivery: November 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8515,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/20 mL (1.5%; 15 mg/mL); Glass Ampul (NDC 0409-4776-01),Revised,9/30/22,Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8516,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 10 mL Multi Dose Vial (NDC 55150-251-10),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8517,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 20 mL Multi Dose Vial (NDC 55150-252-20),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8518,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 10 mL Multi Dose Vial (NDC 55150-254-10),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8519,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% 20 mL Multi Dose Vial (NDC 55150-255-20),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8520,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 5 mL vial, Preservative Free (NDC 0143-9595-25)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia,Current,,
8521,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 5 mL vial, Preservative Free (NDC 0143-9594-25)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia,Current,,
8522,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 50 mL vial, Preserved (NDC 0143-9577-10)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia,Current,,
8523,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 50 mL vial, Preserved (NDC 0143-9575-10)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia,Current,,
8524,Lidocaine Hydrochloride (Xylocaine) Injection,"Spectra Medical Devices, Inc.",978-657-0889 ext. 5231,1% 5 mL ampule (NDC 65282-1605-1),Revised,1/7/22,Available,,,Other,Anesthesia,Current,,
8525,Lidocaine Hydrochloride (Xylocaine) Injection,"Huons Co., Ltd. (South Korea)", intbiz@huons.com,"Methylparaben Free Lidocaine HCl Injection, USP 1% 50mg/5mL (Vial) (NDC 73293-0001-2)",New,9/6/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
8526,Lidocaine Hydrochloride (Xylocaine) Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,2% MDV 1000mg/50mL (NDC 55150-256-50),Revised,9/28/22,Currently on backorder - next shipment TBD,,,Demand increase for the drug,Anesthesia,Current,,
8527,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 00409-0996-01)",Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
8528,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8529,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8530,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02)",Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8531,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03)",Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8532,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01)",Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8533,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01)",Revised,9/12/22,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8534,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01)",Revised,9/12/22,Limited Supply Available. Next Delivery: October 2022; Estimated Recovery: May 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8535,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02)",Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: April 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8536,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03)",Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: June 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8537,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
8538,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2% w/EPI 1:50,000; 1.8mL syringe (NDC 00409-7263-01)",Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
8539,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
8540,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17)",Revised,9/14/22,Backordered. Next release August 2022.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
8541,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
8542,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
8543,Lindane Shampoo 1%,Wockhardt Bio A.G.,847-410-6929,"60 mL, (NDC 60432-834-60)",New,6/22/22,,,,,Other,To be Discontinued,,
8544,Linezolid Injection,Teva Pharmaceuticals,800-545-8800,"600 mg/300 mL, 300 mL/Bag (NDC 0703-9060-33)",New,9/13/22,,Product has not been marketed for at least 5 years,,,Anti-Infective,To be Discontinued,9/13/22,9/13/22
8545,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01),New,3/28/18,,,,,Endocrinology/Metabolism,To be Discontinued,,
8546,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01),New,3/28/18,,,,,Endocrinology/Metabolism,To be Discontinued,,
8547,Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2.5 mg (NDC 0378-2072-01); 5 mg (NDC 0378-2073-01); 5 mg (NDC 0378-2073-10); 10 mg (NDC 0378-2074-01); 10 mg (NDC 0378-2074-10); 20 mg (NDC 0378-2075-01); 20 mg (NDC 0378-2075-10); 30 mg (NDC 0378-2077-01); 40 mg (NDC 0378-2076-01; 40 mg (NDC 0378-2076-05,New,4/11/18,,,,,Cardiovascular,To be Discontinued,,
8548,Lithium Oral Solution,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,8 mEq/5 mL 500 mL bottle (NDC 0054-3527-63),Reverified,10/6/22,"Unavailable, Estimated Shortage: TBD",,,Shortage of an active ingredient,Psychiatry,Current,,
8549,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial (NDC 0641-6001-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8550,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 10 mL vial (NDC 0641-6000-10)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8551,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 1 mL vial (NDC 0641-6003-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8552,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 10 mL vial ((NDC 0641-6002-10)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8553,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 1 mL vial (NDC 0641-6044-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8554,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 10 mL vial (NDC 0641-6046-10)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8555,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 1 mL vial (NDC 0641-6045-25)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8556,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 10 mL vial (NDC 0641-6002-10)",Reverified,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Neurology,Current,,
8557,Lorazepam Injection,"Hospira, Inc.",844-646-4398,4 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1539-31),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
8558,Lorazepam Injection,"Hospira, Inc.",844-646-4398,2 mg/mL; Carpuject Luer Lock Glass Syringe  (NDC 00409-1985-30),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Neurology,Current,,
8559,Lorazepam Injection,"Hospira, Inc.",844-646-4398,2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02),Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
8560,Lorazepam Injection,"Hospira, Inc.",844-646-4398,4 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6779-02),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
8561,Lorazepam Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-6780-02),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
8562,Lorazepam Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1)",Reverified,8/12/22,Backorder due to the increase in demands,,,Other,Neurology,Current,,
8563,Lorazepam Injection,Akorn Pharmaceuticals,800-932-5676,Lorazepam Injection 2 mg/mL (NDC 17478-040-01),Reverified,5/19/21,Available,,,Demand increase for the drug,Neurology,Current,,
8564,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,
8565,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,
8566,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,
8567,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,,
8568,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 100 count bottle (NDC 0527-1394-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,
8569,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 100 count bottle (NDC 0527-1395-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,
8570,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 100 count bottle (NDC 0527-1396-01)",Revised,6/13/22,,,Available,Other,Psychiatry,Resolved,,
8571,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 100 count bottle (NDC 0527-1397-01)",Revised,6/13/22,,,Available,,Psychiatry,Resolved,,
8572,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0591-0369-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,
8573,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count bottle (NDC 0591-0371-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,
8574,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0591-0372-01)",Revised,6/14/22,,,Available,,Psychiatry,Resolved,,
8575,Lutetium Lu 177 Dotatate (LUTATHERA) Injection,"Advanced Accelerator Applications USA, Inc.",862-778-8300,"Lutathera® (lutetium Lu 177 dotatate) injection, for intravenous use 10 mCi/mL; Colorless Type I glass 30 mL single-dose vial containing 7.4 GBq (200 mCi) ± 10% of lutetium Lu 177 dotatate (NDC 69488-003-01)",Revised,8/1/22,,,Available,,Oncology,Resolved,8/1/22,
8576,Mannitol Injection,B. Braun Medical Inc.,800-227-2862,20% 500 mL Excel Bag L5781 (NDC 0264-7578-20),New,6/10/22,Product on allocation for contracted customers,,,Other,Renal,Current,,
8577,Mannitol Injection,"Fresenius Kabi USA, LLC",888-386-1300,25% (12.5 grams per 50 mL)(250 mg per mL) Single dose vial (NDC 63323-024-25),Revised,9/14/22,Backordered. Next release October 2022.,Check wholesalers for inventory,,Demand increase for the drug,Renal,Current,,
8578,Mannitol Injection,"Hospira, Inc.",844-646-4398,12.5 g/50 mL (25%); Single Dose Glass Fliptop Vial (NDC 0409-4031-01),Reverified,9/12/22,Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Renal,Current,,
8579,Mannitol Injection,Baxter Healthcare,888-229-0001,"10% OSMITROL Injection (10% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5613Q (NDC 0338-0535-03)",Revised,8/26/22,Available,,,,Renal,Current,,
8580,Mannitol Injection,Baxter Healthcare,888-229-0001,"20% OSMITROL Injection (20% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5633Q (NDC 0338-0357-03); 250 mL Viaflex Plastic Container Product Code 2D5632Q (NDC 0338-0357-02)",Revised,8/26/22,Available,,,,Renal,Current,,
8581,Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 500 mL (Legacy Hospira NDC 0409-7715-03)(ICU Medical NDC 0990-7715-03)",Reverified,10/3/22,On allocation,,,Other,Renal,Current,,
8582,Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 250 mL (Legacy Hospira NDC 0409-7715-02)(ICU Medical NDC 0990-7715-02)",Reverified,10/3/22,On allocation,,,Other,Renal,Current,,
8583,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,718-276-8607,"12.5mg tablets, 100 count (NDC 42806-012-01)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,
8584,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"12.5mg tablets, 1000 count (NDC 42806-012-10)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,
8585,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 100 count (NDC 42806-014-01)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,
8586,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 1000 count (NDC 42806-014-10)",New,2/28/18,,,,,Gastroenterology,To be Discontinued,,
8587,Medroxyprogesterone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-6801-01 (150 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently  unavailable and no future production expected for an extended period.,,,Reproductive,To be Discontinued,8/11/22,8/11/22
8588,Medroxyprogesterone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-6801-04 (150 mg/mL  25 x 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Reproductive,To be Discontinued,8/11/22,8/11/22
8589,Megestrol Acetate Oral Suspension,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,"40 mg/mL (NDC 60432-126-08) [8 oz (240 mL)], (NDC 60432-126-16) [1 Pint (480 mL)]",New,5/26/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8590,Megestrol Acetate Suspension,Par Pharmaceutical,"800-828-9393, option 5 then option 2","125mg/1ml, 150ml Bottle (NDC 49884-230-69)",New,12/1/21,,,,,Endocrinology/Metabolism,To be Discontinued,,
8591,Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,7.5 mg tablets (NDCs 0597-0029-01 and 0597-0029-94),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,,
8592,Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,15 mg tablets (NDCs 0597-0030-01 and 0597-0030-56),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,,
8593,Memantine Hydrochloride Extended-Release Capsules,"ANI Pharmaceuticals, Inc.",800-434-1121,14mg tablets(NDCs 43975-264-03 and 43975-264-09),New,4/8/22,,,,,Neurology,To be Discontinued,,
8594,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 1% (500 mg per 50 mL), (10 mg per mL), MDV, (NDC 63323-0283-57)",Revised,9/14/22,Available,Check wholesaler inventory,,,Anesthesia,Current,,
8595,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 2% (1,000 mg per 50 mL), (20 mg per mL), MDV, (NDC 63323-0296-57)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler inventory,,,Anesthesia,Current,,
8596,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1% (300 mg per 30 mL), (10 mg per mL), SDV, (NDC 63323-0260-37)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,,Anesthesia,Current,,
8597,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1.5% (450 mg per 30 mL), (15 mg per mL), SDV, (NDC 63323-0293-37)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler inventory,,Manufacturing delay,Anesthesia,Current,,
8598,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 2% (400 mg per 20 mL), (20 mg per mL), SDV, (NDC 63323-0294-27)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Manufacturing delay,Anesthesia,Current,,
8599,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (10 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1036-30),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,
8600,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/20 mL (20 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1067-20),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,
8601,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,450 mg/30 mL (15 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1041-30),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,
8602,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 0409-1038-50),Revised,6/10/22,,,,,Anesthesia,To be Discontinued,,
8603,Mesalamine (CANASA®)  Suppositories,Allergan,800-678-1605,"1 gm, Rectal Suppositories, 42 suppositories in 1 box (NDC 58914-501-42)",New,7/30/20,,,,,Gastroenterology,To be Discontinued,,
8604,Metaxalone Tablets,Pfizer Pharmaceuticals,800-533-4535,Skelaxin 800 mg tablet; Bottle of 100 (NDC 60793-136-01),New,2/25/22,,,,,Musculoskeletal,To be Discontinued,,
8605,Metaxalone Tablets,Pfizer Pharmaceuticals,800-533-4535,Skelaxin 800 mg tablet; Bottle of 500 (NDC 60793-136-05),New,2/25/22,,,,,Musculoskeletal,To be Discontinued,,
8606,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ),New,6/24/20,,,,,Endocrinology/Metabolism,To be Discontinued,,
8607,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10),New,6/24/20,,,,,Endocrinology/Metabolism,To be Discontinued,,
8608,Methadone Hydrochloride Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Methadone Hydrochloride Injection (Solution in Multi Dose Vials) [200 mg / 20 ml](NDC 67457-217-20),Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,,
8609,Methadone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) , 20 mL multidose vials (NDC 17478-380-20)",Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,,
8610,Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 5 mg tablets; bottle of 100 (NDC 60793-104-01),New,11/5/21,,,,,Endocrinology/Metabolism,To be Discontinued,,
8611,Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 10 mg tablets; bottle of 100 (NDC 60793-105-01),New,11/5/21,,,,,Endocrinology/Metabolism,To be Discontinued,,
8612,Methocarbamol Injection,"Mylan Specialty, a Viatris Company",800-796-9526,100 mg/mL (NDC 67457-273-10),New,5/9/22,,,,,Analgesia/Addiction,To be Discontinued,,
8613,Methohexital Sodium (Brevital) Injection,Par Pharmaceutical,800-828-9393,"500 mg/vial, 50 mL multiple dose vial, box of 1 (NDC 42023-105-01)",Revised,11/15/21,,,Available,,Anesthesia,Resolved,,
8614,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 100s (16729-03-001),Revised,4/7/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,
8615,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 500s (16729-03-016),Revised,4/7/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,
8616,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 100s (16729-03-101),Revised,4/7/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,
8617,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 500s (16729-03-116),Revised,4/7/22,No additional lots are anticipated at this time.,,,API procurement delay,Cardiovascular,Current,,
8618,Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,250 mg (NDC 0378-0611-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,,
8619,Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,500 mg (NDC 0378-0421-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,,
8620,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0045-01 (400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8621,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0043-01 (200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8622,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0063-01 (400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8623,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0031-01 (40 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8624,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0031-04 (40 mg/mL 25 x 1 mL Single-Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8625,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0051-01 (80 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8626,Methylprednisolone Acetate Injectable Suspension,Teva,800-545-8800,NDC 0703-0051-04 (80 mg/mL 25 x 1 mL Single-Dose Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Rheumatology,To be Discontinued,8/11/22,8/11/22
8627,Methylprednisolone Acetate Injection,"Par Pharmaceutical, Inc.",800-828-9393,"400 mg/5 mL (80 mg/mL), 5 mL multiple dose vial, box of 1 (NDC 42023-240-01)",New,6/16/22,Available,,,,Rheumatology,Current,,
8628,Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,40MG/ML 1X10ML (NDC 25021-820-010),Reverified,8/22/22,Available,,,,Rheumatology,Current,,
8629,Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,40MG/ML 1X5ML (NDC 25021-820-05),Reverified,8/22/22,Backorder. Estimated availability June 2022,,,,Rheumatology,Current,,
8630,Methylprednisolone Acetate Injection,Sagent Pharmaceuticals,866-625-1618,80MG/ML 1x5ML (NDC 25021-821-05),Reverified,8/22/22,Available,,,,Rheumatology,Current,,
8631,Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"40mg/mL, 1 single-dose vial (NDC 70121-1573-01)",New,12/15/21,Unavailable,,,Increase in demand,Rheumatology,Current,,
8632,Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"40 mg/mL, 25 single-dose vials (NDC 70121-1573-05)",New,12/15/21,Unavailable,,,Increase in demand,Rheumatology,Current,,
8633,Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"80 mg/mL, 1 single-dose vials (NDC 70121-1574-01)",New,12/15/21,Unavailable,,,Increase in demand,Rheumatology,Current,,
8634,Methylprednisolone Acetate Injection,Amneal Pharmaceutical,866-525-7270,"80 mg/mL, 25 single-dose vials (NDC 70121-1574-05)",New,12/15/21,Unavailable,,,Increase in demand,Rheumatology,Current,,
8635,Methylprednisolone Acetate Injection,Northstar,972-446-4800,"40mg/ml, 1ml/1 vial X 25 (NDC 16714-088-25)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8636,Methylprednisolone Acetate Injection,Northstar,972-446-4800,"40mg/ml, 1ml/1 vial (NDC 16714-088-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8637,Methylprednisolone Acetate Injection,Northstar,972-446-4800,200mg/5ml (40mg/ml) (NDC 16714-089-01),New,12/15/21,Out of Stock,,,Other,Rheumatology,Current,,
8638,Methylprednisolone Acetate Injection,Northstar,972-446-4800,"80mg/ml, 1ml/1 vial X 25 (NDC 16714-472-25)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8639,Methylprednisolone Acetate Injection,Northstar,972-446-4800,"80mg/ml, 1ml/1 vial (NDC 16714-472-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8640,Methylprednisolone Acetate Injection,Northstar,972-446-4800,"400mg/5ml (80mg/ml), 5ml/1 vial (NDC 16714-473-01)",New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8641,Methylprednisolone Acetate Injection,Northstar,972-446-4800,400mg/10ml (40mg/ml) (NDC 16714-090-01),New,12/15/21,Available; Product on allocation,,,Other,Rheumatology,Current,,
8642,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial (NDC 0703-0045-01),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8643,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0063-01),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8644,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0043-01),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8645,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,40 mg/mL 1 mL Single-Dose Vial (NDC 0703-0031-01),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8646,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,80 mg/mL 1 mL Single-Dose Vial(NDC 0703-0051-01),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8647,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,40 mg/mL 25 x 1 mL Single-Dose Vial (NDC 0703-0031-04 40),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8648,Methylprednisolone Acetate Injection,Teva Pharmaceuticals,800-545-8800,80 mg/mL 25 x 1 mL Single-Dose Vial(NDC 0703-0051-04),Reverified,10/5/22,Backordered; Estimated duration TBD,,,Other,Rheumatology,Current,,
8649,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,20 mg/mL; Multidose Vial (NDC 0009-0274-01),Revised,9/12/22,Next Delivery and Estimated Recovery: December 2022,,,Other,Rheumatology,Current,,
8650,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-02),Revised,9/12/22,Next Delivery and Estimated Recovery: November 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8651,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-03),Revised,9/12/22,Limited Supply Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand increase for the drug,Rheumatology,Current,,
8652,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-51),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8653,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Multidose Vial (NDC 0009-0280-52),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8654,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Multidose Vial (NDC 0009-0306-02),Revised,9/12/22,Available,,,Other,Rheumatology,Current,,
8655,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Multidose Vial (NDC 0009-0306-12),Revised,9/12/22,Next Delivery and Estimated Recovery: September 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8656,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial (NDC 0009-3073-01),Revised,9/12/22,Limited Supply Next Delivery: December 2022; Estimated Recovery: July 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8657,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial (NDC 0009-3073-03),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: December 2022,,,Demand increase for the drug,Rheumatology,Current,,
8658,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,40 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-22),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8659,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-23),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8660,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial (NDC 0009-3475-01),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8661,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial (NDC 0009-3475-03),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: July 2023,,,Demand increase for the drug,Rheumatology,Current,,
8662,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-22),Revised,9/12/22,Next Delivery and Estimated Recovery: July 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8663,Methylprednisolone Acetate Injection,Pfizer Pharmaceuticals,844-646-4398,80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-23),Revised,9/12/22,Next Delivery: February 2023; Estimated Recovery: July 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Rheumatology,Current,,
8664,Methylprednisolone Tablets,Pfizer,800-533-4535,32 mg tablet; Bottle of 25 (NDC 0009-0176-01),New,9/12/22,,Discontinuation of the manufacture of the drug.,,,Rheumatology,To be Discontinued,9/12/22,9/12/22
8665,Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg tablets (NDC 0591-0790-01),New,12/5/19,,,,,Neurology,To be Discontinued,,
8666,Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-01",New,7/6/21,,,,,Gastroenterology,To be Discontinued,,
8667,Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-05)",New,7/6/21,,,,,Gastroenterology,To be Discontinued,,
8668,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,50 mg tablets (NDCs 0591-0462-01 and 0591-0462-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,,
8669,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,100 mg tablets (NDCs 0591-0463-01 and 0591-0463-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,,
8670,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 100 bottle (NDC 0025-1821-31),New,10/13/21,,,,,Anti-Infective,To be Discontinued,,
8671,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 50 bottle (NDC 0025-1821-50),New,10/13/21,,,,,Anti-Infective,To be Discontinued,,
8672,Metronidazole Injection,B. Braun Medical Inc.,800-227-2862,500 mg/100 mL (5 mg/mL) NDC 0264-5535-32 (Product code D5353-5224),New,1/13/22,Available. On allocation.,,,Demand increase for the drug,Anti-Infective,Current,,
8673,Metronidazole Injection,Baxter Healthcare,888-229-0001,"500 mg/100 mL in VIAFLEX Plastic Container. Product Code 2B3421, (NDC 0338-1055-48)",Reverified,8/26/22,Available,,,,Anti-Infective,Current,,
8674,Metronidazole Injection,Sagent Pharmaceuticals,866-625-1618,5mg/ml 500mg per 100mL bag in 24 pack (NDC 25021-113-82),Reverified,8/12/22,Available,,,Demand increase for the drug,Anti-Infective,Current,,
8675,Metronidazole Injection,"Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-7811-37),Reverified,9/12/22,Available,,,Other,Anti-Infective,Current,,
8676,Metronidazole Injection,"Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-7811-24),Revised,8/17/22,,Discontinuation of the manufacture of the drug. Replaced with NDC 00409-0152-24,,,Anti-Infective,To be Discontinued,8/17/22,8/17/22
8677,Metronidazole Injection,"Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 0409-0152-24),Reverified,9/12/22,Available,,,Other,Anti-Infective,Current,,
8678,Metronidazole Injection,Gland Pharma Limited,TBD,100 mL Single Dose Bag (NDC 47335-993-01),New,4/11/22,Lots are anticipated in April; with additional inventory arriving in May.,,,Other,Anti-Infective,Current,,
8679,Midazolam Injection,WG Critical Care,888-493-0861,50mg/50mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag  (NDC 44567-610-10),Reverified,10/3/22,Available,,,,Anesthesia;Neurology,Current,,
8680,Midazolam Injection,WG Critical Care,888-493-0861,100mg/100mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag  (NDC 44567-611-10),Reverified,10/3/22,Available,,,,Anesthesia;Neurology,Current,,
8681,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,50 mg/10mL vial (NDC 23155-601-42),Reverified,8/23/22,Available,,,Other,Anesthesia;Neurology,Current,,
8682,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,25 mg/5mL vial (NDC 23155-601-41),Reverified,8/23/22,Available,,,Other,Anesthesia;Neurology,Current,,
8683,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,2 mg/2mL vial (NDC 23155-600-41),Reverified,8/23/22,Available; On allocation due to increased demand,,,Other,Anesthesia;Neurology,Current,,
8684,Midazolam Injection,"Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: April 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8685,Midazolam Injection,"Hospira, Inc.",844-646-4398,2 mg/2 mL (1 mg/mL) CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2306-62),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Neurology,Current,,
8686,Midazolam Injection,"Hospira, Inc.",844-646-4398,5 mg/mL CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2307-60),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Neurology,Current,,
8687,Midazolam Injection,Akorn Pharmaceuticals,800-932-5676,10 ML Vial - Pack of 10 (NDC 17478-0524-10),Revised,10/22/21,Available,,,,Anesthesia;Neurology,Current,,
8688,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8689,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8690,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8691,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8692,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8693,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8694,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8695,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8696,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8697,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8698,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8699,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25)",Revised,8/26/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8700,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8701,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10)",Revised,8/26/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8702,Midazolam Injection,"Hospira, Inc.",844-646-4398,2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: April 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8703,Midazolam Injection,"Hospira, Inc.",844-646-7398,5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology,Current,,
8704,Midazolam Injection,"Hospira, Inc.",844-646-4398,5 mg/mL (5 mg/mL)  Single Dose Glass Fliptop Vial (NDC 00409-2308-01),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8705,Midazolam Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05),Revised,9/12/22,Available,,,Other,Anesthesia;Neurology,Current,,
8706,Midazolam Injection,"Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8707,Midazolam Injection,"Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03),Revised,9/12/22,Next Delivery and Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8708,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10),Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8709,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05),Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8710,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17),Reverified,9/12/22,No stock available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8711,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91),Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8712,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 70860-600-02),Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8713,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 47781-588-68),Reverified,9/12/22,Available,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
8714,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,15mg tablets (NDC 0591-2469-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,
8715,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,30mg tablets (NDC 0591-2470-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,
8716,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,45mg tablets (NDC 0591-2471-15),New,5/29/18,,,,,Psychiatry,To be Discontinued,,
8717,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 59762-5008-2),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8718,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; 10x10 blister (NDC 0025-1451-34),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8719,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 0025-1451-60),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8720,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 0025-1461-31),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8721,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 0025-1461-60),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8722,Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 60 (NDC 43386-160-06),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8723,Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 120 (NDC 43386-160-12),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8724,Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 60 (NDC 43386-161-06),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8725,Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 100 (NDC 43386-161-01),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8726,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 59762-5007-1),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8727,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 59762-5007-2),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8728,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 59762-5008-1),Revised,3/11/22,,,Available,,Gastroenterology,Resolved,,
8729,Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4685-01 (20 mg/10 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22
8730,Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4680-01 (25 mg/12.5 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22
8731,Mitoxantrone Injection,Teva,800-545-8800,NDC 0703-4686-01 (30 mg/15 mL (2 mg/mL) Multiple Dose Vial),New,8/11/22,,Product is unavailable and no future production expected for an extended period.,,,Oncology; Neurology,To be Discontinued,8/11/22,8/11/22
8732,Mometasone Furoate Monohydrate Nasal Spray,Merck Sharp & Dohme Corp.,800-672-6372,50 mcg (NDC 0085-1288-01),New,6/9/21,,,,,Pulmonary/Allergy,To be Discontinued,,
8733,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,4 mg  (NDCs 0093-7424-98 and 0093-7424-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,
8734,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,5 mg  (NDCs 0093-7425-98 and 0093-7425-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,
8735,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,"10 mg (NDCs 0093-7426-10, 0093-7426-56, and 0093-7426-98)",New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,,
8736,Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"4 mg  (NDCs 0781-5554-05, 0781-5554-06, 0781-5554-13, 0781-5554-31, 0781-5554-64, 0781-5554-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,,
8737,Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"5 mg  (NDCs 0781-5555-05, 0781-5555-06, 0781-5555-13, 0781-5555-31, 0781-5555-64, 0781-5555-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,,
8738,Montelukast Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-5201-93),New,3/20/18,,,,,Pediatric;Pulmonary/Allergy,To be Discontinued,,
8739,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-2658-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8740,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 100s (NDC 0378-2659-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8741,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"60 mg, 100s (NDC 0378-2660-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8742,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100s (NDC 0378-2661-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8743,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100s (NDC 0378-2662-01)",New,5/8/18,,,,,Analgesia/Addiction,To be Discontinued,,
8744,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-452-01)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8745,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-454-01)",Revised,9/14/22,Backordered. Next release October 2022.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8746,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single dose vial, (NDC 63323-455-01)",Revised,9/14/22,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8747,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single dose vial, (NDC 63323-458-01)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8748,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, (NDC 63323-451-01)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8749,Morphine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"30 mg/30 mL (1 mg/1 mL) Single-Dose (Preservative-Free PCA Vial), (NDC 76329-1912-1)",Reverified,8/12/22,Backorder in the U.S. due to a manufacturing delay,,,,Analgesia/Addiction,Current,,
8750,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,250 mg/10 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1135-02),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8751,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8752,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1890-11),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8753,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8754,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1891-11),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8755,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8756,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1892-11),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8757,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01),Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8758,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1893-11),Revised,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
8759,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8760,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12),Revised,9/12/22,Available,,,Other,Analgesia/Addiction,Current,,
8761,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03)",Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8762,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,"2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05)",Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
8763,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10)",Revised,9/14/22,Check wholesalers for inventory,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8764,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10)",Revised,9/14/22,Check wholesalers for inventory,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8765,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10)",Revised,9/14/22,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8766,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single-use prefilled syringe (NDC 76045-007-10)",Revised,9/14/22,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8767,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8768,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6125-25)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8769,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"8 mg/mL, 1 mL vial (NDC 0641-6126-25)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8770,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-6127-25)",Revised,4/8/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8771,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8772,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8773,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8774,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
8775,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-004-11)",Revised,9/14/22,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8776,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-005-11)",Revised,9/14/22,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
8777,Moxifloxacin (Moxeza) Ophthalmic Solution,Novartis,888-669-6682,"5mg/mL, 3mL in 1 bottle, (NDC 0065-0006-03)",New,7/2/21,,,,,Ophthalmology,To be Discontinued,,
8778,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 10 mL Single Dose Dual Glass Fliptop Vials (NDC 61703-0434-82),Reverified,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8779,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 2 x 50 mL Pharmacy Bulk Package Dual Glass Fliptop Vials (NDC 61703-0422-83),Reverified,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8780,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Pediatric; Single Dose Glass Fliptop Vial (NDC 61703-0421-53),Reverified,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8781,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)",Reverified,7/1/22,Available on allocation,,,Demand increase for the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8782,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)",Reverified,7/1/22,Available on allocation,,,Demand increase for the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8783,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5650-2)",Reverified,7/1/22,Stocked out; Recovery TBD,,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8784,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)",Reverified,7/1/22,Stocked out; Recovery TBD,,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8785,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,1 g; Single Dose Vial (Powder)(NDC 0409-3713-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,
8786,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,2 g; Single Dose Vial (Powder)(NDC 0409-3714-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,
8787,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,10 g per Pharmacy Bulk Package; Pharmacy Bulk Vial (Powder)(NDC 0409-3715-01),New,10/20/21,,,,,Anti-Infective,To be Discontinued,,
8788,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-3124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8789,Nafcillin Sodium Injection,Sandoz,800-525-8747,2 gram vial packaged in 10s (NDC 0781-3125-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8790,Nafcillin Sodium Injection,Sandoz,800-525-8747,Pharmacy Bulk Package bottle (NDC 0781-3126-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8791,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-9124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8792,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9224-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8793,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9225-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8794,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3128-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8795,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3129-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,,
8796,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,
8797,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,
8798,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,
8799,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,,
8800,Naratriptan Hydrochloride Tablets,GlaxoSmithKline,888-825-5249,1 mg 9-count blisterpack (NDC 0173-0561-00),New,4/7/22,,,,,Neurology,To be Discontinued,,
8801,Naratriptan Hydrochloride Tablets,GlaxoSmithKline,888-825-5249,2.5 mg 9-count blisterpack (NDC 0173-0562-00),New,4/7/22,,,,,Neurology,To be Discontinued,,
8802,Nebivolol Hydrochloride Tablets,Abbvie,800-678-1605,"BYSTOLIC® (nebivolol) tablets, NDC 0456-1420-30 (30 tablets in 1 bottle)",New,6/9/22,,,,,Cardiovascular,To be Discontinued,,
8803,Nedocromil Sodium Ophthalmic Solution,Allergan,800-678-1605,2% (NDC 0023-8842-05),New,5/18/22,,,,,Ophthalmology,To be Discontinued,,
8804,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,50 mg 100 Tablets (NDC 0093-7178-01),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,
8805,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,100 mg 60 Tablets (NDC 0093-1024-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,
8806,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,150 mg 60 Tablets (NDC 0093-7113-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,
8807,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,200 mg 60 Tablets (NDC 0093-1025-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,
8808,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,250 mg 60 Tablets (NDC 0093-1026-06),Revised,6/10/22,,,Available,,Psychiatry,Resolved,,
8809,Nesiritide Powder (NATRECOR) for Injection,Janssen Pharmaceuticals,800-526-7736,1.5 mg (NDC 65847-205-25),New,2/5/18,,,,,Cardiovascular,To be Discontinued,,
8810,Nevirapine (Viramune) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,200 mg tablets (NDC 0597-0046-60),New,5/29/20,,,,,Antiviral,To be Discontinued,,
8811,Nevirapine Oral Suspension,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,50mg/5mL (NDC 0597-0047-24),New,10/1/21,,,,,Antiviral,To be Discontinued,,
8812,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 30 count bottle (NDC 0591-3138-30)",Reverified,9/21/22,"Backorder, Recovery expected TBD",,,Other,Gastroenterology,Current,,
8813,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg, 60 count bottle (NDC 0591-3137-60)",Reverified,9/21/22,Available,,,Other,Gastroenterology,Current,,
8814,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"300 mg, 30 count bottle (NDC 68462-0426-30)",New,3/27/20,Unavailable,,,,Gastroenterology,Current,,
8815,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"150 mg, 60 count bottle (NDC 68462-0425-60)",New,3/27/20,Unavailable,,,,Gastroenterology,Current,,
8816,Norepinephrine Bitartrate Injection,Teva,800-545-8800,NDC 0703-1153-03 (4 mg/4 mL (1 mg/mL) 10 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiology,To be Discontinued,8/11/22,8/11/22
8817,Norepinephrine Bitartrate Injection,Teva,800-545-8800,NDC 0703-1153-83 (4 mg/4 mL (1 mg/mL) 10 Vials) PREMIERProRx®,New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Cardiology,To be Discontinued,8/11/22,8/11/22
8818,Norethindrone (NOR QD) Tablets,Allergan,800-678-1605,"Nor QD, 0.35 mg norethindrone, Tablets, (NDC  52544-235-28)",New,2/23/18,,,,,Reproductive,To be Discontinued,,
8819,Nystatin and Triamcinolone Acetonide Cream,Teva Pharmaceuticals,800-545-8800,"0.1%  (NDCs 0472-0150-15, 0472-0150-30, 0472-0150-60)",New,4/8/22,,,,,Dermatology,To be Discontinued,,
8820,Nystatin and Triamcinolone Acetonide Ointment,Teva Pharmaceuticals,800-545-8800,"0.1%  (NDCs 0472-0155-15, 0472-0155-30, 0472-0155-60)",New,4/8/22,,,,,Dermatology,To be Discontinued,,
8821,Nystatin Ointment,Sandoz,800-525-8747,15 g tube (NDC 0168-0007-15 ),New,6/3/22,,,,,Dermatology,To be Discontinued,,
8822,Nystatin Ointment,Sandoz,800-525-8747,30 g tube (NDC 0168-0007-30 ),New,6/3/22,,,,,Dermatology,To be Discontinued,,
8823,Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3343-01 (5000 mcg/5 mL (1000 mcg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22
8824,Octreotide Acetate Injection,Teva,800-545-8800,"NDC 0703-3321-04 (500 mcg/mL, 25 x 1 mL Single Dose Vials)",New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22
8825,Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3333-01 (1000 mcg/5 mL (200 mcg/mL) 5 mL Multiple Dose Vial),New,8/11/22,,Product is available with an expected supply duration until JUL 2022.  No future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22
8826,Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3311-04 (100 mcg/mL 1 mL Single Dose Vial 25 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22
8827,Octreotide Acetate Injection,Teva,800-545-8800,NDC 0703-3301-04 (50 mcg/mL 1 mL Single Dose Vial 25 Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Endocrinology; Oncology,To be Discontinued,8/11/22,8/11/22
8828,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,12mg/50mg per capsule (NDC Package Code 0002-3234-30),New,7/15/20,,,,,Psychiatry,To be Discontinued,,
8829,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,6mg/50mg per capsule (NDC Package Code 0002-3233-30),New,7/15/20,,,,,Psychiatry,To be Discontinued,,
8830,Olopatadine Hydrochloride Nasal Spray,Novartis Pharmaceuticals,888-669-6682,"PATANASE (olopatadine hydrochloride) nasal spray, 665 mcg  (NDC 0078-0834-30) 1 BOTTLE in 1 CARTON (0078-0834-30) > 240 SPRAY, METERED in 1 BOTTLE",New,6/21/22,,,,,Pulmonary/Allergy,To be Discontinued,,
8831,Olopatadine Hydrochloride Nasal Spray,Novartis Pharmaceuticals,888-669-6682,"Olopatadine hydrochloride nasal spray, 665 mcg (NDC 61314 320-01) 1 BOTTLE in 1 CARTON (61314-320-01) > 30500 uL in 1 BOTTLE",New,6/21/22,,,,,Pulmonary/Allergy,To be Discontinued,,
8832,Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets,Abbvie,800-255-5162,212.5mg; 75mg; 50mg (NDC 0074-3082-28),New,5/22/18,,,,,Antiviral,To be Discontinued,,
8833,Omeprazole and Sodium Bicarbonate Powder for Suspension,Endo Pharmaceuticals. Inc.,"800-828-9393, option 5, then option 2",40mg and 1680mg  (NDC 49884-269-11),New,6/28/22,,,,,Gastroenterology,To be Discontinued,,
8834,Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",20mg and 1680mg  (NDC 49884-268-11),New,6/28/22,,,,,Gastroenterology,To be Discontinued,,
8835,Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",20mg; 1680mg  (NDCs 49884-268-52 and 49884-268-11),New,2/2/22,,,,,Gastroenterology,To be Discontinued,,
8836,Omeprazole and Sodium Bicarbonate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",40mg; 1680mg (NDCs 49884-269-11 and 49884-269-52),New,2/2/22,,,,,Gastroenterology,To be Discontinued,,
8837,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)",Revised,4/25/22,Available,,Available,,Gastroenterology,Resolved,,
8838,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8839,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8840,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9890-01)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8841,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"2 mg/mL , 20 mL vials (NDC 23155-549-31)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8842,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"PPRX 2 mg/mL , 2 mL Vial, 25 pack (NDC 23155-548-42)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8843,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"PPRX 2 mg/mL , 2 mL Vial, 10 pack (NDC 23155-548-41)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8844,Ondansetron Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8845,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"2 mg/mL , 2 mL Vial (NDC 23155-547-41)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8846,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01),Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8847,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 2 mL vial (NDC 0641-6078-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8848,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03),Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8849,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12),Revised,10/6/21,,,,,Gastroenterology,To be Discontinued,,
8850,Ondansetron Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)",Revised,4/25/22,,,,,Gastroenterology,Resolved,,
8851,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 2mL vial (NDC 70860-776-02),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8852,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 20mL vial (NDC 70860-777-20),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8853,Ondansetron Hydrochloride Injection,Apotex Corp.,800-706-5575,Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8854,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,40mg/20mL EA 1 Vial (NDC 25021-782-20),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8855,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,4mg/2mL PK 25 Vials (NDC 25021-777-02),Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8856,Ondansetron Hydrochloride Injection,Baxter Healthcare,800-229-0001,"Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8857,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 2 mL vial (NDC 72266-123-25)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8858,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 20 mL vial (NDC 72266-124-01)",Revised,4/25/22,,,Available,,Gastroenterology,Resolved,,
8859,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 50 mg/10 mL vial (NDCs 0024-0590-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8860,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 100 mg/20 mL vial (NDC 0024-0591-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8861,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Eloxatin 200 mg/40 mL vial (NDC 0024-0592-40),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8862,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Oxaliplatin 50 mg/10 mL vial (NDC 0955-1725-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8863,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Oxaliplatin 100 mg/20 mL vial (NDC 0955-1727-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8864,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Premier Oxaliplatin 50 mg/10 mL vial (NDC 0955-1731-10),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8865,Oxaliplatin Injection,Sanofi-Aventis,800-633-1610; Option 7,Winthrop Premier Oxaliplatin 100 mg/20 mL vial (NDC 0955-1733-20),New,9/8/22,,,,,Oncology,To be Discontinued,9/8/22,9/8/22
8866,Oxcarbazepine Oral Suspension,Novartis Pharmaceuticals Corporation,888-669-6682,300mg/5mL (NDC 0781-6270-43),New,8/8/22,,,,,Neurology,To Be Discontinued,8/8/22,8/8/22
8867,Oxybutynin Chloride Syrup,Wockhardt,800-346-6854,"5mg/5mL, 473mL (NDC 60432-0092-16)",New,4/11/22,,,,,Urology,To be Discontinued,,
8868,Oxytocin Injection,Fresenius Kabi,888-386-1300,100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial; (NDC 63323-012-10),New,9/23/22,Currently unavailable.  Next release October 2022.,,,Manufacturing delay,Anesthesia; Urology; Other,Current,,
8869,Oxytocin Injection,Fresenius Kabi,888-386-1300,300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30),New,9/23/22,Currently unavailable. Next release October 2022.,,,Manufacturing delay,Anesthesia; Urology; Other,Current,,
8870,Oxytocin Injection,Fresenius Kabi,888-386-1300,10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11),New,9/23/22,Currently unavailable.  Next release October 2022.,,,Manufacturing delay,Anesthesia; Urology; Other,Current,,
8871,Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06)",Revised,10/3/22,Limited availability,Limited supply due to low market share,,,Anesthesia; Urology; Other,Current,,
8872,Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25)",Revised,10/3/22,Limited availability,Limited supply due to low market share,,,Anesthesia; Urology; Other,Current,,
8873,Oxytocin Injection,Par Pharmaceuticals,800-828-9393,"Pitocin: Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02)",Revised,10/3/22,Limited availability,Limited supply due to low market share,,,Anesthesia; Urology; Other,Current,,
8874,Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"100 mg, single dose vial (NDC 24979-710-51)",New,5/27/22,No supply constraint or anticipated shortage,,,,Oncology,Current,,
8875,Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"100 mg, single dose vial (NDC 60505-6230-4)",New,5/27/22,No supply constraint or anticipated shortage,,,,Oncology,Current,,
8876,Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"Abraxane® 100 mg, single dose vial (NDC 68817-134-50)",Revised,5/27/22,No longer on allocation; recovery to normal inventory levels in progress.,,,Other,Oncology,Current,,
8877,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17)",New,11/22/19,,,,,Oncology,To be Discontinued,,
8878,Pantoprazole Sodium for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"40 mg, 10 vials (NDC 55150-202-10)",Reverified,9/28/22,Available,,,Demand increase for the drug,Gastroenterology,Current,,
8879,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-0923-55)",Revised,9/12/22,Available,,,Other,Gastroenterology,Current,,
8880,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-0923-60)",Revised,9/12/22,Available,,,Other,Gastroenterology,Current,,
8881,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-2001-10; Amerinet)",Revised,9/12/22,Next Delivery and Estimated Recovery: February 2025,,,Other,Gastroenterology,Current,,
8882,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-2001-25; Amerinet)",Revised,9/12/22,Next Delivery and Estimated Recovery: February 2025,,,Other,Gastroenterology,Current,,
8883,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-4001-10; PremierPro)",Revised,9/12/22,Limited Supply Next Delivery and Estimated Recovery: October 2022,Demand increase for the drug,,Other,Gastroenterology,Current,,
8884,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-4001-25; PremierPro)",Revised,9/12/22,Available,,,Other,Gastroenterology,Current,,
8885,Pantoprazole Sodium for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg, 10 vials (NDC 0143-9284-10)",Revised,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Gastroenterology,Current,,
8886,Pantoprazole Sodium for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,"40 mg, 10 vials (NDC 62756-129-44)",Revised,4/5/22,Available,,,Other,Gastroenterology,Current,,
8887,Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 72572-550-10)",Reverified,10/3/22,Available,Marketed by Civica,,,Gastroenterology,Current,,
8888,Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 65219-433-15)",Reverified,10/3/22,Limited Supply,Marketed by Fresenius Kabi,,Demand increase for the drug,Gastroenterology,Current,,
8889,Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 0781-3232-95)",Reverified,10/3/22,Limited Availability,,,Demand increase for the drug,Gastroenterology,Current,,
8890,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,25mcg Cartridge: (NDC 68875-0202-1); Carton: (NDC 68875-0202-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
8891,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,50mcg   Cartridge: (NDC 68875-0203-1); Carton: (NDC 68875-0203-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
8892,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,75mcg   Cartridge: (NDC 68875-0204-1); Carton: (NDC 68875-0204-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
8893,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,100mcg   Cartridge: (NDC 68875-0205-1); Carton: (NDC 68875-0205-2) (contains 2 cartridges),Revised,12/6/21,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
8894,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 200 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4347-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,
8895,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 300 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4348-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,
8896,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 600 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4349-01)",New,2/28/18,,,,,Oncology,To be Discontinued,,
8897,Pentamidine Isethionate (Nebupent) For Inhalation Solution,"Fresenius Kabi USA, LLC",888-386-1300,"300 mg per vial, SDV, PF (NDC 63323-877-15)",Revised,9/13/19,,,,,Anti-Infective,Resolved,,
8898,Pentostatin Injection,"Hospira, Inc.",844-646-4398,"10 mg, single dose vial (NDC 0409-0801-01)",Reverified,9/12/22,Available,,,Other,Oncology,Current,,
8899,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 100s (NDC 0378-0357-01)",New,5/8/18,,,,,Cardiovascular,To be Discontinued,,
8900,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 500s (NDC 0378-0357-05)",New,5/8/18,,,,,Cardiovascular,To be Discontinued,,
8901,Phenobarbital Oral Solution,Torrent Pharma Inc.,908-280-3333,1 pint 473mL (NDC 16571-330-16),New,11/25/19,,,,,Neurology,To be Discontinued,,
8902,Physostigmine Salicylate Injection,Akorn Pharmaceuticals,800-932-5676,"Physostigmine Salicylate Injection, USP  1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02)",Reverified,1/21/22,Unavailable. Expected to release Q4 2022.,,,Other,Neurology,Current,,
8903,Pindolol Tablets,Sun Pharmaceutical Industries Inc.,800-818-4555,"Pindolol Tablets, 5mg and 10mg (100 count bottles)(NDC 57664-655-88, 57664-656-88)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8904,Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 5mg Tabs 100s (NDC 0378-0052-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8905,Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 10mg Tabs 100s (NDC 0378-0127-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8906,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,5 mg/ 100 count (NDC 76385-131-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8907,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,10 mg/ 100 count (NDC 76385-132-01),Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8908,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"5 mg: Bottles of 100 tablets, (NDC 62559-560-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8909,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"10 mg; Bottles of 100 tablets, (NDC 62559-561-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8910,Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"5 mg, Bottle of 100 tablets (NDC 29033-028-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8911,Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"10 mg, Bottle of 100 tablets (NDC 29033-029-01)",Revised,1/11/22,,,Available,,Cardiovascular,Resolved,,
8912,Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,15 mg/1 (NDC 0781-5420-64),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8913,Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,30 mg/1 (NDC 0781-5421-10),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8914,Pioglitazone Hydrochloride Tablets,Sandoz,800-525-8747,45 mg/1 (NDC 0781-5422-10),New,1/10/22,,,,,Endocrinology/Metabolism,To be Discontinued,,
8915,Pioglitazone/Metformin HCl (ACTOPLUS MET®) Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,15mg/500mg tablet (NDC 64764-0155-60),New,10/18/21,,,,,Endocrinology/Metabolism,To be Discontinued,,
8916,Piroxicam Capsules,Pfizer Pharmaceuticals,800-533-4535,10 mg capsules; Bottles of 100 (NDC 59762-0140-1),New,8/10/21,,,,,Analgesia/Addiction,To be Discontinued,,
8917,Piroxicam Capsules,Pfizer Pharmaceuticals,800-533-4535,20 mg capsules; Bottles of 100 (NDC 59762-0145-1),New,8/10/21,,,,,Analgesia/Addiction,To be Discontinued,,
8918,Polymyxin B Sulfate and Trimethoprim Sulfate Ophthalmic Solution,"Allergan Sales, LLC",800-678-1605,"10,000 units/mL; 1 mg/mL (NDC 0023-7824-10)",New,8/8/22,,,,,Ophthalmology,To Be Discontinued,8/8/22,8/8/22
8919,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-51)",Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8920,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)",Revised,9/12/22,Next Delivery and Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8921,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3294-25), Novaplus",Revised,9/12/22,Next Delivery and Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8922,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"40 mEq/20 mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 0409-8183-25), Novaplus",Revised,9/12/22,Next Delivery: November 2022; Estimated Recovery: March 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8923,Potassium Acetate Injection,"Exela Pharma Sciences, LLC",828-758-5474,Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4),Revised,5/16/22,Product shipped to and available in wholesalers. Additional shipment end of May 2022. Increased supply available in mid-June.,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8924,Potassium Chloride Concentrate Injection,B. Braun Medical Inc.,800-227-2862,Concentrated Potassium Chloride Injection USP 250 mL Plastic Bag P9402 (NDC 0264-1944-20),Revised,9/14/22,Backordered.  Next release not available at this time.,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8925,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,10 mEq/5 mL (2 mEq/mL) Single Dose Glass Fliptop Vial (NDC 0409-6635-01),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8926,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,20 mEq/10 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 0409-6651-06),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand Increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8927,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 00409-6653-05),Revised,9/12/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8928,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"60 mEq per 30 mL (2 mEq per mL), Multi dose, plastic vial, (NDC 63323-967-30)",Revised,9/14/22,Available,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8929,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mEq per 5 mL(2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-05)",Revised,9/14/22,Available,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8930,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mEq per 10 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-10)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8931,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mEq per 20 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-20)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8932,Potassium Chloride Concentrate Injection,B. Braun Medical Inc.,800-227-2862,(2 mEq K /mL) 250mL bulk package Catalog# S9402-11(NDC 0264-1940-20),Revised,9/14/22,Inventory depleted.,,,Discontinuation of manufacturing,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8933,Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 20 mEq/50 mL (Legacy Hospira NDC 0409-7077-14) (ICU Medical NDC 0990-7077-14)",Reverified,10/3/22,Allocation,,,Demand Increase for the Drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8934,Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 10 mEq/100 mL (Legacy Hospira NDC 0409-7074-26) (ICU Medical NDC 0990-7074-26)",Reverified,10/3/22,Allocation,,,Demand Increase for the Drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8935,Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 10 mEq/50 mL (Legacy Hospira NDC 0409-7075-14) (ICU Medical NDC 0990-7075-14)",Reverified,10/3/22,Allocation,,,Demand Increase for the Drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8936,Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 20 mEq/100 mL (Legacy Hospira NDC 0409-7075-26) (ICU Medical NDC 0990-7075-26)",Reverified,10/3/22,Allocation,,,Demand Increase for the Drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8937,Potassium Chloride Concentrate Injection,"ICU Medical, Inc.",877-976-7747,"Potassium Chloride Injection, 40 mEq/100 mL (Legacy Hospira NDC 0409-7077-26) (ICU Medical NDC 0990-7077-26)",Reverified,10/3/22,Available,,,Demand Increase for the Drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8938,Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,10 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0826 (NDC 0338-0709-48),Reverified,9/28/22,Available on allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8939,Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,10 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0821 (NDC 0338-0705-41),Reverified,9/28/22,Available on allocation,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8940,Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,20 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0827 (NDC 0338-0705-48),Reverified,9/28/22,Limited Supply on Allocation; Recovery late June 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8941,Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,20 mEq/50 mL in VIAFLEX Plastic Container; Product Code 2B0822 (NDC 0338-0703-41),Reverified,9/28/22,Limited Supply on Allocation; Recovery mid-July 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8942,Potassium Chloride Concentrate Injection,Baxter Healthcare,888-229-0001,40 mEq/100 mL in VIAFLEX Plastic Container; Product Code 2B0824 (NDC 0338-0703-48),Reverified,9/28/22,Available on allocation,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8943,Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,29.8 g/L (20 mEq) 50 mL (NDC 14789-107-08),New,2/2/22,Backordered. Available early March 2022.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8944,Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,29.8 g/L (40 mEq) 100 mL (NDC 14789-107-16),New,2/2/22,Backordered. Available early March 2022.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8945,Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,14.9 g/L (20 mEq) 100 mL (NDC 14789-108-16),New,2/2/22,Backordered. Available early March 2022.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8946,Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,14.9 g/L (10 mEq) 50 mL (NDC 14789-108-08),New,2/2/22,Backordered. Available early March 2022.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8947,Potassium Chloride Concentrate Injection,"Nexus Pharmaceuticals, Inc.",888-806-4606,7.45 g/L ( 10 mEq) 100 mL (NDC 14789-109-16),New,2/2/22,Backordered. Available early March 2022.,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
8948,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.375mg (NDC 10370-251-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8949,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",0.75mg (NDC 10370-252-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8950,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",1.5mg (NDC 10370-253-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8951,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",2.25mg (NDC 10370-305-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8952,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",3mg (NDC 10370-254-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8953,Pramipexole Dihydrochloride Extended Release Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",3.75mg (NDC 10370-306-11),New,12/16/21,,,,,Neurology,To be Discontinued,,
8954,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (Pred Forte) (NDC 11980-180-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8955,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8956,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (NDC 60758-119-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8957,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (NDC 60758-119-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8958,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 5mL in 1 bottle (NDC 61314-637-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8959,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 10mL in 1 bottle (NDC 61314-637-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8960,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 15mL in 1 bottle (NDC 61314-637-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8961,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8962,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 60758-119-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,,
8963,Prednisolone Sodium Phosphate Oral Solution,Wockhardt Bio AG/Morton Grove Pharmaceuticals,847-410-6929,15 mg/5mL (NDC 60432-212-08) (8 fl oz.),New,5/26/22,,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,
8964,Procainamide Hydrochloride Injection,Pfizer,844-646-4398,"1,000 mg/2 mL (500 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 0409-1903-01)",New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Cardiology,To be Discontinued,8/30/22,8/30/22
8965,Procardia Capsules,Pfizer Pharmaceuticals,800-533-4353,10 mg capsule; Bottle of 100 (NDC 0069-2600-66),New,5/10/21,,,,,Cardiovascular,To be Discontinued,,
8966,ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 10 mL pre-filled syringe, (NDC 0270-1111-16)",New,6/1/21,,,,,Medical Imaging,To be Discontinued,,
8967,ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 17 mL pre-filled syringe, (NDC 0270-111-45)",New,6/1/21,,,,,Medical Imaging,To be Discontinued,,
8968,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL vial (NDC 0641-0928-25)",Reverified,4/8/22,Inventory is currently available.,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8969,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL ,1 mL vial (NDC 0641-0929-25)",Reverified,4/8/22,Inventory is currently available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8970,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL ampul (NDC 0641-1495-35)",Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8971,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL ampul (NDC 0641-1496-35)",Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8972,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25)",Reverified,4/8/22,Inventory is currently available.,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8973,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25)",Reverified,4/8/22,Inventory is currently available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8974,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25)",Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8975,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25)",Reverified,4/8/22,Inventory is currently available.,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8976,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3)",Reverified,2/25/21,Available,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8977,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6)",Reverified,2/25/21,Available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
8978,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,
8979,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,
8980,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,
8981,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04)",New,12/19/19,,,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,,
8982,Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",150mg (NDCs 0603-5448-21 and 0603-5448-25),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,
8983,Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",225mg (NDCs 0603-5449-21 and 0603-5449-25),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,
8984,Propafenone Hydrochloride Tablets,"Endo Pharmaceuticals, Inc.","800-823-9393, option 5, then option 2",300mg (NDC 0603-5450-21),New,2/2/22,,,,,Cardiovascular,To be Discontinued,,
8985,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0209-10),Revised,9/12/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia,Current,,
8986,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0234-20),Revised,9/12/22,Available,,,Other,Anesthesia,Current,,
8987,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0248-10),Revised,9/12/22,Available,,,,Anesthesia,Current,,
8988,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6194-10)",Reverified,4/8/22,This presentation is temporarily on backorder.  Recovery is TBD at this time.,,,Demand increase for the drug,Anesthesia,Current,,
8989,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 50 mL vial (NDC 0641-6195-20",Reverified,4/8/22,This presentation is temporarily on backorder.  Recovery is TBD at this time.,,,Demand increase for the drug,Anesthesia,Current,,
8990,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 100 mL vial (NDC 0641-6196-10",Reverified,4/8/22,This presentation is temporarily on backorder.  Recovery is TBD at this time.,,,Demand increase for the drug,Anesthesia,Current,,
8991,Propofol Injectable Emulsion,Avet Pharmaceuticals,855-228-9470,200 mg/20mL (pack 10) (NDC 23155-235-41),New,9/7/22,Available,,,,Anesthesia,Current,,
8992,Propofol Injectable Emulsion,Avet Pharmaceuticals,855-228-9470,200 mg/20mL (pack of 20) (NDC 23155-235-44),New,9/7/22,Available,,,,Anesthesia,Current,,
8993,Propofol Injectable Emulsion,Avet Pharmaceuticals,855-228-9470,500 mg/50 mL (pack of 20) (NDC 23155-345-42),New,9/7/22,Available,,,,Anesthesia,Current,,
8994,Propofol Injectable Emulsion,Avet Pharmaceuticals,855-228-9470,"1,000 mg/100 mL (pack of 10) (NDC 23155-345-13)",New,9/7/22,Available,,,,Anesthesia,Current,,
8995,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Reverified,10/5/22,Available,Market Exit - Estimated Run Out TBD,,Discontinuance of Manufacturing,Anesthesia,Current,,
8996,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Reverified,10/5/22,Available,Market Exit - Estimated Run Out TBD,,Discontinuance of Manufacturing,Anesthesia,Current,,
8997,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Reverified,10/5/22,Available,Market Exit - Estimated Run Out TBD,,Discontinuance of Manufacturing,Anesthesia,Current,,
8998,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, 10ct (NDC 43598-549-10)",Reverified,9/19/22,Allocating to Wholesalers,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
8999,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, individual (NDC 43598-549-52)",Reverified,9/19/22,Allocating to Wholesalers,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
9000,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, 25ct (NDC 43598-265-25)",Reverified,9/19/22,No current supply,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
9001,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9002,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,200mg per 20ml (NDC 25021-608-20),Reverified,8/22/22,Available,,,Demand increase due to Covid-19,Anesthesia,Current,,
9003,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,
9004,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand increase for the drug,Anesthesia,Current,,
9005,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33),Revised,9/12/22,Available,,,Other,Anesthesia,Current,,
9006,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2023,,,Demand increase for the drug,Anesthesia,Current,,
9007,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,200mg/20mL  10ct (NDC 43598-265-58),Reverified,9/19/22,Pack size discontinued,,,,Anesthesia,Current,,
9008,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, individual (NDC 43598-265-20)",Reverified,9/19/22,No current supply,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
9009,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,500mg/50mL  20ct (NDC 43598-548-21),Reverified,9/19/22,Allocating to Wholesalers,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
9010,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"500mg/50mL vial, individual (NDC 43598-548-50)",Reverified,9/19/22,Allocating to Wholesalers,,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
9011,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,
9012,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Revised,3/14/22,,,,,Anesthesia,To be Discontinued,,
9013,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10)",Reverified,9/14/22,Available,,,,Anesthesia,Current,,
9014,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9015,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50)",Reverified,9/14/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9016,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,500mg per 50ml (NDC 250-21-608-50),Reverified,8/22/22,Available,,,,Anesthesia,Current,,
9017,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,1000mg per 100ml (NDC 25021-608-51),Reverified,8/22/22,Available,,,,Anesthesia,Current,,
9018,Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL (10 mg per mL), single dose vial, preservative free,  (NDC 63323-229-05)",Revised,9/14/22,Available,Check wholesaler inventory,,,Hematology,Current,,
9019,Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg per 25 mL (10 mg per mL), single dose vial, preservative free, (NDC 63323-229-30)",Revised,9/14/22,Available,Check wholesaler inventory,,,Hematology,Current,,
9020,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500 mg  (NDC 45963-418-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,,
9021,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,1000 mg  (NDC 45963-419-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,,
9022,Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,1 mg (NDC 67457-198-03),Revised,9/28/22,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
9023,Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,2 mg (NDC 67457-198-05),Revised,9/28/22,Unavailable,Re-supply in December 2022.,,Demand increase for the drug,Analgesia/Addiction,Current,,
9024,Remifentanil Injection,"Mylan, a Viatris Company",800-796-9526,5 mg (NDC 67457-198-10),Revised,9/28/22,Unavailable,Re-supply in January 2023.,,Demand increase for the drug,Analgesia/Addiction,Current,,
9025,Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,1 mg/vial (NDC 0143-9391-10),Revised,8/26/22,This presentation is on backorder. Product will be available September 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
9026,Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,2 mg/Vial (NDC 0143-9392-10),Revised,8/26/22,This presentation is on backorder. Product will be available September 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
9027,Remifentanil Injection,Hikma Pharmaceuticals,800-631-2174,5 mg/mL (NDC 0143-9393-10),Revised,8/26/22,Currently available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
9028,Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"1 mg per vial, SDV (NDC 63323-723-03)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
9029,Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"2 mg per vial, SDV (NDC 63323-724-05)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
9030,Remifentanil Injection,Fresenius Kabi USA,888-386-1300,"5 mg per vial, SDV (NDC 63323-725-10)",Revised,9/14/22,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
9031,Repaglinide Tablets,Sandoz,800-525-8747,1mg tablets (NDC 0781-5149-01),New,2/2/18,,,,,Endocrinology/Metabolism,To be Discontinued,,
9032,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg capsules (NDC 0068-0510-30),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,
9033,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,300 mg capsules (NDC 0068-0508-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,
9034,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,150 mg Bottles of 30 (NDC 61748-015-30),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22
9035,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 30 (NDC 61748-018-30),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22
9036,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 60 (NDC 61748-018-60),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22
9037,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 100 (NDC 61748-018-01),New,9/12/22,,Discontinuation of manufacture of the drug.,,,,To be Discontinued,9/12/22,9/12/22
9038,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,150 mg (NDC 42806-801-30),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9039,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,150 mg (NDC 42806-801-01),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9040,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-30),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9041,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-60),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9042,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-01),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9043,Rifampin Capsules,"Epic Pharma, LLC",888-374-2791,300 mg (NDC 42806-799-05),Revised,1/11/22,Available,,,Other,Anti-Infective,Current,,
9044,Rifampin Capsules,Lupin,866-587-4617,150 mg - Bottles of 30 (NDC 68180-658-06),Reverified,7/15/22,Limited quantities available. More quantities will be available in coming weeks/months.,,,Shortage of an active ingredient.,Anti-Infective,Current,,
9045,Rifampin Capsules,Lupin,866-587-4617,300 mg - Bottles of 30 (NDC 68180-659-06),Reverified,7/15/22,Limited quantities available. More quantities will be available in coming weeks/months.,,,Shortage of an active ingredient.,Anti-Infective,Current,,
9046,Rifampin Capsules,Lupin,866-587-4617,300 mg - Bottles of 60 (NDC 68180-659-07),Reverified,7/15/22,Limited quantities available. More quantities will be available in coming weeks/months.,,,Shortage of an active ingredient.,Anti-Infective,Current,,
9047,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,150 mg Bottles of 30 (NDC 61748-015-30),Revised,9/12/22,Unavailable,Discontinuation of manufacture of the drug.,,Other,Anti-Infective,Current,,
9048,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 30 (NDC 61748-018-30),Revised,9/12/22,Unavailable,Discontinuation of manufacture of the drug.,,Other,Anti-Infective,Current,,
9049,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 60 (NDC 61748-018-60),Revised,9/12/22,Unavailable,Discontinuation of manufacture of the drug.,,Other,Anti-Infective,Current,,
9050,Rifampin Capsules,Akorn Pharmaceuticals,800-932-5676,300 mg Bottles of 100 (NDC 61748-018-01),Revised,9/12/22,Unavailable,Discontinuation of manufacture of the drug.,,Other,Anti-Infective,Current,,
9051,Rifampin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"600 mg per vial, PF, Lyophilized powder (NDC 63323-351-20)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,,Anti-Infective,Current,,
9052,Rifampin Injection,Sanofi,800-633-1610,"600 mg/10 mL, Lyophilized powder (NDC 0068-0597-01)",Revised,6/22/21,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,
9053,Rifampin Injection,"Mylan Institutional, a Viatris company",800-796-9526,"600 mg, (Lyophilizate in Single Dose Vials) (NDC 67457-445-60)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anti-Infective,Current,,
9054,Rifampin/Isoniazid (Rifamate) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg capsules (NDC 0068-0509-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,
9055,Rifampin/Isoniazid/Pyrazinamide (Rifater) Tablets,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg/120 mg tablets (NDC 0088-0576-41),New,6/15/20,,,,,Anti-Infective,To be Discontinued,,
9056,Rifapentine Tablets,Sanofi,800-633-1610 Option 7,"Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24)",Revised,6/22/22,Intermittent supply,,,Demand increase for the drug,Anti-Infective,Current,,
9057,Risankizumab-rzaa Injection,Abbvie,800-255-5162,75 mg/0.83 mL Prefilled Syringe (NDC numbers 0074-2042-01 and 0074-2042-02),New,9/20/22,,,,,Rheumatology,To be Discontinued,9/20/22,9/20/22
9058,Risedronate Sodium Tablets,Allergan Sales LLC,800-678-1605,30 mg (NDC 0430-0470-15),New,5/9/22,,,,,Musculoskeletal,To be Discontinued,,
9059,Risedronate Tablets,Allergan Sales LLC,800-678-1605,5 mg tablets (NDC 0430-0471-15),New,12/9/19,,,,,Musculoskeletal,To be Discontinued,,
9060,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9061,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9062,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9063,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9064,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9065,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9066,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9067,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9068,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9069,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9070,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9071,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9072,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9073,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-60),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9074,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9075,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-10),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9076,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 3 mg (NDC 50458-330-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9077,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 2 mg (NDC 50458-320-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9078,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 1 mg (NDC 50458-300-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9079,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.5 mg (NDC 50458-302-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9080,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-50),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9081,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-01),New,5/24/18,,,,,Pediatric;Psychiatry,To be Discontinued,,
9082,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 5mL vial (NDC 70860-651-05),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,,
9083,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 10mL vial (NDC 70860-651-10),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,,
9084,Ropivacaine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"0.5% 5mg/mL, 30mL, 1 Vial (NDC 17478-0081-30)",Revised,2/12/21,Available,,,Other,Anesthesia,Current,,
9085,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-10),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/12/22
9086,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22
9087,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9301-30),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22
9088,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/20 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9302-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22
9089,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-10),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22
9090,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-20),Revised,9/8/22,,Discontinuation of the manufacture of the drug,,,Anesthesia,To be Discontinued,9/8/22,9/8/22
9091,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.2% 20 mL Single Dose Vials (NDC 55150-195-20),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9092,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.2% 100 mL Single Dose Infusion Bottles (NDC 55150-196-99),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9093,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 20 mL Single Dose Vials (NDC 55150-197-20),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9094,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-198-30),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9095,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,0.75% 20 mL Single Dose Vials (NDC 55150-199-20),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9096,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 10 mL Single Dose Vials (NDC 55150-200-10),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9097,Ropivacaine Hydrochloride Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,1% 20 mL Single Dose Vials (NDC 55150-201-20),Reverified,9/28/22,Long-term backorder,,,Shortage of active ingredient,Anesthesia,Current,,
9098,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10)",Revised,9/14/22,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9099,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,
9100,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,
9101,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9102,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10)",Revised,9/14/22,Backordered. Next release not available at this time.,,,Available,Anesthesia,Current,,
9103,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9104,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9105,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9106,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65)",Revised,9/14/22,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
9107,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64)",Revised,9/14/22,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9108,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9109,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63)",Revised,9/14/22,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
9110,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9111,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
9112,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9113,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23)",Revised,9/14/22,Backordered. Next release September 2022.,,,Manufacturing delays,Anesthesia,Current,,
9114,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21)",Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9115,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11)",Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
9116,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
9117,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31)",Revised,9/14/22,Backordered. Next release not available at this time.,,,,Anesthesia,Current,,
9118,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,0.2% 2mg/mL 10x100mL (NDC 25021-671-82),Revised,4/25/22,Available,,,,Anesthesia,Current,,
9119,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,0.2% 2mg/mL 10x200mL (NDC 25021-671-87),Revised,4/25/22,Available,,,,Anesthesia,Current,,
9120,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,500 mg per 100 mL (5 mg per mL 0.5%) (NDC 25021-652-82 ),Revised,4/25/22,Available,,,,Anesthesia,Current,,
9121,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"1,000 mg per 200 mL (5 mg per mL 0.5%) (NDC 25021-652-87)",Revised,4/25/22,Backordered. Estimated availability TBD,,,,Anesthesia,Current,,
9122,Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 1 vial (NDC 70069-064-01)",New,4/20/22,Available,,,,Anesthesia,Current,,
9123,Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 10 vials (NDC 70069-064-10)",New,4/20/22,Available,,,,Anesthesia,Current,,
9124,Ropivacaine Hydrochloride Injection,"Somerset Therapeutics, LLC",732-554-1019,"0.5% (5 mg/mL), 30 mL, 25 vials (NDC 70069-064-25)",New,4/20/22,Available,,,,Anesthesia,Current,,
9125,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"0.2% 2mg/mL 10x100mL (NDC 25021-671-66), Novaplus",New,4/25/22,Available,,,,Anesthesia,Current,,
9126,Ropivacaine Hydrochloride Injection,InfoRLife SA,Sagent: 866-625-1618,"0.2% 2mg/mL 10x200mL (NDC 25021-671-67), Novaplus",New,4/25/22,Available,,,,Anesthesia,Current,,
9127,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.2%, 40 mg/20 mL (2 mg/mL) single dose vial (NDC 43066-015-10)",Revised,9/28/22,Limited Supply Recovery Q1 2023,,,Demand increase,Anesthesia,Current,,
9128,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 100 mg/20 mL (5 mg/mL) single dose vial (NDC 43066-019-10)",Revised,9/28/22,Limited supply. Recovery Q1 2023,,,Demand increase,Anesthesia,Current,,
9129,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 150 mg/30 mL (5 mg/mL) single dose vial (NDC 43066-023-10)",Revised,9/28/22,Available:  Recovery Q1 2023,,,Demand increase,Anesthesia,Current,,
9130,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"1%, 200 mg/20 mL (10 mg/mL) single dose vial (NDC 43066-027-10)",Revised,9/28/22,Limited supply. Recovery Q1 2023,,,Demand increase,Anesthesia,Current,,
9131,Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,5 mg (NDC 0781-5400-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,
9132,Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,10 mg (NDC 0781-5401-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,
9133,Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,20 mg (NDC 0781-5402-92),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,
9134,Rosuvastatin Calcium Tablets,Sandoz,800-525-8747,40 mg (NDC 0781-5403-31),New,6/16/22,,,,,Cardiovascular,To be Discontinued,,
9135,Samarium SM 153 Lexidronam  (Quadramet) Injection,Lantheus Medical Imaging INC,800-362-2668,150mCi (NDC 11994-016-01),New,10/28/21,,,,,Oncology,To be Discontinued,,
9136,Saquinavir Mesylate (Invirase) 200mg Capsules,"Genentech, Inc",877-436-3683,200 mg capsules (NDC 0004-0245-15),New,2/6/18,,,,,Antiviral,To be Discontinued,,
9137,Sclerosol Intrapleural Aerosol,Lymol Medical Corp.,781-935-0004,Sclerosol 4 GM (NDC 63256-100-30),Revised,6/14/22,,,,,Pulmonary/Allergy,To be Discontinued,,
9138,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 24s (NDC 0378-6470-44),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,,
9139,"Selenium Sulfide Lotion, 2.5%",Wockhardt,800-346-6854,4 fl oz (118 mL) (NDC 60432-528-04),New,6/13/22,,,,,Dermatology,To be Discontinued,,
9140,Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,0.25 mg / 0.5mg (NDC 0169-4132-12),Revised,10/3/22,Limited availability; Intermittent supply disruption will continue through November 2022,Localized short term stock outages in pharmacies,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
9141,Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,1 mg (NDC 0169-4130-13),Revised,10/3/22,Currently available,,,,Endocrinology/Metabolism,Current,,
9142,Semaglutide (Ozempic) Injection,"Novo Nordisk, Inc.",866-696-4090 and press 0  ,2 mg (NDC 0169-4772-12),Revised,10/3/22,Limited availability; Intermittent supply disruption will continue through October 2022,Localized short term stock outages in pharmacies,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
9143,Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-493-4689,0.25 mg / 0.5mL (NDC 0169-4525-14),Revised,9/14/22,"Distribution of this dose temporarily paused, resumption of supply expected towards the end of 2022.",,,Requirements related to complying with good manufacturing practices.,Endocrinology/Metabolism,Current,,
9144,Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-493-4689,0.5 mg / 0.5mL (NDC 0169-4505-14),Revised,9/14/22,"Distribution of this dose temporarily paused, resumption of supply expected towards the end of 2022.",,,Requirements related to complying with good manufacturing practices.,Endocrinology/Metabolism,Current,,
9145,Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,1 mg / 0.5mL (NDC 0169-4501-14),Revised,9/14/22,Currently unavailable; Resumption of supply expected towards the end of 2022.,,,Requirements related to complying with good manufacturing practices.,Endocrinology/Metabolism,Current,,
9146,Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,1.7 mg / 0.75mL (NDC 0169-4517-14),Revised,9/14/22,Currently available,,,Requirements related to complying with good manufacturing practices.,Endocrinology/Metabolism,Current,,
9147,Semaglutide (WEGOVY®) Injection,"Novo Nordisk, Inc.",833-496-4689,2.4 mg / 0.75mL (NDC 0169-4524-14),Revised,9/14/22,Currently available,,,Requirements related to complying with good manufacturing practices.,Endocrinology/Metabolism,Current,,
9148,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,"20mg/ml, 60ml  (NDC 16714-601-02)",Revised,4/13/21,,,Northstar Rx label. Product Distributed by McKesson:  +1 (972) 446-4800,,Psychiatry,Resolved,,
9149,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 30 count (NDC 16729-215-10)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9150,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 90 count (NDC 16729-215-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9151,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 500 count (NDC 16729-215-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9152,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 90 count (NDC 16729-216-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9153,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 500 count (NDC 16729-216-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9154,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 90 count (NDC 16729-217-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9155,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 500 count (NDC 16729-217-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9156,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 65862-011-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9157,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 65862-011-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9158,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 65862-011-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9159,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 65862-012-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9160,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 65862-012-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9161,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 65862-012-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9162,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 65862-013-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9163,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 65862-013-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9164,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 65862-013-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9165,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 16714-611-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9166,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 16714-611-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9167,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 16714-611-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9168,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 1000 count (NDC 16714-611-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9169,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 16714-612-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9170,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 16714-612-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9171,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 16714-612-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9172,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 1000 count (NDC 16714-612-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9173,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 16714-613-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9174,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 16714-613-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9175,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 16714-613-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9176,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 1000 count (NDC 16714-613-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9177,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 25 mg; Bottle of 30 tablets (NDC 0049-4960-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9178,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Bottle of 30 tablets (NDC 0049-4900-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9179,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Blister of 10 tablets (NDC 0049-4900-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9180,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Bottle of 30 tablets (NDC 0049-4910-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9181,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Blister of 10 tablets (NDC 0049-4910-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9182,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,25 mg; Bottle of 30 tablets (NDC 59762-6347-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9183,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,50 mg; Bottle of 30 tablets (NDC 59762-6443-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9184,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 30 tablets (NDC 59762-5160-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9185,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 100 tablets (NDC 59762-5160-2); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,,
9186,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 30 count (NDC 68180-351-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9187,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 90 count  (NDC 68180-351-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9188,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 1000 count (NDC 68180-351-03)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9189,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 30 count (NDC 68180-352-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9190,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 90 count (NDC 68180-352-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9191,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 500 count (NDC 68180-352-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9192,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 5000 count (NDC 68180-352-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9193,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 30 count (NDC 68180-353-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9194,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 90 count (NDC 68180-353-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9195,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 500 count (NDC 68180-353-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9196,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 5000 count (NDC 68180-353-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9197,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 69097-833-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9198,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 69097-833-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9199,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 69097-833-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9200,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 69097-834-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9201,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 69097-834-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9202,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 69097-835-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9203,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 69097-835-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9204,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 76282-212-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9205,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 60 count (NDC 76282-212-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9206,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 76282-212-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9207,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 100 count (NDC 76282-212-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9208,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 180 count (NDC 76282-212-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9209,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 76282-212-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9210,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 76282-213-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9211,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 60 count (NDC 76282-213-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9212,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 90 count (NDC 76282-213-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9213,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 100 count (NDC 76282-213-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9214,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 180 count (NDC 76282-213-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9215,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 76282-213-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9216,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 76282-214-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9217,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 60 count (NDC 76282-214-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9218,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 90 count (NDC 76282-214-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9219,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 100 count (NDC 76282-214-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9220,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 180 count (NDC 76282-214-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9221,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 76282-214-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,,
9222,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/12.5 mL; vial (NDC 0069-0338-01),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,
9223,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,20 mg; tablets (NDC 0069-4190-68),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,
9224,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/mL (powder); bottle (NDC 0069-0336-21),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,
9225,Sildenafil Citrate (REVATIO),Novitium Pharma LLC,845-652-0377,"10 mg/mL, (NDC 70954-168-10)",Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,,
9226,Simeprevir Capsules,Janssen Pharmaceuticals,800-526-7736,150mg capsules (NDC 59676-225-28),New,5/23/18,,,,,Antiviral,To be Discontinued,,
9227,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,5 mg (NDC 0093-7152-98),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9228,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,10 mg (NDCs 0093-7153-93 / 0093-7153-56 / 0093-7153-19 / 0093-7153-31 / 0093-7153-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9229,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,20 mg (NDCs 0093-7154-93 / 0093-7154-56 / 0093-7154-31 / 0093-7154-19 / 0093-7154-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9230,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,40 mg (NDCs 0093-7155-93 / 0093-7155-56 / 0093-7155-31 / 0093-7155-19 / 0093-7155-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9231,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,80 mg (NDCs 0093-7156-98 / 0093-7156-93 / 0093-7156-56 / 0093-7156-19 / 0093-7156-10),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9232,Simvastatin (Zocor) Tablets,Merck Sharp & Dohme Corp.,800-637-2579,5 mg Tablets bottles of 30 (NDC 0006-0726-31),New,2/6/18,,,,,Cardiovascular,To be Discontinued,,
9233,Simvastatin Tablets,Merck Sharp & Dohme Corp.,800-672-6372,80 mg (NDCs 0006-0543-31 and 0006-0543-54),New,7/27/21,,,,,Cardiovascular,To be Discontinued,,
9234,Sincalide (Kinevac) Lyophilized Powder for Injection,Bracco Diagnostics,877-272-2269,Supplied in packages of 10 single dose vials containing 5 mcg of sincalide per vial (NDC 0270-0556-15),Reverified,7/16/21,Available,,,Delay in shipping of the drug,Medical Imaging;Other,Current,,
9235,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,100 mEq/50 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-05),Revised,9/12/22,Next Delivery and Estimated Recovery: November 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9236,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,200 mEq/100 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 0409-3299-06),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9237,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 0409-7299-73),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: January 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9238,Sodium Acetate Injection,"Fresenius Kabi USA, LLC",888-386-1300,32.8% 400 mEq 100mL PBP (NDC 63323-0032-00),Reverified,9/14/22,Backordered. Next release not available at this time.,,,Manufacturing delay,Total Parenteral Nutrition,Current,,
9239,Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,100 mEq/50 mL (2 mEq/mL) (NDC 69784-230-20),Reverified,12/3/21,Available,,,Other,Total Parenteral Nutrition,Current,,
9240,Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,200 mEq/100 mL (2 mEq/mL) (NDC 69784-231-20),Reverified,12/3/21,Available,,,Other,Total Parenteral Nutrition,Current,,
9241,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial (4.2% Concentration) (NDC 0409-5555-02),Revised,9/30/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9242,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial Novaplus®  (4.2% Concentration) (NDC 0409-5555-01),Revised,9/30/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9243,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,44.6 mEq/50 mL (0.9 mEq/mL) LifeShield™ ABBOJECT™ Glass Syringe (7.5% concentration) (NDC 0409-4916-14),Revised,9/30/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9244,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Glass Fliptop Vial (8.4% concentration) (NDC 0409-6625-14) (old NDC 0409-6625-02),Revised,9/30/22,Limited Supply Available. Next Delivery and Estimated Recovery: September 2022,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9245,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Vial Novaplus® (8.4% concentration) (NDC 0409-6625-35),Revised,9/30/22,Available,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9246,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Pediatric 10 mEq/10 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-4900-14),Revised,9/30/22,Limited Supply Available. Next Delivery: November 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9247,Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,10 mEq/10 mL (NDC 2551754-5011-04),New,1/31/22,Currently on backorder,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9248,Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"5 mEq/10 mL, 4.2%, (NDC 51754-5012-04)",New,1/31/22,On backorder,,,,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9249,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Neut (Sodium Bicarbonate Additive Solution); 200 mg/5 mL (4%); Single Dose Glass Fliptop Vial (NDC 0409-6609-02),Revised,9/30/22,Discontinued,,,Discontinuation of the manufacture of the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9250,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Infant 5 mEq/10 mL (0.5 mEq/mL) ABBOJECT® Glass Syringe (4.2% Concentration) (NDC 0409-5534-14) (old NDC 0409-5534-34),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9251,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-6637-14),Revised,9/30/22,Next Delivery: September 2022; Estimated Recovery: June 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9252,Sodium Bicarbonate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1)",Reverified,8/12/22,Backorder due to the increase in demands,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9253,Sodium Bicarbonate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05)",Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9254,Sodium Bicarbonate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL)  (84 mg per mL)(NDC 63323-089-50)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9255,Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"8.4%, 50mL (NDC 51754-5001-05)",Revised,1/31/22,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
9256,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 50 mL (Legacy Hospira NDC 0409-7984-13)(ICU Medical NDC 0990-7984-13)",Reverified,10/3/22,Allocated to Contracted Customers Only,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
9257,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 50 mL 4-1 (Legacy Hospira NDC 0409-7984-36)(ICU Medical NDC 0990-7984-36)",Reverified,10/3/22,Available to Contracted Customers Only,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
9258,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 100 mL (Legacy Hospira NDC 0409-7984-37)(ICU Medical NDC 0990-7984-37)",Reverified,10/3/22,Allocated to Contracted Customers Only,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
9259,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 100 mL (Legacy Hospira NDC 0409-7984-23)(ICU Medical NDC 0990-7984-23)",Reverified,10/3/22,Allocated to Contracted Customers Only,,,Other,Gastroenterology;Other;Pediatric,Current,,
9260,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 25 mL (Legacy Hospira NDC 0409-7984-20)(ICU Medical NDC 0990-7984-20)",Reverified,10/3/22,Available,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
9261,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,1000 mL Excel Bag L8000 (NDC 0264-7800-00),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9262,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,500 mL Excel Bag L8001 (NDC 0264-7800-10),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9263,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,250 mL Excel Bag L8002 (NDC 0264-7800-20),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9264,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,1000 mL E3 Bag E8000 (NDC 0264-7800-09),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9265,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,100 mL PAB Bag S8004-5264 (NDC 0264-1800-32),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9266,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,50 mL PAB Bag S8004-5384 (NDC 0264-1800-31),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9267,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,25 mL PAB Bag S8004-5410 (NDC 0264-1800-36),New,12/10/21,Product available for contracted customers,,,Other,Gastroenterology;Other;Pediatric,Current,,
9268,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,50 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-66),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Other;Pediatric,Current,,
9269,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,100 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-67),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: October 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Other;Pediatric,Current,,
9270,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,250 mL ADD-Vantage™ Flexible Container (NDC 00409-7101-02),Revised,9/12/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9271,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 76297-001-21)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9272,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 76297-001-31)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9273,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9274,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC NDC 76297-001-41)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9275,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 76297-001-11)",New,3/16/22,Available,,,Other,Gastroenterology;Other;Pediatric,Current,,
9276,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (450 mg per 50 mL), (9 mg per mL), Single Dose freeflex bag, 50 mL, (NDC: 63323-623-53)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9277,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (900 mg per 100 mL), (9 mg per mL), Single Dose freeflex bag, 100 mL, (NDC: 63323-623-61)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9278,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (2,250 mg per 250 mL), (9 mg per mL), Single dose freeflex bag, 250 mL, (NDC: 63323-623-74)",Revised,9/14/22,Backordered. Next release August 2022.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9279,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (4,500 mg per 500 mL), (9 mg per mL), Single dose freeflex bag, 500 mL, (NDC: 63323-623-75)",Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9280,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"0.9% (9,000 mg per 1,000 mL), (9 mg per mL), Single dose freeflex bag, 1,000 mL, (NDC: 63323-623-76)",Revised,9/14/22,Backordered. Next release August 2022.,Check wholesaler inventory,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9281,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Quad Pack; Product Code 2B1302; (NDC 0338-0049-18)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9282,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Product Code 2B1306 (NDC 0338-0049-41)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9283,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Product Code 2B1307 (NDC 0338-0049-48)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9284,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B1308 (NDC 0338-0049-31)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9285,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLEX Plastic Container, Product Code 2B1322Q (NDC 0338-0049-02)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9286,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLEX Plastic Container, Product Code 2B1323Q (NDC 0338-0049-03)",Reverified,9/28/22,Limited supply; Recovery August,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9287,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLEX Plastic Container, Product Code 2B1324X (NDC 0338-0049-04)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9288,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"25 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B1300 (NDC 0338-0049-10)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9289,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B1301 (NDC 0338-0049-11)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9290,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B1309 (NDC 0338-0049-38)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9291,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLO Plastic Container, Product Code UE1322D (NDC 0338-9543-02)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9292,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLO Plastic Container, Product Code UE1324D (NDC 0338-9543-06)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9293,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLO Plastic Container, Product Code UE1323D (NDC 0338-9543-04)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9294,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL MINI-BAG Plus Container, Quad Pack, Product Code 2B0042 (NDC 0338-0553-11)",Reverified,9/28/22,Available,,,Manufacturing delay,Gastroenterology;Other;Pediatric,Current,,
9295,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"50 mL MINI-BAG Plus Container, Single Pack, Product Code EZPB0042 (NDC 0338-9151-30)",Reverified,9/28/22,Supply available on allocation,,,,Gastroenterology;Other;Pediatric,Current,,
9296,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL MINI-BAG Plus Container, Single Pack, Product Code EZPB0043 (NDC 0338-9159-30)",Reverified,9/28/22,"Limited Supply on Allocation, Recovery 2023",,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9297,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"100 mL MINI-BAG Plus Container, Quad Pack, Product Code 2B 0043 (NDC 0338-0553-18)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9298,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL VIAFLO Plastic Container, Product Code UE1322D (NDC 0338-9543-02)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9299,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL VIAFLO Plastic Container, Product Code UE1323D (NDC 0338-9543-04)",Reverified,9/28/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9300,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL VIAFLO Plastic Container, Product Code UE1324D (NDC 0338-9543-06)",Reverified,9/28/22,Available,,,Demand increase,Gastroenterology;Other;Pediatric,Current,,
9301,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 79672-613-01)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,
9302,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 79672-613-02)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,
9303,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 79672-613-03)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,
9304,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC 79672-613-04)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,
9305,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC 79672-613-05)",New,3/16/22,Product available for contracted customers.,,,Other,Gastroenterology;Other;Pediatric,Current,,
9306,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 500 mL (Legacy Hospira (NDC 0409-7983-03)(ICU Medical NDC 0990-7983-03)",Reverified,10/3/22,Available,,,,Gastroenterology;Other;Pediatric,Current,,
9307,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-976-7747,"0.9% Sodium Chloride, USP 1000 mL (Legacy Hospira NDC 0409-7983-09)(ICU Medical NDC 0990-7983-09)",Reverified,10/3/22,Allocation,,,Demand increase for the drug,Gastroenterology;Other;Pediatric,Current,,
9308,Sodium Chloride 14.6% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mEq per 20 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-20)",New,4/5/22,Backordered. Next release June 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9309,Sodium Chloride 14.6% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mEq per 40 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-40)",New,4/5/22,Backordered. Next release June 2022.,,,Increase in Demand,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9310,Sodium Chloride 14.6% Injection,"Hospira, Inc.",844-646-4398,14.6% 100 mEq/40 mL (2.5 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6660-75),Reverified,9/12/22,Next Delivery and Estimated Recovery: March 2023,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9311,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mL vials (NDC 63323-0095-61),Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
9312,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mL vials (NDC 63323-0088-63),Revised,9/14/22,Backordered. Next release October 2022.,Check wholesaler inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
9313,Sodium Chloride 23.4% Injection,"Hospira, Inc.",844-646-4398,400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02),Revised,9/12/22,Next Delivery: October 2022; Estimated Recovery: March 2023,,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
9314,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,30 mL vials (NDC 63323-0093-30),Revised,9/14/22,Backordered. Next release September 2022.,Check wholesaler inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
9315,"Sodium Chloride Injection, 0.9% Vials and Syringes","Medefil, Inc.",630-682-4600,"Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30)",Revised,10/3/22,Available,,,Available,Other,Current,,
9316,"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02)",Revised,10/3/22,Backordered. Next release Q4-2022.,,,Increase in Demand,Other,Current,,
9317,"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10)",Revised,10/3/22,Backordered. Next release October 2022.,Check wholesalers for inventory,,Demand increase,Other,Current,,
9318,"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20)",Revised,10/3/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase,Other,Current,,
9319,"Sodium Chloride Injection, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00)",Revised,10/3/22,Backordered.  Next release date not available at this time.,,,Increase in Demand,Other,Current,,
9320,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10),Revised,10/3/22,Available,,,Demand increase for the drug,Other,Current,,
9321,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12),Revised,10/3/22,Next Delivery: October 2022; Estimated Recovery: December 2022,,,Demand increase for the drug,Other,Current,,
9322,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20),Revised,10/3/22,Available,,,Other,Other,Current,,
9323,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50),Revised,10/3/22,Next Delivery: October 2022; Estimated Recovery: August 2023,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Demand increase for the drug,Other,Current,,
9324,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-32),Revised,10/3/22,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
9325,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-33),Revised,10/3/22,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
9326,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-35),Revised,10/3/22,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
9327,"Sodium Chloride Injection, 0.9% Vials and Syringes","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.9%, 2 mL vial (NDC 0641-0497-25)",Revised,10/3/22,This presentation is temporarily on backorder.  Recovery is TBD at this time.,,,Demand increase for the drug,Other,Current,,
9328,"Sodium Chloride Injection, 0.9% Vials and Syringes","Spectra Medical Devices, Inc.",978-657-0889,0.9% 10mL Ampule (NDC 65282-1510-1),Revised,10/3/22,"Currently available, in stock, Production is ongoing",,,Other,Other,Current,,
9329,"Sodium Chloride Injection, 0.9% Vials and Syringes","Spectra Medical Devices, Inc.",978-657-0889,0.9% 5mL Ampule (NDC 65282-1505-1),Revised,10/3/22,"Currently available, in stock, Production is ongoing",,,Other,Other,Current,,
9330,"Sodium Chloride Injection, 0.9% Vials and Syringes",Guerbet LLC,877-729-6679,125 mL PFS (NDC 0019-1188-81),Revised,10/3/22,"On backorder. Next batch will be available in April 2022, and the current demand can be fulfilled by May 2022.",,,Other,Other,Current,,
9331,"Sodium Chloride Injection, 0.9% Vials and Syringes",Guerbet LLC,877-729-6679,125 mL PFS RFID Tag (NDC 0019-1188-27),Revised,10/3/22,Available; Next batch will be available May 2022.,,,Other,Other,Current,,
9332,Sodium Phosphates Injection,"Hospira, Inc.",844-646-4398,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 0409-7391-72)",Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9333,Sodium Phosphates Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 15 mmol/5 mL, Sodium 20 mEq/5 mL, vial (NDC 63323-170-05)",Revised,9/14/22,Available,Check wholesaler inventory,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9334,Sodium Phosphates Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 63323-881-16)",Revised,9/14/22,Available,Check wholesaler inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
9335,Somatropin Recombinant (Humatrope) Injection,Eli Lilly and Co.,800-545-5979,5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent,New,7/7/20,,,,,Hematology,To be Discontinued,,
9336,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 100 (NDC 0228-2803-11)",New,5/22/18,,,,,Renal,To be Discontinued,,
9337,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 500 (NDC 0228-2803-50)",New,5/22/18,,,,,Renal,To be Discontinued,,
9338,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 100 (NDC 0228-2672-11)",New,5/22/18,,,,,Renal,To be Discontinued,,
9339,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 500 (NDC 0228-2672-50)",New,5/22/18,,,,,Renal,To be Discontinued,,
9340,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 100 (NDC 0228-2673-11)",New,5/22/18,,,,,Renal,To be Discontinued,,
9341,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 500 (NDC 0228-2673-50)",New,5/22/18,,,,,Renal,To be Discontinued,,
9342,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-496-9526,20mg capsules (NDC 0378-5041-91),New,4/30/18,,,,,Antiviral,To be Discontinued,,
9343,Sterile Water for Injection,"Medefil, Inc.",630-682-4600,10 mL in plastic syringe (NDC 64253-020-30),Revised,3/1/22,Available,,,Available; Demand Increase for the drug,Other,Current,,
9344,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single Dose free flex bag, 1,000 mL fill, (NDC 63323-178-76)",Revised,9/14/22,Backordered. Next release October 2022.,,,,Other,Current,,
9345,Sterile Water for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mL vial (NDC 0641-6147-10),Revised,6/3/22,This presentation is temporarily on backorder.,,,Demand increase for the drug,Other,Current,,
9346,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,10 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-10),Revised,9/12/22,Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: May 2023,,,Demand increase for the drug,Other,Current,,
9347,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,20 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-20),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: October 2022,,,Demand increase for the drug,Other,Current,,
9348,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,50 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-50),Revised,9/12/22,Next Delivery: September 2022; Estimated Recovery: October 2023,,,Demand increase for the drug,Other,Current,,
9349,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,100 mL Single Dose Glass Fliptop Vial (NDC 00409-4887-99),Revised,9/12/22,Next Delivery: February 2023; Estimated Recovery: March 2023,,,Demand increase for the drug,Other,Current,,
9350,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mL Vial (NDC 63323-0185-10),Revised,9/14/22,Available,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,
9351,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mL Vial (NDC 63323-0185-20),Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,
9352,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mL Vial (NDC 63323-0185-50),Revised,9/14/22,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Other,Current,,
9353,Sterile Water for Injection,Nephron Pharmaceuticals Corporation,803-569-2800,5 mL Plastic Vials (NDC 0487-6105-01),New,2/22/22,Available,,,Other,Other,Current,,
9354,Sterile Water for Injection,American Regent/Luitpold,800-645-1706,10mL Vial (NDC 0517-3010-25),New,5/26/22,"Backordered, Next release August 2022",,,Demand increase for the drug,Other,Current,,
9355,Sterile Water for Injection,American Regent/Luitpold,800-645-1706,20mL Vial (NDC 0517-3020-25),New,5/26/22,Backordered Next release July 2022,,,Demand increase for the drug,Other,Current,,
9356,Streptozocin (Zanosar) Sterile Powder,Teva Pharmaceuticals,800-545-8800,Streptozocin (Zanosar®) Sterile Powder: (NDC 0703-4636-01) (1 gram Single Dose Vial),Reverified,10/5/22,"Backorder, Recovery expected TBD",,,Other,Oncology,Current,,
9357,Streptozocin (Zanosar) Sterile Powder,Teva,800-545-8800,NDC 0703-4636-01 (1 gram Single Dose Vial),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
9358,Succimer (Chemet) Capsules,Recordati Rare Diseases,866-209-7604,100 mg capsules (NDC 55292-201-11),Revised,9/14/21,,,Available,,Hematology,Resolved,,
9359,Sufentanil Citrate Injection,"Hospira, Inc.",844-646-4398,50 mcg/mL Single Dose Glass Fliptop Vial (NDC 0409-3382-21),Reverified,9/12/22,Next Delivery and Estimated Recovery: March 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
9360,Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-01), 1mL vial, 10 pack",Revised,5/4/22,On backorder,,,Availability of API,Analgesia/Addiction;Pediatric,Current,,
9361,Sufentanil Citrate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,Information pending,New,5/3/22,Information pending,,,Information pending,Analgesia/Addiction;Pediatric,Current,,
9362,Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-02), 2mL vial, 10 pack",New,5/4/22,On backorder,,,Availability of API,Analgesia/Addiction;Pediatric,Current,,
9363,Sufentanil Citrate Injection,Akorn Pharmaceuticals,800-932-5676,"50 mcg/mL (NDC 17478-050-05), 5mL vial, 10 pack",New,5/4/22,On backorder,,,Availability of API,Analgesia/Addiction;Pediatric,Current,,
9364,Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,Blephamide (prednisolone acetate; sulfacetamide sodium) (NDC 11980-022-05) - 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,
9365,Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,Blephamide S.O.P. (sulfacetamide sodium 10% and prednisolone acetate 0.2%) 1 TUBE in 1 CARTON 3.5 g in 1 TUBE (NDC 0023-0313-04),New,9/13/21,,,,,Ophthalmology,To be Discontinued,,
9366,Sulfacetamide Sodium Solution,Abbvie,800-678-1605,Bleph-10® (sulfacetamide sodium) (NDC 11980-011-05) - 5 mL in 10 mL bottle,New,6/9/22,,,,,Ophthalmology,To be Discontinued,,
9367,Sulfasalazine Tablets,Chartwell Pharma,845-268-5000  Ext: 510,500 mg tablets; Bottle of 100 (NDC 23155-019-01),Revised,9/7/22,"Product Available. Distributed by Chartwell. For inquiries, call Customer Service number 845-268-5000  Ext: 510.",,,Other,Gastroenterology,Current,,
9368,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 100 (NDC 0013-0101-10),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9369,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 300 (NDC 0013-0101-20/0013-0101-30),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9370,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 100 (NDC 0013-0102-50),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9371,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 300 (NDC 0013-0102-20/0013-0102-60),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9372,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 100 (NDC 59762-0104-1/59762-0104-5),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9373,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 300 (NDC 59762-0104-6),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9374,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 100 (NDC 59762-5000-1/59762-5000-5),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9375,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 300 (NDC 59762-5000-6),Reverified,9/12/22,Available,,,Other,Gastroenterology,Current,,
9376,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 100 Count (NDC 00591-0796-01),Revised,10/5/22,Allocation,,,,Gastroenterology,Current,,
9377,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 1000 Count (NDC 00591-0796-10),Revised,10/5/22,Allocation,,,,Gastroenterology,Current,,
9378,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 500 Count (NDC 00591-0796-05),Revised,10/5/22,Allocation,,,,Gastroenterology,Current,,
9379,Sumatriptan (Sumavel DosePro) Injection,"Endo Pharmaceuticals, Inc.",800-462-3636,Sumavel DosePro (sumatriptan injection) 6mg/0.5mL (NDC 63481-367-06),New,2/27/18,,,,,Neurology,To be Discontinued,,
9380,Sumatriptan Succinate Injection,Teva Pharmaceuticals,800-545-8800,6 mg/0.5 mL  (NDC 0703-7351-01),New,12/5/19,,,,,Neurology,To be Discontinued,,
9381,Synercid Injection,Pfizer,844-646-4398,500 mg; 10 mL Single Dose Glass Vial  (NDC 61570-260-10),New,8/30/22,,Discontinuation of the manufacture of the drug.,,,Antibiotic,To be Discontinued,8/30/22,8/30/22
9382,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,0.5 mg 100’s count (NDC 67877-278-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9383,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,1 mg 100’s count (NDC 67877-279-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9384,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,5 mg 100’s count (NDC 67877-280-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9385,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,0.5 mg 100 count bottles (NDC 68462-685-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9386,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,1 mg 100 count bottles (NDC 68462-686-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9387,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,5 mg 100 count bottles (NDC 68462-687-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9388,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9389,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9390,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9391,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"0.5 mg, 100s (NDC 0378-2045-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,
9392,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"1 mg, 100s (NDC 0378-2046-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,
9393,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100s (NDC 0378-2047-01)",Revised,5/2/22,,,Available,,Transplant,Resolved,,
9394,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",0.5 mg 100 count (NDC 1672904101),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9395,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",1 mg 100 count (NDC 1672904201),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9396,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",5 mg 100 count (NDC 1672904301),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9397,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9398,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9399,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9400,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9401,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9402,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9403,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,1 mg 100 count bottles (NDC 64338-721-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9404,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,0.5 mg 100 count bottles (NDC 64380-720-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9405,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,5 mg 100 count bottles (NDC 64380-722-06),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9406,Tacrolimus Capsules,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-2102-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9407,Tacrolimus Capsules,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-2103-04),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9408,Tacrolimus Capsules,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-2104-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9409,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9410,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9411,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9412,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9413,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9414,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9415,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9416,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9417,Tacrolimus Capsules,"BPI Labs, LLC",727-471-0850 ext. 275,1 mg 100 count bottle (NDC 54288-135-01),Revised,5/2/22,,,Available,,Transplant,Resolved,,
9418,"Talwin (Pentazocine Lactate Injection, USP, CIV)","Hospira, Inc.",844-646-4398,30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01),New,4/16/18,,,,,Analgesia/Addiction,To be Discontinued,,
9419,Technetium Tc 99m Sulfur Colloid Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,5 Vial Kit (NDC 45567-0030-1),Revised,4/29/22,,,Available,,Medical Imaging,Resolved,,
9420,Technetium TC-99M Mebrofenin Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,5 vial kit (NDC 45567-0455-1),Revised,6/28/22,On backorder.,,,Other,Medical Imaging,Current,,
9421,Technetium TC-99M Mebrofenin Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,30 vial kit (NDC 45567-0455-2),Revised,6/28/22,On backorder.,,,Other,Medical Imaging,Current,,
9422,Technetium TC-99M Mebrofenin Injection,Bracco Diagnostics,877-272-2269,"CHOLETEC- mebrofenin injection, powder, lyophilized, for solution; Kit for the Preparation of Technetium Tc 99m Mebrofenin, supplied as 10 sterile multidose reaction vials per kit. (NDC 0270-0083-20)",Reverified,9/13/22,Available,,,Delay in shipping of the drug,Medical Imaging,Current,,
9423,Technetium Tc99m Succimer Injection (DMSA),Theragnostics Inc.,617-286-7479,ROTOP DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection). One vial contains 1.74 mg powder with the active substance: 1.0 mg succimer.  Five vials included in a carton (NDC 71647-001-01),Revised,1/7/21,Available,,,Other,Medical Imaging,Current,,
9424,Telmisartan and Amlodipine (Twynsta) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",203-798-4375,"Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37)",New,3/6/18,,,,,Cardiovascular,To be Discontinued,,
9425,Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1121,5mg capsules (NDCs 62559-920-51 and 62559-920-14),New,4/12/22,,,,,Oncology,To be Discontinued,,
9426,Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,20mg capsules (NDCs 62559-921-51 and 62559-921-14),New,4/12/22,,,,,Oncology,To be Discontinued,,
9427,Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,100mg capsules (NDCs 62559-922-51 and 62559-922-14),New,4/12/22,,,,,Oncology,To be Discontinued,,
9428,Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,140mg capsules (NDCs 62559-923-51 and 62559-923-14),New,4/12/22,,,,,Oncology,To be Discontinued,,
9429,Temozolomide Capsules,"ANI Pharmaceuticals, Inc.",800-434-1211,180mg capsules (NDCs 62559-924-51 and 62559-924-14),New,4/12/22,,,,,Oncology,To be Discontinued,,
9430,Teprotumumab-trbw,Horizon Therapeutics,866-479-6742,500 mg lyophilized powder (NDC 75987-130-15),Revised,3/31/21,Product available.,,,Other,Ophthalmology,Current,,
9431,Testosterone Transdermal Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",25mg/2.5g  (NDC 49884-418-72),New,8/29/22,,,,,Urology,To be Discontinued,8/29/22,8/29/22
9432,Testosterone Transdermal Gel,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",50mg/5g  (NDC 49884-510-72),New,8/29/22,,,,,Urology,To be Discontinued,8/29/22,8/29/22
9433,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"1 mg, 100 count bottle (NDC 0378-1001-01)",Revised,7/1/22,Limited Availability (until 6.30.22),,,Other,Psychiatry,Current,,
9434,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg, 100 count bottle (NDC 0378-2002-01)",Revised,7/1/22,Limited Availability (until 6.30.22),,,Other,Psychiatry,Current,,
9435,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100 count bottle (NDC 0378-3005-01)",Revised,7/1/22,Limited Availability (until 6.30.22),,,Other,Psychiatry,Current,,
9436,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"10 mg, 100 count bottle (NDC 0378-5010-01)",Revised,7/1/22,Limited Availability (until 6.30.22),,,Other,Psychiatry,Current,,
9437,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"1 mg, 100 count bottle (NDC 70954-014-10)",Reverified,3/16/22,Available,,,,Psychiatry,Current,,
9438,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"2 mg, 100 count bottle (NDC 70954-015-10)",Reverified,3/16/22,Available,,,,Psychiatry,Current,,
9439,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"5 mg, 100 count bottle (NDC 70954-016-10)",Reverified,3/16/22,Available,,,,Psychiatry,Current,,
9440,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"10 mg, 100 count bottle (NDC 70954-017-10)",Reverified,3/16/22,Available,,,,Psychiatry,Current,,
9441,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 2.5mL bottle (NDC 60505-1005-04),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9442,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 5mL bottle (NDC 60505-1005-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9443,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 7.5 mL bottle (NDC 24208-004-01)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9444,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 10 ml bottle (NDC 24208-004-03)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9445,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%,  2.5ml (NDC 68682-045-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9446,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%, 5ml (NDC 68682-045-50)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9447,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 5mL (NDC 64980-513-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9448,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25%  10 mL (NDC 64980-513-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9449,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 15 mL (NDC 64980-513-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9450,Timolol Maleate Ophthalmic Solution,FDC Limited,201-964-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 5mL (NDC 64980-514-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9451,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 10mL (NDC 64980-514-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9452,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 15mL (NDC 64980-514-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9453,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x5ml BTL (NDC 60758-802-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9454,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x10ml BTL (NDC 60758-802-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9455,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x5ml BTL (NDC 60758-801-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9456,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x10ml BTL (NDC 60758-801-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9457,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5% 5mg/mL, 5mL, 1 Bottle/EA (NDC 17478-0288-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9458,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 10mL, 1 Bottle / EA (NDC 17478-0288-11)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9459,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 15mL, 1 Bottle / EA (NDC 17478-0288-12)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9460,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 5 mL bottle, (NDC 61314-227-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9461,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 10 mL bottle (NDC 61314-227-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9462,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 15 mL bottle (NDC 61314-227-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9463,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 5 mL bottle, ()NDC 61314-226-05",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9464,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 10 mL bottle, (NDC 61314-226-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9465,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 15 mL bottle, (NDC 61314-226-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9466,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.25%, 5 mL in a 7.5 mL bottle (NDC 24208-812-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9467,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 5 mL in a 7.5 mL bottle (NDC 24208-813-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9468,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 10 mL in a 10 mL bottle (NDC 24208-813-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9469,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,Authorized Generic Timolol Maleate Ophthalmic Solution 0.5% 5 mL in a 7.5 mL bottle (NDC 68682-813-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9470,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE® (timolol maleate) Sterile Ophthalmic Solution, 0.25% 0.3 mL in 60 individual doses (NDC 0187-1498-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9471,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE®  (timolol maleate) Sterile Ophthalmic Solution, 0.5% 0.3 mL in 60 individual doses (NDC 0187-1496-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,,
9472,Tipranavir Oral Solution,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,100mg/mL (NDC 0597-0002-01),New,6/29/21,,,,,Antiviral,To be Discontinued,,
9473,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",2 mg  (NDC 49884-611-53),New,6/30/21,,,,,Neurology,To be Discontinued,,
9474,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",4 mg (NDC 49884-719-53),New,6/30/21,,,,,Neurology,To be Discontinued,,
9475,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",6 mg (NDC 49884-765-53),New,6/30/21,,,,,Neurology,To be Discontinued,,
9476,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,4 mg (NDC 0378-0724-19),New,11/21/19,,,,,Neurology,To be Discontinued,,
9477,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0722-19),New,11/21/19,,,,,Neurology,To be Discontinued,,
9478,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,
9479,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,
9480,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, bottle (NDC 39822-0412-1)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,
9481,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, pack of 6 bottles (NDC 39822-0412-6)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,,
9482,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"200mg/10mL, (NDC 50242-0136-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,
9483,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"400mg/20mL, (NDC 50242-0137-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,
9484,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"80mg/4mL, (NDC 50242-0135-01)",Revised,3/30/22,,,Available,,Rheumatology,Resolved,,
9485,Topotecan Injection,Teva,800-545-8800,NDC 0703-4714-01 (4 mg/4 mL (1 mg/mL) Single-Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
9486,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"4 mg tablets, 100 count (NDC 16252-543-90)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,
9487,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg tablets, 100 count (NDC 16252-542-90)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,
9488,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg tablets, 100 count (NDC 16252-541-30)",New,4/18/18,,,,,Cardiovascular,To be Discontinued,,
9489,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 30 Tablets per Bottle,  (NDC 60505-3638-3)",New,12/4/19,,,,,Hematology,To be Discontinued,,
9490,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 100 Tablets per Bottle,  (NDC 60505-3638-1)",New,12/4/19,,,,,Hematology,To be Discontinued,,
9491,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/1g (NDC 40085-029-80),New,3/20/18,,,,,Dermatology,To be Discontinued,,
9492,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1mg/1g (NDC 40085-029-16),New,3/20/18,,,,,Dermatology,To be Discontinued,,
9493,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,0.25mg/1g (NDC 40085-028-80),New,3/20/18,,,,,Dermatology,To be Discontinued,,
9494,Triamcinolone Acetonide Injectable Suspension,Novartis,888-669-6682,"40mg/mL vial, 1mL in 1 vial (NDC 0065-0543-01)",Reverified,9/30/22,Availability through wholesalers: not available. Estimated duration of supply shortage: 3-18 months.,,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
9495,Triamcinolone Hexacetonide Injectable suspension,Medexus,1-855-336-3322 Option 9,"Hexatrione 2% (triamcinolone hexacetonide) Injectable suspension, 20mg/ml, 2-mL glass ampoule (NDC 59137-570-01)",Revised,12/8/21,Available,,,,Rheumatology,Current,,
9496,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 0781-5068-01)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9497,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 0781-5068-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9498,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 0781-5067-01)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9499,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 0781-5067-05)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9500,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 68001-0216-00)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9501,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 68001-0216-03)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9502,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 68001-0215-00)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9503,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 68001-0215-03)",New,2/23/18,,,,,Cardiovascular,To be Discontinued,,
9504,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 30 (NDC 43386-660-03)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
9505,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 100 (NDC 43386-660-24)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
9506,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 500 (NDC 43386-660-26)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
9507,Trimethobenzamide Hydrochloride Capsules,Pfizer Pharmaceuticals,800-533-4535,"300 mg, bottle of 100 (NDC 61570-079-01)",Reverified,9/12/22,Discontinued,,,Discontinuation of the manufacture of the drug.,Gastroenterology,Current,,
9508,Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",Revised,10/26/21,Unavailable,,,Shortage of an active ingredient.,Gastroenterology,Current,,
9509,Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",New,10/26/21,,,,,Gastroenterology,To be Discontinued,,
9510,Umbrasilib Tosylate Tablets,"TG Therapeutics, Inc.",877-848-9462,"Umbralisib Tosylate (Ukoniq) Tablets, 200 mg (free base), 120 Tablets per bottle (NDC 73150-200-12)",Revised,5/31/22,,,,,Oncology,To be Discontinued,,
9511,Valproate Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9785-10)",Reverified,8/26/22,Currently on backorder.,,,Demand increase for the drug,Neurology,Current,,
9512,Valproate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg per 5 mL (100 mg per mL) (NDC 63323-494-05),Reverified,8/13/22,Backordered. Next release Q4 - 2022.,,,Manufacturing delays,Neurology,Current,,
9513,Valproic Acid Oral Solution,Wockhardt,800-346-6854,"250mg/5mL, 473mL (NDC 60432-0621-16)",New,4/11/22,,,,,Neurology,To be Discontinued,,
9514,Vancomycin Hydrochloride for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vancomycin Hydrochloride Injection (Lyophilisate in Single Dose Vials) [250 mg] (NDC 67457-822-99),New,7/26/21,,,,,Anti-Infective,To be Discontinued,,
9515,Vandetanib Tablets,Sanofi,800-633-1610,Vandetanib (Caprelsa) 100mg Tablets (NDC 58468-7820-3),Revised,9/9/22,Available,,,Shortage of an active ingredient,Oncology,Current,,
9516,Vandetanib Tablets,Sanofi,800-633-1610,Vandetanib (Caprelsa) 300mg Tablets (NDC 58468-7840-3),Revised,9/9/22,Out of stock.,,,Shortage of an active ingredient,Oncology,Current,,
9517,Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2",Starter Pack (NDC 49884-944-99),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9518,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg; bottle of 56 tablets (NDC 60505-4765-5),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9519,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg; bottle of 56 tablets (NDC 60505-4766-6),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9520,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg and 1 mg; Starter Blister Pack of 53 tablets; (NDC 60505-4767-0),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9521,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg: Continuation Blister Pack of 56 tablets (NDC 60505-4766-5),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9522,Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","0.5 mg, 56 ‘s count bottle pack (NDC 49884-155-76)",Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9523,Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","1 mg, 56 ‘s count bottle pack (NDC 49884-156-76)",Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9524,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 0.5 mg; bottle of 56 (NDC 0069-0468-56),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9525,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 1 mg; bottle of 56 (NDC 0069-0469-56),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9526,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Starting wallet; 0.5 mg 1x11 1 mg FCT 3x14 BLS WL US (NDC 0069-0471-03),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9527,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Continuing wallet; 1 mg FCT 4x14 BLS WL US (NDC 0069-0469-03),Revised,5/26/22,,,,,Analgesia/Addiction,Resolved,,
9528,Vecuronium Bromide for Injection,Teva Pharmaceuticals,800-545-8800,NDC 0703-2914-03 (10 mg (1 mg/ml when reconstituted to 10 mL) 10 x 10 mL Vials),Revised,7/20/22,,Product is temporarily unavailable and no future production expected for an extended period.,,,Anesthesia,To be Discontinued,7/20/22,7/20/22
9529,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,10 mg Single Dose Glass Fliptop Vial (NDC 00409-1632-01),Reverified,9/12/22,Available,,,Other,Anesthesia,Current,,
9530,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,20 mg Single Dose Glass Fliptop Vial (NDC 00409-1634-01),Revised,8/30/22,,,,,Anesthesia,To be Discontinued,8/30/22,8/30/22
9531,Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [10 mg](NDC 67457-438-10),Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9532,Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [20 mg](NDC 67457-475-20),Reverified,9/28/22,Backordered,Re-supply October 2022.,,Demand increase for the drug,Anesthesia,Current,,
9533,Vecuronium Bromide for Injection,Fresenius Kabi,888-386-1300,10 mg/vial (NDC 63323-781-10),Revised,9/28/22,Available,,,,Anesthesia,Current,,
9534,Vecuronium Bromide for Injection,Fresenius Kabi,888-386-1300,20 mg/vial (NDC 63323-782-20),Revised,9/28/22,Available,,,,Anesthesia,Current,,
9535,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,10 mg (NDC 47335-931-44),Reverified,9/23/22,Available,,,,Anesthesia,Current,,
9536,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,20 mg (NDC 47335-932-44),Reverified,9/23/22,Available,,,,Anesthesia,Current,,
9537,Vecuronium Bromide for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"10 mg/vial, packages of 10 (NDC 55150-235-10)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9538,Vecuronium Bromide for Injection,Eugia Pharma Specialties LTD. (formerly Aurobindo),888-238-7880,"20 mg/vial, packages of 10 (NDC 55150-236-20)",Reverified,9/28/22,Available,,,Demand increase for the drug,Anesthesia,Current,,
9539,Vecuronium Bromide Injection,Teva,800-545-8800,NDC 0703-2914-03 (10 mg (1 mg/mL when reconstituted to 10 mL) 10 x 10 mL Vials),New,8/11/22,,Product is currently unavailable and no future production expected for an extended period.,,,Anesthesia,To be Discontinued,8/11/22,8/11/22
9540,Verapamil Hydrochloride Tablets,Pfizer,800-533-4535,240 mg; Bottle of 100 caplets (NDC 0025-1891-31),New,9/8/22,,Supply expected to exhaust late September 2022; Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,9/8/22,9/8/22
9541,Vibramycin Hyclate (Doxycycline Hyclate) for Suspension,Pfizer Pharmaceuticals,800-533-4535,25 mg/5 mL oral suspension; 1 x 60 mL bottle (NDC 0069-0970-65),New,11/16/21,,,,,Anti-Infective,To be Discontinued,,
9542,Vincristine Sulfate (Vincasar PFS) Injection,Teva,800-545-8800,NDC 0703-4402-11 (1 mg/mL 1 mL Single-Dose Vial),New,8/11/22,,Product is available with an expected supply duration until AUG 2022.  No future production expected for an extended period.,,,Oncology,To be Discontinued,8/11/22,8/11/22
9543,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-06),New,4/16/18,,,,,Oncology,To be Discontinued,,
9544,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 50 mg/5mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-09),New,4/16/18,,,,,Oncology,To Be Discontinued,,
9545,Vitamin A Palmitate (Aquasol A) Injection,"Casper Pharma, LLC",844-522-7737,"50,000 USP units/mL (15 mg retinol), single dose vial (NDC 70199-0026-11)",Revised,4/14/22,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,,
9546,Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Zafirlukast 10 mg Tablets, (NDC 49884-549-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,
9547,Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Zafirlukast 20 mg Tablets, (NDC 49884-554-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,
9548,Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Accolate® Zafirlukast 10 mg Tablets, (NDC 49884-589-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,
9549,Zafirlukast Oral Tablets,Par Pharmaceutical,800-828-9393,"Accolate® Zafirlukast 20 mg Tablets, (NDC 49884-590-02)",New,3/17/22,,,,,Pulmonary/Allergy,To be Discontinued,,
9550,Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, bottle of 250 (NDC 57844-215-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,,
9551,Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, bottle of 250 (NDC 57844-208-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,,
9552,Zolpidem Tartrate (Edluar) Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0037-6010-30),Revised,11/21/18,,,Available,,Psychiatry,Resolved,,
9553,Zolpidem Tartrate Oral Spray,Aytu BioPharma,855-298-8246,5 mg per spray (NDCs 69654-510-30 and 69654-510-60),New,6/13/22,,,,,Psychiatry,To be Discontinued,,
9554,,Etomidate Injection,"Caplin Steriles, Ltd.","2 mg/mL, 20 mL vial (NDC 25021-674-20)",New,10/5/22,Available,Marketed by Sagent,,,Anesthesiology,Current,,